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Abstract 
 
The roles of hepatocyte growth factor family members in 
androgen-regulation of human hair growth 
 
Saeed A. Al-Waleedi 
 
Keywords: HGF, MSP, c-Met, RON, hair follicles, androgen, androgenetic alopecia,                                                          
                   PCR, gene microarray, balding, immunohistochemistry. 
 
 
Androgens are the main regulators of human hair growth stimulating larger, terminal hair 
development e.g. beard and causing scalp balding, androgenetic alopecia. Hair disorders 
cause psychological distress but are poorly controlled. Androgens probably act by 
altering regulatory paracrine factors produced by the mesenchyme-derived dermal 
papilla. This study aimed to investigate paracrine factors involved in androgen-regulated 
alopecia, particularly hepatocyte growth factor (HGF) family members, by investigating 
their in vivo status.  
Balding and non-balding scalp hair follicles and their component tissues were isolated 
and analysed by molecular biological methods (reverse transcriptase-polymerase chain 
reaction (RT-PCR), quantitative PCR and DNA microarray analysis), cell culture and 
immunohistochemistry. Scalp follicles expressed a range of paracrine messenger genes. 
The dermal papilla, cultured dermal papilla cells and dermal sheath expressed several 
HGF family genes, while matrix cells only produced the receptor RON suggesting 
autocrine roles for HGF and MSP, but a paracrine route only for MSP.  
Comparing balding and non-balding follicles from the same individuals revealed the 
expected reduction in several keratin and keratin-related protein genes supporting this 
approach’s validity. There were also significant differences in paracrine factors 
previously implicated in androgen action by in vitro studies. Several factors believed to 
increase during androgen stimulation of larger, darker follicles, e.g. IGF-I and SCF, were 
lowered in balding follicles, while putative inhibitory factors, e.g. TGFß-1, were 
increased. HGF and MSP and their receptors, c-Met and RON, were significantly 
reduced. These results increase our understanding of androgen action in human hair 
follicles; this could lead to better treatments for hair disorders.  
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1- Introduction 
1.1 Hair functions & its importance:   
Mammals have hair all over their bodies as a unique character which differentiates them 
from other animals in the Animal Kingdom (Valkovic, 1977; Porter, 2003). Previously, 
mammals were named Pilifera or hair bearers, from the latin word "pilus" for hair 
(Ebling, 1976). Most human skin produces hair, except for some particular parts of the 
body, the glabrous skin, including the lips, palms of the hands and soles of the feet 
(Ebling, 1986).  
 
Hairs are greatly variable in colour, diameter, length, and cross-sectional shape (Schlake, 
2007). There are three main types of hair: lanugo, vellus and terminal. Lanugo hair is soft 
and fine, and is formed in foetal life. This type of hair starts growing on human embryo 
skin at about the 20
th  
week of pregnancy, and then sheds in uterus at about the 36
th
 week 
of pregnancy. After birth, an infant has two types of hair, vellus and terminal. Vellus hair 
is short, small, fine, unmedullated and unpigmented hair. It is located in areas of the body 
described as hairless regions, for instance the facial hair of a child or adult women 
(Blume et al., 1991). Terminal hair is long, thick and pigmented, often with a medullated 
hair shaft. It grows on various parts of the human body such as the scalp, face, eyelashes, 
eyebrows, arms, legs and axillae (Gray & Dawber, 1998; Randall, 2007).   
      
In mammals, hair performs several functions. It plays an important role in thermal 
insulation and regulation of body temperature by trapping a layer of air next to the skin or 
by allowing heat loss when flattened (Vaughan, 1986). Hair provides protection from 
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extreme temperatures to enable some mammals to live in some of the most difficult 
environments on earth, for example polar bears and seals at the North Pole. Hair also 
serves as a physical barrier to protect the skin from harmful rays such as ultraviolet rays 
(Oliver & Jahoda, 1989). Hair provides, through its coloration, camouflage for animals 
against their environment (Flux, 1970; Stenn and Paus, 2001). Animals change their coats 
seasonally to adapt to seasonal changes in their surrounding environment. For example, 
the arctic hare produces a brown coat during the summer and a white coat during the 
winter to remain camouflaged (Severaid, 1945). In addition, hair may play sensory 
functions in certain mammals and act as a neuroreceptor, for example whiskers. Hair may 
also serve as a visible signal which may play a role in social and sexual communication, 
for instance the production of the mane in the lion (West and Packer, 2002). 
 
However, in human beings many of these functions are reduced. The main functions of 
human hair are protection and communication. Eyebrows and eyelashes protect eyes from 
incoming objects (Martini, 1998). Scalp hair protects the head and neck from the harmful 
effects of sunlight, ultraviolet light, cold and physical damage (Goodhart, 1960; Martini, 
1998; Costin and Hearing, 2007). In addition, scalp hair provides insulation for the head 
due to the lack of adipose tissue on the scalp. Thermoregulatory function is less important 
in human beings, however the small amount of terminal hair on the human body helps to 
cool the body through evaporation from sweat glands (Ebling, 1985). 
  
One of the most important functions of human hair is social and sexual communication. 
Hair plays a role in beauty; strong healthy hair indicates good health to others, whereas 
sparse and brittle growth of the hair indicates poor nutrition and bad health (Bradfield, 
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1971). Hair removal generally has strong depersonalizing roles, for instance shaving 
prisoners and Christian or Buddist monks, while long uncut hair has positive 
connotations like strength and its association with religion in Sikhs (Randall, 2008). 
There are clear differences in hair type and distribution between males and females, and 
between adults and children. The growth of pubic and axillary hair is a sign of maturation 
and puberty (Reynolds, 1951; Marshall and Tanner, 1969, 1970; Randall, 2007). 
 
In addition, hair disorders such as hirsutism or excessive hair growth and alopecia or hair 
loss can have negative effects on the quality of life such as social restriction and 
psychological distress to those who suffer from them (Randall, 2008). Although hair loss 
is not life threatening in human beings, the important communication roles of hair explain 
its importance for most people (Jansen and Van Baalen, 2006). Since hair plays a vital 
role in a person's appearance, self image and communication, this provides an insight into 
why it is possible for hair growth disorders to be at the root of serious psychological 
distress (Girman et al., 1998; Gulec et al., 2004). Unfortunately, many hair disorders can 
not currently be effectively treated, mainly due to our lack of understanding of hair 
follicle function. Therefore a greater understanding of the mechanisms regulating hair 
growth, leading to the control of these conditions is of great interest worldwide.       
1.2 Hair structure:  
Hair is a fully keratinised flexible structure of epithelial cells which originates from hair 
follicles that extend down to various lengths into the dermis and often into the 
subcutaneous adipose tissue (Montagna & Van Scott, 1958; Montagna, 1976). The hair 
follicle has a complex structure which results from epithelial-mesenchymal interactions 
- 08 - 
 
initiated around the 3rd month of embryonic development (Sengel, 1983; Hardy, 1992; 
Gorpinich and Nozdrin, 2007). A typical hair consists of two main parts; the first part is 
the hair shaft which is located above the level of the epidermis. The other part is the hair 
root which is enclosed within the hair follicle under the level of the epidermis (Slobodan 
and Snezana, 1998), (figure 1.1).    
 
 
 
 
                                 
 
 
 
 
 
 
 
 
 
Figure 1.1 A schematic diagram showing the hair follicle and associated structures.  
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The hair shaft is formed of a type of protein called keratin. Outside the skin, hair consists 
of dead epithelial cells which form flexible, thin, fully keratinized tubes. The hair shaft is 
composed of three layers: the medulla in the centre of the hair shaft, which is surrounded 
by another layer called the cortex, which is surrounded by an outer layer called the cuticle 
(Chase, 1954; Schlake, 2007).  
 
The cortex is made of millions of parallel microfibrils which are assembled in bundles to 
make macrofibrils, which run parallel to the long axis of the hair (Gray & Dawber, 1998). 
Macrofibrils are intertwined like a heavy rope, to give the hair strength and elasticity. 
Cortical cells appear without nuclei, although sometimes there are some visible remains 
of nuclei in the centre of each cell. Each cortical cell is about 100 µm in length and no 
more than 5 µm in width, but this varies between species (Ryder, 1973). The cortex is the 
major site of keratinization and therefore it is essential for hair shaft strength (Langbein et 
al., 2001).  
 
The medulla is an air space which is located in the centre of the hair. The medulla is 
missing in much human hair, but is well developed in animals to provide the insulator 
properties of animal hair. Not all types of hair have medulla, such as thin hair, however it 
is most obviously present in large thick terminal hair and it can be continuous or 
discontinuous. Hair fibres with a continuous medulla, such as eyelashes, are stiff in 
character (Forslind, 2000). There are three main kinds of medulla: the latticed type, non 
latticed type, and ladder type (Ryder, 1973).  
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The cuticle is the thin outer layer which covers the hair. This layer is colorless and 
protects the cortex. It has flat, thin, unpigmented and transparent cells which overlap to 
give a structure like scales (figure 1.2).  There are tiny regular spaces between cuticle 
cells, almost 10 µm. Cuticle cells overlap from the root to the tip of the hair shaft to make 
the outer layer of the hair. The cuticle thickness is nearly 6-10 cells (Valkovic, 1977). 
This layer can easily become damaged by mechanical or chemical treatments.   
 
 
 
 
 
 
 
 
 
 
The hair root is a part of the hair which is within the skin under the level of the epidermis 
and enclosed within the hair follicle. Each hair arises from a long narrow pocket inside 
the skin which is called the hair follicle. Hair follicles are continuous with the epidermis; 
their cylindrical epithelial layers grow to various depths downwards into the dermis and 
in some species project into the subcutaneous adipose layer. Each follicle can be divided 
morphologically into three parts: the upper infundibulum, the middle isthmus and the 
inferior part which includes the hair bulb (Sperling, 1991; Gray and Dawber, 1998).  
Figure 1.2 Scanning electron micrograph of the hair shaft shows the cuticle which 
appears as scales. Reproduced from Wolfram (2003), with the author's permission.                                        
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The follicle is surrounded by two main layers: the inner and outer root sheaths. The inner 
root sheath surrounds the hair fibre from the bulb up to the level of the sebaceous gland 
allowing the hair fibre elasticity (Forslind, 2000). It is in contact with the hair cuticle and 
contains three sub-layers: the inner layer is the cuticle which is in touch with the hair 
cuticle to form a structure like a zip. The middle layer is Huxley's layer which contains 
square cells that are arranged in one row. The outer layer of the inner root sheath is 
Henle's layer; its cells are polygonal, flattened and arranged in one row (Hardy, 1992; 
Kaufman, 2003; Alibardi, 2004). Around the outside of the outer root sheath is a layer of 
connective tissue which separates the follicle from the dermis. It divided into two parts: 
the outer reticular and inner papillary layers (Bartosova et al., 1984). There is a vitreous 
membrane between the outer root sheath and the connective tissue sheath (Bernard, 
2006), (figure 1.3). 
 
The bottom of the follicle is the hair bulb where the epithelial cells surround the 
mesenchyme-derived dermal papilla, a pear-shaped structure located within its centre. 
The dermal papilla plays an important role throughout the hair follicle development and 
life cycle, as it contains specialised fibroblasts, known as dermal papilla cells, which are 
surrounded by extracellular matrix containing mucopolysaccharides and basement 
membrane proteins (Couchman, 1986; Couchman et al., 1990). The non-cellular part of 
the dermal papilla includes collagen types I and III, and fibronectin (Messenger et al., 
1991). The size of the dermal papilla and its cells is proportional to the size of the hair 
follicle, and therefore the hair fibre produced (Van Scott and Ekel, 1958; Ibrahim and 
Wright, 1982; Elliott et al., 1999). The dermal papilla is almost completely surrounded by 
the epithelial matrix, except a small gap at the base of the hair bulb, to allow blood 
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vessels and nerves to enter the papilla. The epithelial matrix is separated from the dermal 
papilla by a trilaminar basement membrane (Nutbrown and Randall, 1995). It is believed 
that the dermal papilla plays main roles in controlling the hair follicle development and 
the production of hair fibres, both during embryogenesis and during the hair growth cycle 
(Jahoda, 1992; Jahoda, 2003); see section 1.5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3  The structure of the hair root                                          
Isometric view of a human hair follicle cut away to show component 
parts, Reproduced with permission, Randall (1994).                                                                                       
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The epithelial hair matrix contains very actively dividing cells which can differentiate, 
under a high level of organisation and control, into the different cell types of the inner 
root sheath and the hair fibre (Camacho et al., 2000; Bernard, 2006). The production of 
hair in the actively growing follicle is a result of rapid cell division of the epithelial 
keratinocytes in the hair matrix. The critical level is an imaginary line across the widest 
diameter of the follicular bulb into two distinctive regions (Auber, 1952). Below the 
critical level, the matrix cells have a high rate of mitosis but appear undifferentiated. 
Above the critical level, the rate of mitotic activity is decreased and cells become 
differentiated into either the inner root sheath or hair fibre cells.  
 
Within the hair matrix, there are a number of melanocytes located above and to the sides 
of the dermal papilla. Follicular melanocytes are derived from epidermal melanocytes 
during hair follicle morphogenesis (Magerl et al., 2001; Tobin, 2008). These cells are 
responsible for production of the hair pigment. Pigmentation is a highly controlled 
process, as melanin incorporation occurs only in the hair shaft. The amount and type of 
pigment, melanin, and the balance of brown/black eumelanin and red/yellow 
phaeomelanin in the hair shaft determines the hair colour (Slominski et al., 2004; 
Slominski et al., 2005; Rousseau et al., 2007). Every division of the matrix cells results in 
a migration of the cells upward from the bulb to the narrower linear region of the follicle, 
cells become elongated and keratinisation takes place. This process continues as the cells 
migrate through the follicle, eventually becoming fully keratinised by the time they reach 
the surface of the skin.  
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There are some important structures of ectodermal or mesodermal origin which are 
associated with the hair follicle. The sebaceous gland and the arrector pili muscle, as part 
of the pilosebaceous unit, are important parts of organized follicular unit structure (Poblet 
et al., 2004). The sebaceous glands produce a waxy secretion into the follicle through the 
sebaceous duct, inducing a waterproof coating over the hair fibre. Apocrine sweat glands 
are also present above the sebaceous ducts in some follicles such as those found in axillae 
and genital areas (Hurley, 2001). The apocrine glands discharge into the upper portion of 
the hair follicle and can be a possible origin of pheromones (Spielman et al., 1995). The 
hair follicle contains stem cells, involved in the regeneration of the follicle during hair 
growth cycle. These cells are located in the outer root sheath and in the bulge area, the 
site of arrector pili muscle attachment (Taylor et al., 2000; Oshima et al., 2001; Waters et 
al., 2007; Morris, 2007). This muscle allows adjustment of the hair for thermoregulation, 
for instance erection of hair on skin in response to cold temperature. 
1.3 Hair growth cycle:  
The hair follicle grows in cycles. However, hair cycles in human beings do not occur at 
the same time for all hairs. Morphologically, the hair cycle process is well understood, 
but is still not clarified at the molecular level. Each hair cycle consists of successive 
stages of growth and involution, which include tissue regression and regeneration. The 
hair growth cycle includes three main stages: the growth phase, anagen, the transitional 
phase, catagen, and the resting phase, telogen (Chase, 1954; Kligman, 1959), (figure 1.4). 
A fourth phase, exogen, is involved in releasing the old hair via an active enzymatic 
releasing process (Forslind, 2000; Stenn, 2005, Higgins et al., 2009). The duration of 
each stage varies between species.            
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Anagen, or the growth phase, extends from the termination of the resting phase, which is 
called telogen, to the beginning of the regression phase, which is called catagen. The 
duration of anagen determines the length of the hair, and depends on the hair follicle 
locaton. For instance, eyebrow hair follicles are in anagen for about two to three weeks 
producing short hairs, whereas scalp hair follicles are in anagen from 2-8 years resulting 
in long hair (Saitoh et al., 1970; Paus and Cotsarelis, 1999). During anagen, the hair 
grows in length by addition of cells to the bottom end, the hair bulb lies deep inside the 
skin and elongates, the hair matrix cells divide to produce cells which grow upward and 
become longer and keratinize to make the growing hair. Melanocyte cells begin to give 
the hair colour. In the meantime, the inner root sheath, which covers the tip of the 
Figure 1.4 Diagram represents the successive phases of human scalp hair growth cycle. 
Reproduced with permission of the BMJ publishing group, from Sinclair (1998).        
     Reproduced with permission of the BMJ publishing group, from Sinclair (1998).   
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growing hair, ruptures to enable the growing hair to penetrate the skin and grow up 
outside the skin (Jarrett, 1977).  
 
The anagen phase is followed by the catagen phase which is a highly controlled process 
involving regression, degradation and cessation of new hair cell production. This phase 
lasts about 2-3 weeks in human scalp (Kligman, 1959). During this phase, the dermal 
papilla becomes smaller, containing less extracellular matrix and its cells have only a 
little amount of cytoplasm (Sugiyama et al., 1976). The dermal papilla is released from 
the bulb, the inner root sheath is lost, the pigmentation process and cell division are 
stopped. The lower part of the hair becomes short with an enlarged end, and becomes 
fully keratinized to form a "club" hair which shrinks and moves towards the skin surface 
until it reaches the level of the sebaceous gland. The dermal papilla forms an assembly of 
flattened and compact dermal cells. At the end of catagen, the ball of the dermal papilla 
cells moves up in the skin to settle below the swollen end of the club hair, under the area 
of hair germ (Montagna and Ellis, 1985). If the dermal papilla fails to reach the bulge 
level, the cycle stops and the hair is lost (Paus and Cotsarelis, 1999). The involution of 
the club hair results in apoptosis of the epithelial components of the hair follicle (Weedon 
and Strutton, 1981; Lindner et al., 1997; Matsuo et al., 1998; Botchkareva et al., 2006).  
 
The catagen phase is followed by a period of rest called telogen. During this phase, the 
follicle becomes inactive and the activities of the dermal papilla are stopped. A telogen 
hair is distinguished by its fully keratinized club hair which is surrounded by thick 
epithelial sac. Below this lies the condensed dermal papilla waiting for the signal to start 
a new hair cycle (Sperling, 1991; Schmidt-Ullrich and Paus, 2005; Jahoda, 2001). The 
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telogen phase lasts around approximately 3 months on the human scalp before re-entering 
anagen phase (Kligman, 1959). After the end of telogen, the hair cycle starts again by 
beginning cell division that leads to reactivation of the hair follicle to begin a new growth 
cycle. The dermal papilla cells are reactivated and move back down into the dermis with 
associated keratinocytes. A new hair bulb is formed, a new hair grows up, the existing 
hair is shed. Previously, it was believed that the new hair pushed the old hair out as a 
result of the physical movement of the new hair upward. Recently, the exogen stage has 
been suggested, which includes an active shedding process of the old hair involving 
enzymatic release (Stenn et al., 1998; Stenn and Paus, 2001; Stenn, 2005; Higgins et al., 
2009). Some recent studies suggest that it is not unusual for the previous hair to be 
retained for more than one hair cycle in rodents (Milner et al., 2002), so this suggests that 
the anagen phase and exogen phase are separate events (Randall, 2007), (figure 1.5). 
Overall, the hair follicle exhibits a highly complex organised architecture and represents 
an attractive experimental system because of its accessibility, dispensability and self-
renewal capacity (Schlake, 2007). 
 
 
 
 
 
 
 
 
Figure 1.5 Diagram showed the different stages of human hair 
growth cycle including anagen, catagen, telogen and exogen. 
Reproduced with the author's permission, Randall (2008). 
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1.4 Hair follicle embryogenesis: 
Human hair follicles first develop late in the second trimester of pregnancy in the regions 
of the developing eyebrow, chin, and upper lip (Pinkus, 1958) and their development is 
completed by the 6th month of foetal life (Gorpinich and Nozdrin, 2007). The process of 
hair formation is a highly co-ordinated process, involving cell-cell communication, cell 
division and cell differentiation. The development of embryonic hair follicles starts as a 
result of interaction between epithelial and mesenchymal cells (Mikkola and Millar, 
2006; Fuchs, 2007). An early embryonic epidermis comprises the periderm, the 
intermediate layer and the basal layer. The pre-germ formation is considered the first 
event of the embryonic development of the hair follicle. This stage initiates as a result of 
localized thicking of the basal layer of the epidermis and an aggregation of mesenchymal 
cells at the junction between the epidermis and dermis (Schmidt-Ullrich and Paus, 2005); 
(figure 1.6). Epidermal and mesenchymal cells continue to develop and start to grow 
downward at an oblique angle to form a slight bulge on the underside of the epidermis 
called the hair germ (Pinkus, 1958; Holbrook and Minami, 1991) which elongates and 
grows deeper into the dermis to form a column of cells called the hair peg. 
 
The free end of the hair peg flattens and enlarges to form a concave-shaped structure 
which is called a bulbous hair peg that eventually encloses the mesenchymal cells to form 
the dermal papilla (Breathnach & Smith, 1968; Robins and Breathnech, 1969). By this 
stage, the melanocytes are mainly localised in the epithelial part of the follicle to form a 
cap over the dermal papilla (Mishima and Widlan, 1966). The hair matrix arises from the 
epidermal cells surrounding the dermal papilla. As the bulbous hair peg elongates, the 
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matrix cells differentiate into the different cell types of the inner root sheath and the hair 
fibre. The development of epithelial cells, which connect the matrix to the interfollicular 
epidermis, forms the outer root sheath, whereas mesenchymal cells, which surround the 
epithelial cells, form the connective tissue sheath. On the posterior side of the follicle, 
two epithelial buds or swellings begin to grow. The most superficial one evolves into one 
or more sebaceous glands, whereas the lower bud forms the bulge area to which the 
arrector pili muscle attaches. In addition, at some certain areas of the body such as axilla 
and groin, follicles develop a third bud situated above the sebaceous gland to form 
apocrine glands.   
 
The hair canal is formed by degeneration of cells in the centre of the bulbous hair peg. 
Meanwhile, epithelial cells almost completely surround the dermal papilla which remains 
attached by a narrow stalk to a basal plate of dermal cells. At this stage, the hair fibre and 
canal begin keratinisation. The different components of the hair follicle proceed to 
differentiate and the hair fibre continues to grow upwards until the hair emanates from 
the epidermis. The hair fiber eruption is preceded by elevation of the epidermis and 
avulsion of the canal roof. In the mean time, the hair follicle keeps its elongation and 
continues to grow downward into the epidermis until it attains its full size within the skin 
(Muller et al., 1991; Hardy, 1992; Paus et al., 1999; Wu-Kuo and Chuong, 2000; 
Schmidt-Ullrich and Paus, 2005; Fuchs, 2007). Hair follicles can therefore serve as an 
excellent model for investigating aspects of cell-cell interaction, patterning processes, cell 
differentiation, stem cell biology and cell lineage specification (Schlake, 2007). 
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Figure 1.6 Development of the hair follicle. Schematic diagram represents the 
different stages of hair follicle embryogenesis.  Adapted from Randall (1994), with the 
author's permission. 
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1.5 The role of the dermal papilla in hair follicle growth and maintenance: 
The hair follicle consists of structures derived from ectodermal and mesenchymal origins. 
Epithelial and mesenchymal interactions are important for both hair follicle development 
and cycling. There is a series of messages between the dermal and epithelial cells of the 
hair germ during the early stage of hair follicle development (Fuchs, 2007). These early 
messages have been illustrated by several tissue recombination experiments on 
embryonic skin from several species (Sengel, 1983; Hardy, 1992; Ferraris et al., 2000).  
 
The dermal papilla is an important feature of hair follicle development and a permanent, 
discrete entity throughout the hair cycle of the hair follicle. The adult dermal papilla 
demonstrates similar features to its mesenchymal origin (Messenger, 1993; Rendl et al., 
2005). Dermal papilla cells play a crucial role in inducing new follicular development 
and determining the type of hair produced (Jahoda et al., 2001). When the dermal 
papillae were amputated from anagen vibrissae follicles, this led to hair growth cessation 
(Oliver, 1966; Link et al., 1990), indicating that the dermal papilla plays an important 
role in hair follicle regulation.  
 
Similarly, it has been reported that re-implanting cultured dermal papilla cells into the 
base of hair follicles after removal of their lower parts, enabled such follicles to 
reconstruct; the re-implantation led to organisation of the outer root sheath cells around 
the dermal papilla to form an epithelial matrix and reformation the hair bulb (Oliver, 
1967; Jahoda et al., 1984). When the germinative epithelium, from the hair bulb matrix, 
was co-cultured with dermal papilla cells, growth occurred and organoid structures were 
formed, but no growth was observed when these cells were cultured alone without dermal 
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papilla cells or even with 3T3 feeder cell layers (Reynolds and Jahoda, 1991). This 
suggests the capability of dermal papilla to induce hair growth. More evidence to testify 
the importance of the dermal papilla in hair growth is that implanting cultured rat 
vibrissae dermal papilla cells superficially in the skin stimulated new hair follicle 
formation (Jahoda and Oliver, 1984). In other experiments, when cultured rat pelage 
dermal papilla cells were implanted into rat foot-pad skin, which does not contain any 
hair follicles normally, they also stimulated new follicle development indicating that the 
adult dermal papilla still has the capability to stimulate new hair follicle growth 
(Reynolds and Jahoda, 1991; 1992). 
  
Importantly, it has been observed that the dermal papilla cells derived from rat vibrissae 
follicles induced the formation of new vibrissae follicles in rat ear wound (Jahoda, 1992). 
This indicates that the determination of the hair follicle and then the type of hair 
produced depends on the original site of which the dermal papilla was taken, not the 
transplantation site (Reynolds and Jahoda, 1992; Jahoda et al., 1993). This observation 
concurs with the concept of the surgical transplantation of hair follicles in which 
transferring hair follicles from non-balding scalp areas to cover balding sites of the scalp 
(Orentreich and Durr, 1982; Orentreich, 1985; Epstein 2007). Dermal papilla signals can 
also cross tissue and species. Embryonic dermal cells were able to reprogram adult 
corneal epithelial cells to form epidermis or epidermal appendages (Ferraris et al., 2000). 
A recent study showed that the dermal papilla cells derived from rat and mouse vibrissae 
also had the ability to induce new hair follicle structures in rabbit corneal epithelium 
(Richardson et al., 2007) and human dermal papilla cell signals can alter rodent hair 
follicle cells both in vitro and in vivo (Hamada and Randall, 2006). 
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Some studies indicated that the germinative epithelium and dermal sheath can play an 
inducible role in hair follicle formation. When germinative epithelial cells and vibrissae 
dermal sheath cells were implanted into the skin of rat ear, they failed to stimulate hair 
growth individually, but when they were implanted together into the ear wound they 
stimulated the formation of new follicles (Reynolds and Jahoda, 1996). This suggests that 
the cells of the dermal sheath require a signal from the germinative epithelial cells to 
modify their differentiation status to behave as dermal papilla cells and stimulate hair 
follicles construction. More recently, using fluorescently-labelled cells in vivo, it was 
observed that cells from the dermal sheath cup surrounding the hair bulb had a similar 
role as dermal papilla cells in inducing hair follicle (McElwee et al., 2003). It has been 
reported that this transformation of dermal sheath cells into dermal papilla cells is not 
completely unidirectional when labelled dermal papilla cells formed new dermal sheath 
in induced follicles (Inamatsu et al., 2006). Overall, these experiments clearly 
demonstrate an important regulatory role for the mesenchyme-derived dermal papilla and 
the dermal sheath surrounding the hair bulb in regulating the type of hair produced by a 
follicle. 
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1.6 The involvement of androgens in human hair growth: 
The hair follicle growth cycle allows the hair produced from the follicle to change and 
adapt to seasonal variation or changes in sexual development. The mechanisms involved 
in the complicated processes of the hair growth cycle are not well understood.  
 
In mammals, seasonal variation can be detected in the changing of coat thickness and 
colour induced by temperature, day length, and nutrient availability (Chase, 1954; 
Galbraith, 1998). These changes in the environment are translated to the follicle via the 
endocrine system, mainly through the pineal and hypothalamus-pituitary route (Ebling et 
al., 1991; Randall, 2007). The hormones involved differ between the species, but 
generally include gonadal hormones, thyroid hormones, corticosteroids, prolactin, and 
melanocyte stimulating hormone (MSH). 
  
In human beings, a few weeks after birth a wave of hair shedding occurs (Pecoraro, 
1968), after this the hair cycle is asynchronous except for the local groups of three 
follicles called DeMijère trios (Saitoh et al., 1970). Circannual variation in the rate of the 
human hair growth has been observed on the scalp, thigh, and beard (Orentreich, 1969; 
Randall and Ebling, 1991; Courtois et al., 1996). Hair growth in human beings is affected 
by various factors such as glucocorticoids (Stenn et al., 1993), thyroid hormones (Jackson 
et al., 1972), pregnancy (Lynfield, 1960), circulating hormones (Randall, 2007) and 
nutrient levels (Bradfield, 1971; Rushton, 2003). However, androgens are the major 
regulating hormones of hair growth (Ebling, 1986; Randall et al., 2008). Human hair 
follicles, which are distributed in various parts of the body, have an innate tendency for 
androgen-dependent growth (Nyholt et al., 2003). Almost all human hair follicles are 
- 35 - 
 
influenced by androgens except some specific areas of the body which produce terminal 
hair in childhood such as eyelashes, eyebrows, and many scalp follicles where androgens 
have no obvious effect (Ebling, 1986; Randall, 2007).   
 
Androgens can exert opposite functions in human hair growth depending on the body 
site. They can transform small vellus hair follicles into large terminal hair follicles, as 
seen during the growth of beard, pubic hair, and axillary hair after puberty (Hamilton, 
1958; Marshall and Tanner, 1969; 1970), whereas they can also transform large terminal 
hair follicles into small vellus hair follicles as seen on the scalp in genetically predisposed 
individuals with androgenetic alopecia (male pattern baldness) in which the follicles 
undergo progressive miniaturisation (Hamilton, 1942; 1960; Nyholt et al., 2003), see 
figure 1.7. These paradoxical effects of androgens on human hair growth have long been 
a mystery. These changes occur gradually with several hair growth cycles occurring 
before the type of hair produced is changed (Randall, 1994a; Randall, 2005). In addition, 
these changes appear to be androgen dependent and determined by the presence of 
sufficient circulating androgens (Hamilton, 1942), as well as the degree of genetic 
predisposition (Nyholt et al., 2003).     
 
One of the first signs of puberty is the gradual replacement of small vellus hair with 
larger, more pigmented hair in the pubis and axillae in both sexes (Marshall and Tanner, 
1969; 1970; Randall, 2007). These changes parallel the rise in plasma androgens which 
occurs earlier in girls than in boys (Winter and Faiman, 1972; 1973). During male 
puberty, the growth of beard initially starts in the moustache area and the middle of the 
chin and later spreads over the lower part of the face and parts of the neck (Marshall and 
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Tanner, 1970). In Japanese and Caucasian men, beard and axillary hair both grow 
rapidly, however while beard growth continues until the seventies, axillary hair growth 
peaks in the mid-twenties and then decreases rapidly in both races (Hamilton, 1958). This 
indicates that the hair follicles in different anatomical locations of the body have different 
responses and sensitivities to androgen.  
  
However, the range of responses of hair follicles to androgens is genetically intrinsic 
(Nyholt et al., 2003) and depends upon body site (Randall et al., 1991; Randall, 2007), as 
well as levels of circulating androgens, for example beard hair growth in males needs 
much higher levels of androgens than post-pubertal axillary and pubic hair in females. 
The effects of androgens on hair growth are clearly illustrated by patients with testicular 
feminisation who have no functional androgen receptors. These individuals do not 
develop beards, axilla or pubic hair. There have been no reports of these patients 
suffering from androgenetic alopecia (Griffin & Wilson, 1989; Imperato-McGinley et al., 
1991; McPhaul, 2004).   
 
 
  
 
 
 
 
 
 
- 37 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 Effects of androgens on human hair follicles. Schematic diagram 
represents the paradoxical effects of androgens on human hair follicles of different 
body sites. Reproduced from (Randall, 2000), with the author's permission.        
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1.7 Androgen-related hair disorders: 
Because of its importance in social and sexual communications, hair plays an important 
role in the standard of a person's appearance and self-image. Therefore, hair disorders 
may cause psychological distress and reduced quality of life as discussed in section 1.1. 
However, hair disorders are not physically painful or life threatening. The two main 
androgen-related problems associated with hair growth are the loss of hair on the scalp in 
males and females, which is more prevalent in males (androgenetic alopecia), and 
excessive hair growth on the face and body of women in the male pattern (hirsutism).  
Androgenetic alopecia: 
Androgenetic alopecia is a common type of hair loss. It is also called common baldness 
or male pattern baldness which mainly affect men (Hamilton, 1951), but can also affect 
women (Ludwig, 1977, Messenger and Sinclair, 2006). Androgenetic alopecia affects up 
to half of the male Caucasian population by middle age and almost all Caucasian men in 
old age (Ellis, 2001). This type of hair disorder is characterised by the gradual 
transformation of thick, pigmented hairs on the scalp to short, thin pale hairs, in both men 
and women (reviewed in Randall, 2005). In androgenetic alopecia and also during 
puberty, the gradual changes in the type of hair produced by the hair follicles are related 
to changes in the stages of the hair growth cycle (Randall, 2007). Therefore, during the 
disorder progression, the anagen phase of hair growth cycle shortens whereas the telogen 
phase remains constant (Hamilton, 1951; Norwood, 1975; Randall, 2005).   
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The distinctive pattern of hair loss was first described by Hamilton (1951) and later by 
Norwood (1975). The hair loss severity was classified into seven classes, starting from 
pre-pubertal scalp (Type I) through gradual recession of bitemporal hairline and thinning 
of the vertex (Type VII). This classification system was later modified by Norwood to 
improve the grading of the middle balding types. This type of male pattern baldness can 
occur in women, however a different pattern of hair loss is more common. It was 
described and graded by Ludwig (1977) as the gradual hair loss in the crown, with 
preservation of the frontal hair line (Sinclair et al., 1999; Price, 2003, Bionodo et al., 
2004).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 The pattern of hair loss in androgenetic alopecia in men. The 
Hamilton scale (as modified by Norwood) is used to classify the type and 
extent of common baldness in men. Reproduced from Randall (2000), with 
permission.      
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There are two main factors involved in the pathogenesis of androgenetic alopecia 
including androgen and genetic predisposition. There is a great deal of evidence to 
support the involvement of androgen in the development of androgenetic alopecia. For 
example, androgenetic alopecia does not occur in male castrated prior to puberty and 
progression is stopped if postpubertal males are castrated (Hamilton, 1960). In castrated 
men, hair loss can be stimulated using testosterone replacement therapy, however 
withdrawal of the hormone led to a cessation in hair loss progression (Hamilton, 1942). 
The role of androgen in hair loss is confirmed by the absence of androgenetic alopecia in 
people with complete androgen insensitivity syndrome in which individuals lack 
functional androgen receptors (McPhaul, 2004). In balding men, testosterone levels are 
normal (Phillipou and Kirk, 1981; Pitts, 1987) and the response to androgen seems to be 
intrinsic to the hair follicle (reviewed by Randall, 2005).  
 
Genetic predisposition is required for the onset of alopecia alongside androgen (Birch and 
Messenger, 2001; Ellis and Harrap, 2001; Nyholt et al., 2003). Androgenetic alopecia has 
been described as an autosomal dominant trait with variable penetrance (Bergfeld, 1995). 
A number of genes have been investigated for an association with androgenetic alopecia, 
it has been reported that male-pattern baldness associated with genetic variants in the 
androgen receptor gene (Ellis and Harrap, 200l; Prodi et al., 2008). In addition, recent 
studies showed susceptibility variants for androgenetic alopecia on chromosome 20p11 
(Hillmer et al., 2008; Richards et al., 2008). This indicates that the inheritance pattern of 
androgenetic alopecia seems to be polygenic.    
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There are a range of treatments for androgenetic alopecia such as surgery, wigs and 
hairpieces, hormonal, and non-hormonal therapy. The surgical treatments are based on 
the intrinsic response of hair follicles to androgens. It involves the relocation of hair 
follicles from the non-balding occipital and parietal areas of the scalp to cover the bald 
sites (Orentreich and Durr, 1982; Epstein, 2007). This type of treatment is long lasting, 
painful and expensive, as well as it may require further surgery as the hair loss develops 
around the transplanted regions.  
 
The main hormonal treatments include anti-androgens and 5α-reductase inhibitors. Anti-
androgen treatment blocks the androgen binding to the androgen receptors; however, this 
is not a desirable treatment for men as it has impractical effects on male masculinity.   
5α-reductase inhibitors, such as finasteride, act by blocking the conversion of testosterone 
to its more active form 5α-dihydrotestosterone (DHT) which binds the same receptor as 
testosterone. It has been observed that finasteride slowed down gradual hair loss and 
promoted hair growth in men under 42 with stage II to V hair loss (Kaufman et al., 1998). 
Another study showed the efficacy of finasteride in older men (Whiting et al., 2003). 
Recently, it has been revealed that dutasteride, a type I and type II 5α-reductase inhibitor, 
increased scalp hair growth in men with androgenetic alopecia more rapidly than 
finasteride, which only inhibits type II 5α-reductase (Olsen et al., 2006). To date,           
5α-reductase inhibitors are the best current treatment for androgenetic alopecia in men, 
however similar to all hormonal treatments, they require long-term continuation.  
 
The most commonly used non-hormonal treatment for androgenetic alopecia in men and 
women is minoxidil (Olsen et al., 2002; Dawber, 2000; Messenger and Rundegren, 
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2004). It belongs to a group of drugs known as potassium channel openers. It was 
initially developed for hypertension treatment, but it was observed to have hypertrichosis 
(excessive hair growth) as a common side effect (Shapiro and Price, 1988; Dawber and 
Rundegren, 2003) and then it was remarketed as a hair loss treatment. It is unclear how 
minoxidil itself functions to stimulate hair growth, however a recent study suggested that 
the mechanism of minoxidil action in hair follicle is via the opening the ATP-sensetive 
potassium channels in the membranes of hair follicle cells (Shorter et al., 2008).  
Hirsutism: 
Hirsutism is the excessive hair growth on areas of the body of women in the pattern of a 
normal post-pubertal male (Dawber, 1994; Azziz, 2003). In normal women, these sites of 
the body are covered by fine hair for instance above the lip, on the chin, chest, forearms, 
back and abdomen. This abnormal hair growth may be triggered by excess production of 
androgen. In these cases androgens cause the transformation of fine, small hairs into 
thick, pigmented hairs. This is a paradoxically different effect of androgens compared to 
their involvement in androgenetic alopecia. It has been reported in a study investigating 
hirsutism in British women between 15 and 64 years of age, that about 10% have hair on 
the chest, 22% on the chin, and 49% on lips (Ehrmann, 2005). There are several 
conditions which can cause hirsutism such as polycystic ovary syndrome (PCOS) which 
is characterised by excessive production of androgen (Bardin and Lipsett, 1967; Franks, 
1989; Ehrmann, 2005). However, a small portion of cases have idiopathic hirsutism, with 
no detectable hormonality (Simpson and Barth, 1997; Elghblawi, 2008).  
 
- 43 - 
 
Treatment of hirsutism can involve cosmetic and/or pharmacological approaches. 
Pharmacological methods include treatment with anti-androgen drugs such as 
cyproterone acetate (CPA), spironolactone (Hammerstein, 1987; Shapiro and Lui, 2005) 
and flutamide (FLU) (Osculati and Castiglioni, 2006). This type of treatment may take 6-
9 months before detecting any effect on hair growth and there may only be partial 
improvement. In addition, there is also a risk of feminisation of a male foetus with anti-
androgen treatment (Hughes and Cunliffe, 1988). Finasteride is also used as a 
competitive inhibitor of 5α-reductase, and has been shown to be effective for treating 
hirsutism with fewer side effects (Moghetti, 2000). The cosmetic approach employs 
various methods which physically remove or lighten excess hair to make it less 
conspicuous; such treatment includes shaving, waxing, bleaching, depilatory creams, 
electrolysis and laser hair removal (Claman et al., 2002).  
  
1.8  Mechanism of androgen action in the hair follicle: 
The main circulating androgen in the human body is testosterone which is derived from 
cholesterol like other steroid hormones. Testosterone is primarily made and secreted by 
leydig cells in the testes of human men and the ovaries of women; the adrenal glands in 
both sexes can also secrete low level of androgens. However, the amounts of testosterone 
produced by human males are much more than those produced by females (Baird, 1970). 
In addition, the concentration of circulating testosterone produced by males is estimated 
as 10-35 nmol whereas it is <3.5 nmol in females (Leshin and Wilson, 1981). Androgens 
are carried in the blood either free or bound to specific proteins such as albumin, and sex-
hormone binding globulin (SHBG), (Selby, 1990; Rommerts, 2004). 
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Systemic androgens can enter the hair follicle via its blood vessels into the dermal papilla 
and the dermal sheath. Because androgens are lipid soluble (lipophilic molecules), they 
can diffuse directly from the blood into the cytoplasm of target cells through the cell 
membrane and then enter the nucleus (Randall et al., 2000). In the cytoplasm, 
testosterone can be metabolised to 5α-dihydrotestosterone (DHT) depending on the site 
of the follicle in the presence of the enzyme 5α-reductase.  
 
Androgens exert their activities on the target cells by binding to specific intracellular 
receptors. Each receptor contains a ligand-binding site and DNA-binding site. Both 
testosterone and 5α-dihydrotestosterone can bind to the ligand-binding domain, which 
causes a conformational change in the receptor, as well as activation of the DNA binding 
site (Janne et al., 1993, Narayanan et al., 2008). However, 5α-dihydrotestosterone is a 
more potent androgen and binds to the androgen receptor with a higher affinity than 
testosterone to modulate gene expression (Randall, 1994b, Randall 2007). The receptor-
androgen complex then binds to a specific DNA sequence of the target gene which is 
called a hormone response element (Handelsman, 2005). This binding process results in 
activation of androgen-dependent genes, and DNA transcription which leads to altering 
the production of specific proteins. The summary of this process is shown in figure 1.9.       
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Androgen insensitivity syndrome: 
The mechanism of androgen action in hair follicles has been illustrated by various forms 
of androgen insensitivity syndrome. Individuals with this syndrome are characterised by 
an XY genotype but they exhibit a female external phenotype. These individuals lack 
functional androgen receptors. Although they have normal or raised circulating androgen 
levels, they lack beard, pubic, and axillary terminal hair and they do not undergo 
androgen-dependent scalp hair thinning (McPhaul, 2004; Randall, 2007). This confirms 
that the terminal hair growth in these sites of the body is androgen dependent, whereas 
follicles in other sites such as scalp, eyebrows, and eyelashes are androgen independent.  
Figure 1.9 Mechanism of androgen action.   
Schematic diagram represents the mechanism of action of testosterone and           
5α-dihydrotestosterone (DHT). Reproduced with permission, Randall et al., (2000).    
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The enzyme 5α-reductase:  
Two isoforms of the enzyme 5α-reductase type I and type II, have been identified 
(Jenkins et al., 1992; Blanchard et al., 2007). The distribution of these isoenzymes varies 
between tissues, however both  types are found in scalp follicles (Eicheler et al., 1995) 
and a recent study showed that the genes for 5α-reductase type I and type II were 
expressed in cultured dermal papilla cells derived from both beard and scalp hair follicles 
(Liu and Yamauchi, 2008). Type I is mainly found in the liver, however its role is not 
obvious. Absence of 5α-reductase type II results in the syndrome of 5α-reductase 
deficiency, a rare form of male pseudohermaphroditism. Individuals with this syndrome 
are born genetic males (XY) with ambiguous external genitalia and they are unable to 
convert testosterone (Andersson et al., 1991). Individuals with 5α-reductase type II 
deficiency do not produce male patterns of body hair, in spite of their circulating 
androgens after puberty. They only produce female patterns of pubic and axillary hair and 
show an absence or reduction of beard growth, although they do develop a masculinized 
male body shape (Imperato-McGinley et al., 1991; Wilson et al., 1993; Randall, 2008). 
This suggests that pubic and axillary follicles respond to testosterone, but the male 
secondary sexual hair growth demands metabolism of testosterone to                              
5α-dihydrotestosterone (Randall, 2007). It is unclear why some follicles require 
testosterone and others 5α-dihydrotestosterone to induce the same cell biological 
changes. This suggests that the cells use different intracellular coactivating proteins to act 
with the receptor (Randall, 2008).  
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Figure 1.10 Human hair patterns under various endocrine conditions. 
reproduced from Randall (2008) with the author's permission. 
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1.9  Current hypothesis of androgen action in hair follicles: 
The molecular mechanisms involved in the control of hair growth are not well 
understood. Androgens are the major regulating hormones of human hair growth 
(Randall, 2008). It is believed that androgens act on the hair follicle via the mesenchyme-
derived dermal papilla which interprets the response indirectly for the other follicular 
components. The current hypothesis of androgen action in hair follicles was proposed by 
Randall (1994). This hypothesis proposed that circulating androgens enter the dermal 
papilla via its well developed blood supply. Within the dermal papilla cells of androgen 
dependent hair follicles, androgens bind to specific intracellular androgen receptors and 
then cause alteration in their production of paracrine factors. These factors then act on 
other components of the hair follicles, altering the type of hair produced (figure 1.11).  
 
Paracrine factors are those for which the target cells are different from, but near to the 
signal-releasing cell. These factors could be soluble mitogenic factors such as growth 
factors and/or extracellular matrix components. Elucidation of these factors may lead to a 
better understanding of hair biology and the mechanisms involved in androgen dependent 
hair disorders. These factors may act on different follicular targets including the 
melanocytes which modify the amount of pigments produced, the keratinocytes which 
propagate to produce the hair fibre and different sheaths, and the follicular endothelial 
cells and the cells of the follicular connective tissue sheath (Randall et al., 2007). In 
addition, another possible target for these factors could be the dermal papilla itself via an 
autocrine regulatory system (Hamada and Randall, 2006), as any change in the dermal 
papilla size leads to a change in hair follicle size and the type of hair produced (Van Scott 
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and Ekel, 1958; Elliot et al., 1999). Therefore, the dermal papilla cells would be the direct 
target for androgen action, whereas the other follicular components would be controlled 
by androgens indirectly.   
 
 
 
 
 
 
 
 
 
 
 
 
 
This hypothesis has received much support by several experimental studies. Using 
autoradiographic localisation, the highest concentrations of radio-labelled testosterone 
were detected in the dermal papilla cells and sebaceous glands in rat skin. This indicates 
that these cells are the main androgen targets of skin (Stumpf and Sar, 1976). It has been 
reported that androgen receptors are localised in human dermal papilla cells, but not hair 
follicle keratinocyte cells using immunohistochemistry (Choudhry et al., 1992; Itami et 
Figure 1.11  Diagrammatic representation of the hypothesis of androgen  action in the 
hair follicles. Circulating androgens enter the dermal papilla via its blood capillaries, 
causing the production of paracrine factors which act on other follicular components. 
Reproduced with permission (Randall, et al., 2008).  T: Testosterone, ?: unknown 
paracrine factors.       
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al., 1995; Thornton et al., 2003). Based on in vitro studies, dermal papilla cells derived 
from androgen-sensitive regions, such as human balding scalp and beard, contain higher 
levels of specific, saturable androgen receptors than those derived from androgen-
insensitive regions such as non-balding scalp (Randall et al., 1992; Hibberts et al., 1998). 
This is also reflected in the red deer follicles where androgen receptors have been 
localised by immunohistochemistry in the dermal papilla cells derived from mane 
follicles taken during the breeding season, whereas they were not detected in those taken 
during non-breeding season (Thornton et al., 2001). The gene for the androgen receptor 
was expressed in cultured human dermal papilla cells taken from axillary and beard hair 
follicles, whereas it was only present at a low level in cells derived from occipital scalp 
hair (Ando et al., 1999). This parallels individuals without functional androgen receptors, 
i.e, with androgen insensitivity syndrome, who exhibit no beard, axillary, and pubic 
terminal hair, and do not develop androgenetic alopecia (McPhaul, 2004). This indicates 
that the dermal papilla plays a main role in androgen-mediated effects in the hair 
follicles. 
 
Further evidence implicating the dermal papilla as an androgen target is that 5α-reductase 
type II mRNA was expressed in the dermal papilla and the dermal sheath cells from both 
balding and non-balding scalp follicles (Asada et al., 2001). Based on in vitro study, the 
metabolism of testosterone has also been examined, and varies between dermal papilla 
cells taken from different body sites. Cultured dermal papilla cells from non-balding 
scalp, beard, pubic and axillary follicles were incubated with radio-labelled testosterone. 
All cells and media contained testosterone and androstenedione, but only beard dermal 
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papilla cells contained the metabolite 5α-dihydrotestosterone (Itami et al., 1990; 
Thornton et al., 1993; Hamada et al., 1996).  
 
Itami and colleagues (1991; 1994; 1995a) used a co-culture system of dermal papilla cells 
and outer root sheath cells to investigate the DNA synthesis level. They observed an 
increase in DNA synthesis measured by ³H-thymidine uptake compared to cells cultured 
separately. Addition of testosterone stimulated ³H-thymidine uptake in the co-culture 
system of both beard and axillary dermal papilla cells with outer root sheath cells. 
However, there was no effect for testosterone on cells cultured alone, or in the co-culture 
of occipital scalp dermal papilla cells and outer root sheath cells. In addition, the 
stimulation of ³H-thymidine uptake under the influence of testosterone was antagonised 
by the addition of anti-androgen, cyproterone acetate. This strongly suggests that the 
stimulatory effects in the co-culture system of both beard and axillary were mediated via 
an androgen receptor pathway. 
 
The production of paracrine factors by cultured dermal papilla cells was examined in the 
presence and absence of androgen (Hibberts and Randall, 1996). Conditioned media 
produced by cultured dermal papilla cells derived from beard, balding and non-balding 
scalp were collected. All media promoted DNA synthesis in epithelial cell line of human 
skin. After incubation with testosterone, media from balding scalp dermal papilla cells 
had a reduced ability to induce the epithelial cell growth compared to untreated media 
from non-balding, balding, and beard dermal papilla cells. This may have been due to the 
production of inhibitory paracrine factors under the influence of testosterone.  
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Another study used a similar experimental design to examine the production of paracrine 
and autocrine factors by androgen-insensitive non-balding scalp and androgen-sensitive 
beard dermal papilla cells (Thornton et al., 1998). The conditioned media by the dermal 
papilla cells were collected and its effects on ³H-thymidine incorporation into other 
dermal papilla cells were investigated. From the study it was found that both non-balding 
and beard dermal papilla conditioned media have inducible effect for both cell types, but 
the response to the factor was greater in beard dermal papilla cells. After incubation with 
testosterone, the production of mitogenic factors was only increased with the conditioned 
media from beard dermal papilla cells. It was observed that only beard dermal papilla 
cells were able to respond to these factors. This suggested that both cell types secreted 
autocrine factors and the testosterone stimulation of autocrine factors production by beard 
dermal papilla cells in vitro reflected the response of these cells to androgens in vivo.     
 
Recently, the production of inhibitory autocrine factors by balding dermal papilla cells 
was investigated (Hamada and Randall, 2006). This study revealed that conditioned 
medium, produced by dermal papilla cells derived from either non-balding or balding 
scalp had growth promoting effect on non-balding scalp dermal papilla cells in vitro. 
However, balding medium was found to stimulate to a lesser extent. In addition, only 
conditioned medium from non-balding scalp stimulated rat vibrissae dermal papilla cells, 
and no significant stimulation was seen with conditioned medium from balding scalp. 
This was due to the secretion of soluble inhibitory factors by balding cells and this study 
also revealed that the conditioned medium from balding dermal papilla cells inhibited 
mouse hair growth in vivo, indicating that this medium contained inhibitory autocrine 
factors.   
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1.10 Paracrine factors in the hair follicle:  
 
The development of epithelial appendages demands cell signaling and interaction 
between epithelial cells, and between epithelia and mesoderm-derived dermis (Sengel, 
1983; Chuong et al., 2001). It is believed that cell signals may play a key role in 
regulation of cell growth, cell differentiation and epithelial appendage formation 
(McElwee and Hoffmann, 2000). Polypeptide growth factors are a variety of proteins 
which play important roles in the regulation of cell growth, movement and 
differentiation, and perform their activities, for example control cell proliferation and 
differentiation, by binding to specific membrane receptors on the cell membrane to 
transduce the growth factor signals (Ullrich and Schlessinger, 1990; Olsnes et al., 2003; 
Carpenter and Liao, 2009)  
 
These proteins can be classified into several main families including; Plasminogen-
Related Growth Factors (PRGFs) (Donate et al., 1994; Comoglio and Boccaccio, 2001), 
Platelet-Derived Growth Factors (PDGFs) (Heldin et al., 1993; Alvarezet al., 2006), 
Nerve Growth Factors (NGFs) (Ebendal, 1992; Wiesmann and de Vos, 2001), Epidermal 
Growth Factors (EGFs) (Derynck, 1988; Leahy, 2004), Insulin Growth Factors (IGFs) 
(Humbel, 1990; Dupont et al., 2003), Fibroblast Growth Factors (FGFs) (Burgess and 
Maciag, 1989; Goldfarb, 2005), Transforming Growth Factors (TGFs) (Massague, 1990; 
Kim et al., 2005) and Vascular Endothelial Growth Factor (Kowanetz and Ferrara, 2006).  
 
The identification of paracrine factors produced by dermal papilla cells in androgen 
dependent follicles has been the focus of much research. A number of growth factors and 
cytokines have been implicated in the regulation of the hair follicle (Blume-Peytavi and 
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Mandt, 2000; Paus, 2000; Philpott, 2000). Only some of these have been implicated in 
androgen action so far, generally by studying cultured dermal papilla cells; the main ones 
include: 
 
Insulin-like growth factor-I (IGF-I) is a highly potent mitogen which maintains cultured 
anagen scalp hair follicles at physiological concentrations in vitro (Philpott et al., 1994). 
Abnormal patterns of hair growth and differentiation have been observed when IGF-I 
actions were blocked in the IGF-I receptor deficient mouse (Liu et al., 1993). Itami and 
others (1995b) observed an increase in gene expression of IGF-I when beard dermal 
papilla cells were cultured with testosterone in vitro. They also reported that androgens 
increased the proliferation of outer root sheath cells when co-cultured with dermal papilla 
cells in vitro. This stimulation by androgens was intercepted when IGF-I action was 
blocked using antibodies.   
 
Transforming growth factor-β1 (TGF-β1) is another possible paracrine factor which 
inhibits hair growth in vitro and may play a role as a negative regulator of hair follicle 
growth (Philpott, 2000). In organ culture, it has been found that TGF-β1 inhibits human 
hair growth in vitro (Philpott et al., 1990). In addition, it was reported that TGF-β1 was 
expressed in mouse dermal papilla cells using immunohistochemistry (Heine et al., 
1987). Inui et al., (2002; 2003) used a co-culture system to investigate TGF-β1 in dermal 
papilla cells of balding scalp with transfected androgen receptors and keratinocytes. 
When a synthetic androgen was added to the culture, a significant inhibition was noticed 
in keratinocyte growth. They also found that TGF-β1 was induced by androgen in 
cultured balding dermal papilla cells. Furthermore, the inhibition of keratinocyte growth 
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was reversed using anti-TGF-β1-antibody in a dose-dependent manner. This suggests that 
androgens stimulate the expression of TGF-β1 in balding dermal papilla cells leading to 
inhibition of epithelial cell growth. TGF-β1 has also been implicated in the control of 
catagen. Premature catagen was induced when TGF-β1 was injected into the back skin of 
mice (Foitzik et al., 2000) and a suppressor of TGF-β1 delayed the progression of catagen 
in mice (Tsuji et al., 2003). Androgen also stimulated balding cultured dermal papilla 
cells to produce TGF-ß2 (Hibino and Nishiyama, 2004) which is associated with the 
transition from anagen to catagen in human hair follicles in vitro (Soma et al., 2002). 
Therefore, androgen stimulation of dermal papilla production of TGF-β could shorten 
anagen. 
 
Another possible androgen-sensitive paracrine factor is Stem cell factor (SCF), also 
called c-kit ligand, mast cell growth factor or steel factor. SCF is known to play a main 
role in development of epidermal (Williams et al., 1992; Grichnik et al., 1998) and hair 
pigmentation (Geissler et al., 1988; Fleischman et al., 1991). Dermal papilla cells derived 
from beard, non-balding and balding scalp follicles can produce SCF (Hibberts et al., 
1996b; Randall et al., 2008). However, beard cells secrete more SCF than those from 
non-balding scalp suggesting that androgens may increase the production of SCF by 
beard dermal papilla cells leading to formation of darker facial hair (Hibberts et al., 
1996b). Similarly, cells derived from the paler balding follicles secreted less SCF than 
normal scalp cells (Randall et al., 2008). The SCF receptor, c-kit, was expressed in adult 
scalp hair follicle melanocytes (Randall, 2001b, Randall et al., 2008). This suggests that 
changes in the amount of SCF produced by the dermal papilla cells may alter hair 
pigmentation by acting on the hair follicle melanocytes. 
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Vascular endothelial growth factor (VEGF) is another possible paracrine factor which 
acts as a modulator of angiogenesis and vascular permeability. Anagen terminal hair 
follicles have a good vascular system, suggesting microvascular angiogenesis may occur 
at an early stage of every new anagen phase (Montagna and Van Scott, 1958). The 
gradual changes in the size of androgen-responsive follicles, for instance during puberty, 
are reflected in the different size of their blood vessels (Montagna and Ellis, 1958). It has 
been reported that cultured dermal papilla cells express the gene for VEGF (Lachgar et 
al., 1996; Hibberts et al., 1996a; Merrick, 1999). Cultured dermal papilla cells derived 
from catagen and telogen follicles of human scalp were found to express low levels of 
VEGF using in situ hybridization (Lachgar et al., 1996). Recently, it has been found that 
the levels of VEGF were decreased in patients undergoing androgen deprivation therapy 
for prostate cancer compared to its levels before treatment indicating an androgen-
regulation of VEGF expression (Aslan et al., 2005).   
 
Better understanding of these factors should elucidate androgen action in hair follicles 
and therefore lead to the development of treatments for androgen dependent hair 
disorders such as androgenetic alopecia and hirsutism. Members of the hepatocyte growth 
factor family, hepatocyte growth factor (HGF) and macrophage stimulating protein 
(MSP), are also potential candidates for paracrine factors produced by dermal papilla 
cells of human hair follicles. 
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1.11 HGF & MSP as possible paracrine factors produced by hair follicles: 
There are currently two plasminogen-related growth factors (PRGFs), hepatocye growth 
factor (HGF), which is also called scatter factor (SF), and macrophage stimulating protein 
(MSP), which is also known as hepatocyte growth factor-like (HGFL). Structurally, the 
domain organization of the PRGFs is remarkably similar to that of the blood proteinase 
plasminogen (Donate et al., 1994; Carafoli et al., 2005) (figure 1.12). HGF and MSP have 
been implicated in the regulation of hair growth (Lindner et al., 2000; McElwee et al., 
2004) and are possible paracrine factors produced by androgen dependent hair follicles 
under androgen regulation.  
 
1.11.1 Structure of HGF and MSP:  
Interestingly, HGF and MSP are structurally related and their overall structure is similar 
to that of the blood protease, plasminogen. HGF, MSP and plasminogen belong to a 
family of polypeptides characterised by the presence of at least one kringle domain, a 
serine protease domain and an activation part. A kringle domain is a triple disulfide-
bonded loop structure composed of 80 amino acids, that is thought to play an important 
role in protein-protein interactions. However, among the members of this family, HGF 
and MSP lack proteolytic activity and are ligands for transmembrane tyrosine kinases 
(Waltz et al., 1997).  
 
The secondary structure of HGF and MSP shows a mature heterodimeric form composed 
of two subunits, alpha and beta, linked together by a disulfide linkage between C487 (α) 
and C604 (β) (Furlong, 1992). Starting from the amino terminal, the α-chain is a heavy 
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chain which consists of 440 amino acids and contains a hairpin loop of about 27 amino 
acids similar to the preactivation peptide of plasminogen (Trusolino et al., 1998) followed 
by four kringle domains. Each kringle domain possesses its respective three disulfide 
linkages. The β-chain is a light chain which consists of 234 amino acids and contains an 
inactive serine protease like structure (Lokker et al., 1992; Ultsch 1998) that includes a 
triad of glutamine, aspartate and tyrosine in HGF, whereas in MSP these are glutamine 
and two tyrosines. In contrast, plasminogen contains five kringle domains and includes 
histidine, aspartate and serine lying within the catalytic site of serine protease (Trusolino 
et al., 1998). In addition, there is a cleavage site between α and β chains.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12   The structure of HGF, MSP, and plasminogen.  
A diagram of the structure of HGF and MSP, compared with plasminogen. reproduced 
from (Trusolino et al., 1998), with the author's permission. Signal peptide (SP), hairpin 
loop (HL), Kringle (K), dibasic argnine-valine (R-V), histidine (H), serine (S), 
glutamine (Q), tyrosine (Y), aspartate (D), and disulphide bond (S-S). 
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1.11.2  Receptors for hepatocyte growth factor  
            & macrophage stimulating protein :  
 
c-Met or HGFR (hepatocyte growth factor receptor) and RON (Recepteur d'origine 
Nantaise) are the receptors of HGF and MSP respectively. They belong to a distinct 
subfamily of receptor tyrosine kinases (RTKs) (Bottaro et al., 1991; Gaudino et al., 
1994). These tyrosine kinases play an important role in performing cell functions by 
transmitting extracellular signals such as growth factors and peptide hormones (Sakamoto 
et al., 1997; Carpenter and Liao, 2009). They all consist of three main domains including 
an extracellular ligand binding domain, a single membrane-spanning domain and a 
cytoplasmic domain (Hanks et al., 1988; Yarden and Ullrich, 1988).  
Interestingly, c-Met and RON are structurally related (Forgie et al., 2003) and both 
receptors have a complex multi-domain architecture (Gherardi et al., 2003). In addition, 
RON has a significant homology to hepatocyte growth factor receptor c-Met (Bottaro et 
al., 1991; Ronsin et al., 1993). Both are synthesised as a single-chain precursor and then 
are cleaved by proteolytic processing to generate the mature disulfide linked α/β 
heterodimer, consisting of two subunits. The α-chain is an extracellular, glycoprotein 
whilst the β-chain is a transmembrane protein responsible for the tyrosine kinase activity 
(Gaudino et al., 1995; Iwama et al., 1995), figure 1.13. 
Full activation of c-Met and RON requires the complete ligand α-β heterodimer (Okigaki 
et al., 1992; Wang et al., 1997). However, the high affinity receptor binding site in HGF 
is located in the α-chain, whereas MSP binds with a high affinity to its receptor RON via 
the β-chain (Danilkovitch et al., 1999). Binding of c-Met and RON by their ligands 
results in tyrosine kinase activity of the cytoplasmic domain and initiates intracellular 
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signal transduction (Muraoka et al., 1999). Activation of c-Met and RON by binding to 
their ligands, elicits multiple biological responses, which include cytoskeletal 
reorganisation, proliferation, cell-polarisation and tubular structure formation in epithelial 
and endothelial cells (Medico et al., 1996). 
The MSP receptor (RON) is mainly found in several tissues such as skin, lungs, central 
and peripheral nervous systems, digestive tract epithelia and bones (Gaudino et al., 1995; 
Okino et al., 2003). More recently it has been found in various reproductive tissues 
including uterus, placenta, testes and epididymis (Hess et al., 2003). Overexpression of 
the HGF receptor, c-Met, has also been associated with a number of epithelial 
malignancies (Wilson and McPhaul, 1994; Marshall and Kornberg, 1998) and with a 
significant rate of prostate adenocarcinoma in men (Inoue et al., 1998). 
 
 
 
 
 
 
 
 
 
 
Figure 1.13  The structure of c-Met.  
Diagrammatic representation of the structure of hepatocyte 
growth factor receptor (c-Met). Reprinted by kind permission of 
the authors from Gentile et al., (2008). 
 
Outside of celll 
Cytoplasm 
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1.11.3  Hepatocyte growth factor (HGF) and hair growth: 
Hepatocyte growth factor (HGF), also known as scatter factor (SF), is a multifunctional 
peptide which acts as a mitogen (Sonnenberg et al., 1993), motogen (Stoker et al., 1987; 
Weidner et al., 1990) and morphogen (Montesano et al., 1991) and has effects on various 
epithelial and endothelial cells. HGF interacts with responsive cells by binding to the cell 
surface receptor, c-Met, activating a tyrosine kinase signaling cascade leading to 
regulation of cell growth, cell proliferation, cell motility, and morphogenesis.    
 
HGF is secreted by mesenchymal cells as a single inactive polypeptide precursor (Naldini 
et al., 1992) which consists of 728 amino acids (Seki et al., 1990; Weidner et al., 1991). 
This HGF precursor is cleaved by proteolytic digestion at a specific site called a dibasic 
site within two amino acids (Arg494-Val495) in the presence of urokinse, which is 
crucial in morphogenesis, tissue repair, and tumor invasion, or by different proteases, 
such as HGF activator, to produce the mature active form of HGF which is a disulfide-
linked heterodimer composed of a 69 kDa α-chain and a 34 kDa β-chain (figure 1.14) 
(Lokker et al., 1992; Birchmeier and Gherardi, 1998). The molecular mass (Mr) of the 
mature form of human HGF and HGF precursor are 76,879 and 83,126 respectively 
(Nakamura et al., 1989). 
 
Hepatocyte growth factor may act as a paracrine factor secreted by mesenchymal-derived 
cells in a variety of organs and acts primarily upon epithelial cells and endothelial cells 
(Rubin et al., 1991; Matsumoto and Nakamura, 1992; Sulpice et al., 2009). HGF also 
plays an important role in embryonic organ development and in adult organ regeneration 
(Stern et al., 1990), for example in lung formation and repair (Ohmichi et al., 1998; 
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Mizuno et al., 2005; Lassus et al., 2006), the early development of the kidney and kidney 
repair (Woolf et al., 1995; Van Adelsberg et al., 2001; Baer and Geiger, 2006), and 
angiogenesis and vascular repair (Montesano et al., 1991; Rosen et al., 1991; McKinnon 
et al., 2006). HGF may interact with other paracrine factors. Based on in vitro studies, 
basic fibroblast growth factor (bFGF), which plays a role in embryonic development and 
wound repair, has been found to stimulate HGF secretion in many of mesenchymal-
derived cell lines in human beings (Roletto et al., 1996).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14  HGF structure.  
Schematic diagram of the structure of hepatocyte growth 
factor. Reprinted by kind permission of the Nature group, 
from Nakamura et al. (1989). 
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HGF has been implicated in hair growth control. HGF has been observed to stimulate 
growth of human scalp hair follicles (Jindo et al., 1995) as well as mouse vibrissae (Jindo 
et al., 1994) in organ culture. Human recombinant HGF can also stimulate the growth of 
mouse pelage hair follicles in vivo and retards murine hair follicles regression into 
catagen (Jindo et al., 1998). When recombinant mouse HGF was injected under the back 
skin of mice, the result showed that HGF significantly delayed catagen development 
during both early and late stages of hair follicle regression in vivo (Lindner et al., 2000). 
The gene for HGF was strongly expressed in rat anagen tissue and slightly in telogen 
tissue, and HGF mRNA was detected in rat cultured dermal papilla cells, using RT-PCR 
(Yamazaki et al., 1999). HGF has also been observed to localise to the dermal papilla 
cells of mouse pelage anagen follicles using immunohistoreactivity (Lindner et al., 2000). 
These results suggest that HGF can regulate rodent hair follicles and is produced by their 
dermal papilla. 
 
Another study showed that HGF can increase DNA synthesis in cultured keratinocytes 
derived from human scalp hair bulb in a dose-dependent manner in vitro (Shimaoka et al., 
1995). In addition, HGF stimulated the proliferation of rat vibrissae dermal papilla cells 
with maximal effect at 50 ng/ml in a concentration-dependent manner, whereas there was 
minimal effect on cultured fibroblasts (Yu et al., 2004). Cultured dermal papilla cells of 
human scalp hair follicles were found to express HGF, which has stimulatory effects on 
human scalp hair follicle growth in vitro (Shimaoka et al., 1995). No effects were noticed 
in HGF gene expression when balding, non-balding scalp and beard cultured dermal 
papilla cells were cultured with testosterone (Merrick, 2000). However, HGF gene 
expression was very low in balding scalp cells whereas beard cells showed a greater 
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expression than non-balding scalp cells. This differential expression suggests that HGF 
may play a role in maintaining large follicles and the levels of HGF in androgen 
dependent follicles may be changed by in vivo androgen exposure (Randall et al., 2001). 
The gene for the HGF receptor, c-Met, was expressed in human scalp and rat vibrissae 
cultured dermal papilla cells as observed by the RT-PCR technique, and it was also found 
in rat vibrissae follicular matrix keratinocytes by in situ hybridization (Yu et al., 2004).  
c-Met was also prominently localised in the inner root sheath and outer root sheath in 
mouse pelage anagen follicles using immunohistochemistry (Lindner et al., 2000).  
 
1.11.4  Macrophage stimulating protein (MSP) and hair growth: 
Another member of hepatocyte growth factor family recently implicated in hair follicle 
growth is macrophage stimulating protein (MSP), also called scatter factor 2 (SF2) and 
hepatocyte growth factor-like protein (HGFL). MSP is a soluble cytokine that belongs to 
plasminogen-related growth factor family (PRGFs) (Stella et al., 2001) (see section 1.11); 
it was initially considered as a serum factor which stimulated chemotaxis of peritoneal 
resident macrophages (Brunelleschi et al., 2001).  
 
MSP is released as a single-chain inactive protein called MSP precursor or pro-MSP 
which is cleaved into biologically active MSP after proteolytic digestion to give a 
disufide-linked heterodimer in the presence of proteases (Bezerra et al., 1998; Wang et 
al., 1996a; Danilkovitch-Miagkova and Leonard, 2001). The mature form of MSP is a 
heterodimer protein (78 kDa) consisting of two chains: large α and small β held together 
by a single disulfide bond (Carafoli et al., 2005).   
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MSP exerts its actions on target cells by binding to a cell surface receptor called RON 
(Recepture d'origin Nantaise) in human beings (Camp et al., 2007), also known as 
macrophage stimulating 1 receptor  (MST1R). In mice, the receptor is named STK (Stem 
cell derived tyrosine kinase) (Ronsin et al., 1993; Wang et al., 1994). RON belongs to the 
Met proto-oncogene family, a distinct subfamily of the receptor tyrosine kinase family 
(Wang et al., 2003). 
 
Several functions for MSP have been determined, including the ability to act as an 
inflammatory cytokine to activate macrophages (Skeel et al., 1991), promote bone 
resorption (Kurihara et al., 1996; 1998), induce cell motility (Santoro et al., 1996), 
promote cellular proliferation (Gandino et al., 1994), stimulate liver cell morphogenesis 
and motogenesis (Medico et al., 1996), promote the growth and motility of keratinocytes 
(Wang et al., 1996b), stimulate maturation of megakaryocytes (Banu et al., 1996), and 
prevent cellular apoptosis (Iwama et al., 1996) of epithelial cells separated from the 
extracellular matrix (Danilkovitch-Miagkova and Leonard, 2001) Based on these studies, 
MSP has been proposed as participating in a wide range of biological process, such as 
inflammation, wound healing, bone formation and hematopoiesis.  
 
Both MSP and HGF belong to the same family, the hepatocyte growth factor family. As 
discussed in section 1.11.3, HGF may act as a powerful modulator of hair growth and be 
involved in morphogenesis, and cycling. More recent studies investigated the effect of 
MSP on hair growth due to the close relationship between MSP and HGF. In an in vivo 
study, MSP was incubated with agarose beads, then injected subcutaneously into mice, 
which induced telogen follicles to enter the anagen growth phase (McElwee et al., 2004). 
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In addition, exposure to different concentrations of MSP in vitro, gave an increase in 
human hair follicle length in organ culture. Using immunohistochemistry, the MSP 
receptor, RON, was localised in human hair follicles. This localisation was with higher 
intensity in the outer and inner root sheath, and hair matrix, whereas it was found to a 
lesser extent in the dermal papilla (McElwee et al., 2004). Therefore MSP may also play 
a role as a paracrine modulator of hair growth.    
 
1.12  Aims and experimental design:   
Androgens are an important regulator of human hair growth. Human hair follicles in 
various sites of the body have a variable individual, inherited susceptibility for androgen 
dependent growth. Androgens regulate the type of hair produced in human follicles, 
which can cause psychological distress in cases of excess large hairs, e.g. in hirsutism, or 
reduced visible hairs, e.g. in androgenetic alopecia (see section 1.7). These disorders are 
poorly controlled. Better understanding of the mechanism of androgen action and the 
structure, functions and growth of hair follicles should lead to better treatment. Changes 
in hair follicle and hair size are believed to involve signalling between the hair follicle 
components via paracrine factors.  
 
The overall aim of this study was to identify key paracrine factors which may be involved 
in androgen regulated changes in the hair follicles to improve our understanding of the 
mechanism of androgen action in human hair follicles. In addition, this study aimed to 
investigate differences in gene expression between balding and non-balding scalp hair 
follicles. Previous research on paracrine factors in human hair follicles has focussed on 
cultured dermal papilla cells whose gene expression is altered from that in vivo as soon as 
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the cells are established (O’Shaughnessy et al., 2004). It has also been suggested that 
balding dermal papilla cells are degenerate and therefore not really a valid model system 
(Bahta et al., 2007). Therefore, the aim of this study was to determine gene expression of 
paracrine factors which may be involved in androgen regulated signalling in individual 
human hair follicles themselves after dissection from human normal and balding scalp.  
  
Since hepatocyte growth factor (HGF) family members, HGF and macrophage 
stimulating protein (MSP), are implicated in hair growth (see sections 1.11.3 and 1.11.4), 
they seem possible candidates for roles as androgen-regulated paracrine factors. HGF has 
been shown as a modulator of hair growth which plays an important role in 
morphogenesis and cycling in rodent follicles (Jindo et al., 1995; Lindner et al., 2000). It 
has also been reported that MSP has a stimulatory effect on hair growth in vitro in organ 
culture and induced telogen hair follicles in mice to enter the anagen growth phase in vivo 
(McElwee et al., 2004). This study was designed to investigate whether, and where, these 
genes were expressed in human hair follicles and whether their expression was altered in 
balding. 
                            
                                                               
Initial experiments focused on investigating the gene expression of these two members of 
the hepatocyte growth factor family and their respective receptors using reverse 
transcription polymerase chain reaction (RT-PCR). For these purposes, firstly deer and 
human hair follicles were individually microdissected. Total RNA, mRNA and cDNA 
were prepared from them and used to check if RNA for specific genes including 
hepatocyte growth factor (HGF), macrophage stimulating protein (MSP) and their 
respective receptors, c-Met and RON, were expressed by human hair follicles. ß-actin 
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was used as a positive control to assess the quality of cDNA samples (Davies, 2001; 
Croft, 2002). The detection of this housekeeping gene indicated that the isolated RNA is 
of sufficient quality for RT-PCR to be performed successfully. The products of the RT-
PCR were confirmed as appropriate by agarose gel electrophoresis and sequencing. 
 
Deer hair follicles were microdissected at the beginning of the work to get practical 
experience to learn these techniques. This is because they are larger than human follicles 
and easy to practise on, dissect and section. Deer hair growth is also synchronous, which 
means that in any given area the hair growth would be at the same hair cycle stage. This 
was followed by investigation of human scalp anagen follicles.  
        
In an attempt to localize the expression of each of the genes in human scalp follicles, the 
three main components of the hair bulb: the epithelial hair matrix, the dermal sheath and 
the regulatory dermal papilla, were also investigated separately by isolating them 
individually by microdissection. Further investigation was done using monoclonal 
antibodies to determine the location of the HGF receptor, c-Met, protein in human hair 
follicles by immunohistochemistry of frozen skin sections. Prior to that, the expression of 
cytokeratin 6 was investigated to gain practical experience with the immunohisto-
chemistry technique. 
                                                                                     
To investigate what changes androgens may cause to gene expression in human hair 
follicles, the work focused on comparing the gene expression in matched non-balding and 
balding scalp hair follicles from the same men with androgenetic alopecia to determine 
whether there are significant differences between them using an advanced, powerful 
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comparative method, DNA microarray analysis. Complex data analysis was used to 
compare expression in these matched sets of follicles.  
 
To confirm these differences for specific genes including HGF, MSP, c-Met, and RON in 
balding scalp hair follicles relative to the same sequence in matched non-balding samples 
from the same individuals, relative quantitative real-time PCR was used to calculate 
relative quantities of nucleic acid sequences of targets. In quantitative real-time PCR, 
reactions are characterized by the point in time during cycling when amplification of a 
target gene is first detected rather than by the amount of target accumulate at the end of 
PCR (Freeman et al., 1999; Raeymaekers, 2000). Therefore, data are collected throughout 
the PCR process rather than at the end of the PCR process. This gives reliable 
quantitative assessment. Due to the limited sample availability and the lower yield of 
total RNA, the extracted total RNA from all six samples was amplified to produce high-
quality RNA for use in quantitative real-time PCR. Hopefully, this research should give 
us a better understanding of the mechanism of androgen action in human hair follicles 
which could lead to better treatment for hair disorders.   
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2. Materials and Methods 
 
 
2.1  Identification of  hepatocyte growth factor family members and their 
receptors in isolated human scalp hair follicles and their components:  
 
2.1.1  The Reverse Transcription-Polymerase Chain Reaction  
         (RT-PCR): 
 
2.1.1.1  Biological materials:  
Human skin samples from non-balding individuals were obtained from healthy donors as 
waste products of cosmetic dermatological surgeries, with full written donor consent. All 
operations took place in private clinics under the University of Bradford Ethical 
Committee approval for such procedures for all research in Dividion of Biomedical 
Sciences/Centre for Skin Sciences. Tissues were collected into 50ml Falcon tubes 
containing RNAlater™ (Sigma-Aldrich Ltd.) to inhibit RNases. The tubes were labeled 
with details of date, sample origin, gender and age and then the tubes were placed on ice 
for the period of transportation. Upon arrival at the university, the samples were stored in 
the fridge at 4°C overnight to allow the RNAlater™ to penetrate the tissues. The next 
day, the tissues were transferred to the freezer and stored at -20°C until required.    
              Table 2.1 Samples used for isolation of whole lower anagen hair follicles 
                              (five healthy donors): 
 
 
 
 
 
 
 
             
 
 
Sample 
no. 
 
Gender 
 
Age 
 
Status 
 
Body region 
No. of 
follicles  
dissected 
 
1 
2 
3 
4 
5 
 
male 
male 
male 
female 
female 
 
30 
29 
37 
37 
32 
 
 
non-balding 
non-balding 
non-balding 
non-balding 
non-balding 
 
 
Occipital scalp 
Occipital scalp 
Occipital scalp 
Occipital scalp 
Occipital scalp 
 
 
60 
60 
60 
60 
60 
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            Table 2.2  Samples used for isolation of individual hair bulb components; the    
                              dermal sheath, matrix and dermal papilla (three healthy donors):  
     
 
 
 
 
 
2.1.1.2  Microdissections and tissues preparation: 
2.1.1.2.1  Microdissections of  whole anagen follicles:  
The Leica MZ8 dissecting microscope (Leitz, Germany) was used for the dissection of 
the hair follicles from the skin samples. All the plastic, glass and dissection tools were 
sterile. All work areas were cleaned using 70% alcohol to prevent any contamination. 
The tissues were stabilised using RNA stabilization reagent, RNAlater™. If frozen, the 
skin samples were thawed on ice approximately at 4°C then transferred to a petri dish 
containing RNAlater™ that was previously cooled in ice to ensure equal temperature to 
the tissues. The skin sample was cut at the junction between the epidermis and dermis 
using a sterile scalpel blade and the dermal layer transferred into a petri dish (60mm x 
15mm) containing RNAlater™. Under the dissecting microscope, the hair follicles were 
plucked from the skin gently using fine forceps and then transferred into another petri 
dish containing fresh RNAlater™ kept on ice. The isolated hair follicles were cleaned of 
any dermis or fat debris under a higher magnification using syringe needles (27G1/2 
tuberculin syringe; Sigma). The clean follicles were transferred to fresh RNAlater™ 
placed on ice. A total of 60 follicles were collected from each sample. Photographs of the 
dissection steps are displayed in figure 2.1. Photographs were taken using the MDG17 
light microscope (Wild Heerbrugg, Switzerland).             
 
Sample 
no. 
 
Gender 
 
Age 
 
Status 
 
Body region 
No. of 
follicles 
dissected 
 
6 
7 
8 
 
 
male 
male 
female 
 
35 
29 
45 
 
 
non-balding 
non-balding 
non-balding 
 
 
Occipital scalp 
Occipital scalp 
Occipital scalp 
 
 
150 
150 
150 
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Figure 2.1 Microdissection steps of human hair follicle. 
The human skin sample (I), scale bar (500 µm), was cut at the junction between the epidermis 
and dermis using a sterile scalpel blade (II), scale bar (496 µm). The hair follicles were plucked 
from the skin gently using fine forceps but still have some of the dermis and subcutaneous fat 
attached (III), scale bar (264 µm). The isolated hair follicles were cleaned of any dermis or fat 
debris under a higher magnification using syringe needles (IV), scale bar (275 µm). Cleaned 
isolated follicles were transferred to fresh RNAlater™ and placed on ice prior to total RNA 
extraction. Photographs were taken using the MDG17 light microscope (Wild Heerbrugg). 
Magnification: (x20, x18, x259, x266, respectively).                                                                               
 
                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                       
I 
II 
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2.1.1.2.2  Microdissections of  hair bulb components:    
For further investigation of the expression of specific genes including HGF, MSP, c-Met 
and RON, to try to localise them within human hair follicles, whole cleaned lower human 
anagen hair follicles were dissected to isolate the dermal sheath, matrix and dermal 
papilla. A total of 150 hair follicles were isolated from each sample. Whole lower 
follicles were dissected in RNAlater™ placed on ice as described above. Under the 
dissecting microscope Leica MZ8 (Leica Germany), each clean follicle was cut above the 
bulb using needles (27G1/2 tuberculin syringe; Sigma) to separate the bulb from the rest 
of the follicle. The bulb then was transferred to another petri dish (60mm x 15mm) 
containing fresh RNAlater™ and the upper part of the follicles were discarded. Holding 
the root sheath with one needle inside, a vertical cut was made towards the side of the 
dermal sheath avoiding the dermal papilla. The dermal sheath was then inverted to 
expose the bulb matrix and the dermal papilla which was still attached to the sheath. The 
dermal papilla was then cut across its base to detach it from the sheath. The clean isolated 
dermal sheath, matrix and dermal papilla were transferred to their respective Eppendorf 
tubes containing 100 µl RNAlater™. Photographs of the dissection steps are displayed in 
figure 2.2. Photographs were taken using the MDG17 light microscope (Wild 
Heerbrugg).       
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I II 
III 
IV 
Figure 2.2 Microdissection steps of human hair bulb components. 
Whole follicles were dissected from scalp skin as described in figure 2.1. Each cleaned follicle (I), 
scale bar (275 µm), was cut above the bulb using needles to separate the bulb from the rest of the 
follicle (II), scale bar (281 µm). The bulb was transferred to another petri dish containing fresh 
RNAlater™ and the upper part of the follicle was discarded (III), scale bar (189 µm). Holding the 
root sheath with one needle inside, a vertical cut was made towards the side of the dermal sheath 
avoiding the dermal papilla (IV), scale bar (195 µm). The dermal sheath was then inverted to 
expose the matrix and the dermal papilla which was still attached to the sheath (V). The dermal 
papilla was then cut across its base to detach it from the sheath. The clean isolated dermal sheath 
(VI) matrix (VII) and dermal papilla (VIII) were transferred to their respective collection tubes 
containing RNAlater™. Photographs were taken using the MDG17 light microscope (Wild 
Heerbrugg). Magnification: (x266, x268, x288, x284, x284, x284, x286,  x300, respectively).                                                                               
VI 
VII 
VIII 
V 
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2.1.1.3  Total RNA isolation for RT-PCR:  
The isolated hair follicles were placed in a glass homogeniser (3 ml) containing lysis 
solution which consisted of 5 µl of 2-mercaptoethanol (14 mM) with 500 µl of lysis 
solution (Total RNA isolation kit, Sigma-Aldrich). The lysis solution contained guanidine 
thiocyanate to inactivate endogenous RNases which may have been introduced during the 
procedure. The follicles were homogenised until there were no visible solid remains.  
 
Total RNA extraction was carried out using the GenElute Mammalian Total RNA kit 
(Sigma, UK). The homogenate was then transferred to a GenElute filtration column and 
centrifuged for 2 minutes at 13000 g (Eppendorf 5415 R) to remove any cellular debris 
and shear the DNA. After centrifugation, the column was discarded and an equal amount 
of 70% alcohol was added to the filtrate. The sample was then mixed thoroughly by 
vortexing.  
 
The filtrate/alcohol mixture (700 µl) was placed in the binding column and then 
centrifuged for 15 seconds at 13000 g. Following centrifugation, the flow-through was 
discarded and the RNA was bound to the column. The binding column was then 
transferred to a new collection tube.  
 
Wash solution 1 (500 µl) was applied to the binding column and then centrifuged for 15 
seconds. The binding column was placed in a new collection tube. After that, 500 µl of 
wash solution 2 was added to the column and centrifuged for 15 seconds at 13000 g. The 
flow-through was discarded. Another 500 µl of wash solution 2 was added again to the 
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binding column and centrifuged for 2 minutes to remove the ethanol. The purpose of this 
washing was to remove any contaminants.  
 
The purified RNA was eluted from the binding column by adding 50 µl of Elution 
solution (10 mM Tris-HCl, pH 7.4) to the centre of the binding column. The column was 
centrifuged for one minute at 13000 g. The column was discarded and the flow-through 
which contained purified RNA was used immediately or stored at -80°C until required.      
 
 
2.1.1.3.1  Checking the quality of total RNA:  
 
2.1.1.3.1.1  Agarose gel preparation: 
The quality of total RNA was checked by agarose gel electrophoresis using 1.5% (w/v) 
agarose gel prepared using 1.5 g of agarose powder (Invitrogen Ltd, Paisley, UK) 
dissolved in 100 ml of 1X TAE (Tris Acetate EDTA) buffer (40 mM Tris-Acetate, 1 mM 
EDTA, pH 8.3). The mixture was dissolved with the aid of the microwave (Proline 
Microchef ST44). The mixture was cooled to around 50°C then 25 µl of ethidium 
bromide (1 mg/ml; Sigma Aldrich Ltd) was added to the mixture. The gel was directly 
poured into a plastic gel tray and gel comb to form wells. The gel was left around 40 
minutes to set and form wells before the gel comb was gently removed. 
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2.1.1.3.1.2  Agarose gel electrophoresis:  
The running buffer was prepared by adding 75 µl of 0.5 µl/ml ethidium bromide to 300ml 
1X TAE buffer (40 mM Tri-Acetate, 1 mM EDTA, pH 38.3). The gel tray containing the 
prepared gel was placed in the electrophoresis tank and the running buffer was poured 
into the tank. Total RNA (10 µl) was mixed with 2 µl of blue/orange 6X loading dye 
(Promega, Ltd, Southampton, UK). This mixture was loaded on to the gel. The purpose 
of using the dye was to assist loading and monitor the resolution of the sample. The tank 
was set to run at 100 V for 35-45 minutes and then total RNA was visualised using the 
Uvitec gel documentation system (Uvitec Limited, Cambridge, UK) at 312 nm 
wavelength and the image captured.   
               
2.1.1.4  Poly (A) RNA isolation:     
The process of poly (A) RNA isolation was carried out by using GenElute mRNA 
Miniprep Kit (Sigma-Aldrich Ltd). The isolated total RNA was brought up to 250 µl with 
RNase-free water and then vortexed thoroughly. The 2X binding solution (250 µl) and 
oligo (dT) beads (15 µl) were added to the mixture and mixed thoroughly before 
incubating for 30 minutes at 70°C for RNA denaturation. The mixture was left at room 
temperature for 10 minutes before centrifugation to pellet the beads: poly (A) RNA 
complex for 2 minutes at 13000 rpm. Following centrifugation, the supernatant was 
removed.  
 
Wash solution (500 µl) was added to resuspend the pellet and then transferred to a spin 
filter-collection tube. The suspension was centrifuged for 2 minutes at 13000 rpm. The 
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flow-through was discarded and 500 µl of wash solution was added again for a second 
wash and then centrifuged for 2 minutes. 
  
The spin filter column was placed into a new collection tube and 50 µl Elution solution 
(10 mM Tris-HCl, pH 7.4, preheated to 70°C) was added to the filter column and 
incubated for 5 minutes at 70°C. The sample was centrifuged for 1 minute at 13000 rpm. 
The elution steps mentioned above were repeated by adding a further 50 µl Elution 
solution. The mRNA present in elute was either used immediately or stored in the freezer 
at -80°C. 
 
2.1.1.5  DNase treatment of poly (A) RNA samples:  
In order to ensure that the RNA samples to be used for cDNA synthesis were free of any 
contaminating DNA, the sample was treated with the DNA amplification Grade I Kit 
(Invitrogen Ltd). A reaction mixture was prepared inside a 0.5 ml RNase free eppendorf 
tube. The mixture consisted of 8 µl of mRNA, 1 µl of 10X DNase I reaction buffer (200 
mM Tris-HCl, 25 mM MgCl2, 50 mM KCl) and 1 µl of DNase I amplification Grade (1 
U/µl, containing enzyme oligodeoxyribonuclease I which digests single and double 
stranded DNA and oligodeoxyribonucleotides containing 5' phosphatase). The reaction 
mix was vortexed thoroughly and then incubated for 15 minutes at room temperature. 
EDTA (1 µl of 25 mM) was added to the mixture to inhibit the DNA digestion and then 
the mixture was incubated for 10 minutes at 65°C. The DNase-treated poly (A) RNA 
sample was then added directly to a reverse transcription reaction, or stored in the freezer 
at -80°C until required. 
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2.1.1.6  cDNA synthesis by reverse transcription:         
cDNA synthesis was carried out by using an Avian Myloblastosis Virus (AMV) reverse 
transcription system (Promega, Southampton, UK) to produce single strand cDNA from 
DNase-treated poly (A) RNA. All reagents were defrosted, mixed and kept on ice during 
preparation. The mixture was done in 0.5 ml eppendorf tube containing 2 µl of reverse 
transcription 10X buffer (25 mM Tris-HCl, pH 8.3, 25 mM KCl, 25 mM spermidine, 50 
mM DTT), 4µl magnesium chloride (25 mM), 1 µl of oligo (dT) primer (0.5 µg/µl), 2 µl 
deoxynucleotide triphosphate (dNTP mix 10 mM: dATP, dTTP, dGTP, dCTP), 0.5 µl of 
recombinant RNase® ribonuclease inhibitor (1 U/µl), 0.8 µl of AMV reverse 
transcriptase (15 U/µl), and 10 µl poly (A) RNA sample.  
 
The mixture was incubated in a PCR machine-sprint thermal cycler (Thermo Hybrid, 
Ashford, UK) and set to run the reverse transcription programme which is 1 hour at 42°C 
to allow cDNA synthesis from poly (A) RNA by reverse transcription, 5 minutes at 99°C 
to inhibit the reverse transcriptase, followed by 5 minutes at 4°C for cooling. The sample 
was then vortexed and centrifuged for a few seconds to collect the cDNA at the base of 
the tube. The cDNA was then kept on ice for immediate use or aliquoted (10 µl) into 
tubes to be stored at -20°C. 
 
2.1.1.7  Polymerase Chain Reaction (PCR): 
PCR components were prepared in 0.5ml eppendorf tubes. The reaction mixture consists 
of:  1µl of dNTP mix (dATP, dCTP, dGTP and dTTP, 10mM; Promega), 1.5-2.5 mM 
MgCl2 depending upon primer set (50 mM; Invitrogen Ltd), 5µl of 10X PCR buffer (20 
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mM Tris-HCl, pH 8.4, 50 mM KCl; Invitrogen), 1-2.5 µl of forward and reverse target 
primers (10 µM), 3-10 µl of cDNA and 0.5 µl of Taq DNA polymerase (5 units/µl; 
Invitrogen Ltd). The volume of the mixture was topped up to 50 µl with nuclease free 
water and then vortexed thoroughly. For each PCR reaction, a negative control was set up 
replacing the cDNA with nuclease free water. To prevent evaporation of the reaction 
mixture, one drop of mineral oil (Sigma-Alrich Ltd) was added on the top of the mixture. 
The tubes were transferred to the PCR thermal cycler.  
 
RT-PCR was performed using specific forward and reverse primers for each cDNA target 
sequence. Each target primer set during PCR required optimisation of the annealing 
temperature and MgCl2 (Magnesium chloride) concentration. Each different gene 
required a specific PCR programme for amplification. The RT-PCR products were 
analysed by agarose gel electrophoresis as described before (section 2.1.1.3.1.2). The 
primer sequences used for RT-PCR had been previously optimised and published. The 
primer sequences, their optimised RT-PCR conditions and expected amplicon size are 
detailed in table 2.3.  
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Reference 
 
Expected 
amplicon 
Size 
 
Conc. of 
MgCl2 
 
Optimal 
thermocycling 
Conditions 
 
 
Primer  sequence 
 
 
Gene 
 
 
 
 
Davies et al., 2005 
 
 
 
838 bp 
 
 
 
2.5 mM 
95°C for 5 min 
95°C for 1 min 
56°C for 1min        
72°C for 1 min 
72°C for 11 min 
4°C hold 
35 cycles 
 
 
F: 5' ATCTGGCACCACACCTTCTACAATG            
AG CTGCG 3' 
R: 5'CGTCATACTCCTGCTTGCTGATCCAC           
AT CTGC 3' 
 
 
 
Β-actin 
 
 
 
 
 
Shimaoka et al., 1995 
 
 
 
261bp 
 
 
 
2.5 mM 
94°C for 5 min 
94°C for 1 min 
63°C for 1min        
72°C for 1 min 
72°C for 2 min 
4°C hold 
45 cycles 
 
 
F: 5' TTCACAACCAATCCAGAGGTACGC 3' 
R: 5' GAGGGTCAAGAGTATAGCACCATG 3' 
 
 
 
 
 
HGF 
 
 
 
 
 
Shorter, 2007 
 
 
 
415 bp 
 
 
 
 
1.5 mM 
95°C for 5 min 
95°C for 1 min 
62°C for 1min        
72°C for 1 min 
72°C for 11 min 
4°C hold 
35 cycles 
 
 
F: 5' AGGAGGATGTGGCAGATGC  3' 
R: 5' GATTTGATGCCGCAGCTCT 3' 
 
 
MSP 
 
 
 
 
 
Matsuzaki et al., 2005 
 
 
 
217 bp 
 
 
 
2.5 mM 
95°C for 5 min 
95°C for 1 min 
56°C for 1min        
72°C for 1 min 
72°C for 11 min 
4°C hold 
35 cycles 
 
 
F: 5' TCAACTCCCACATCACCATCTG 3' 
R: 5' AGTGTAAAGCCAGCAGCTCCAT 3' 
 
 
RON 
 
 
 
 
 
Imaizumi et al., 2003  
 
 
 
536 bp 
 
 
 
2.5 mM 
94°C for 1 min 
94°C for 1 min 
60°C for 1min        
72°C for 1 min 
72°C for 1min 
4°C hold 
30 cycles 
 
 
F: 5' ACTCCCCCTGAAAACCAAAGCC 3' 
R: 5' GGCTTACACTTCGGGCACTTAC 3' 
 
 
c-Met 
 
 
 
Table 2.3 Primer sequences and PCR conditions for each specific gene used for RT-PCR 
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2.1.1.8  DNA sequencing of PCR products:  
After analysis of PCR products by electrophoresis, the identity of DNA fragments were 
verified and confirmed by sequencing. The PCR products were separated by using a low 
melting point agarose gel to allow the use of a low temperature for dissolving the gel and 
to facilitate the isolation of DNA fragments from the gel. The DNA fragments were 
extracted from the gel using a MinElute Gel Extraction Kit (Qiagen, Crawly, UK). The 
DNA fragments were excised from the agarose gel by using a clean and sharp scalpel 
blade. The gel slices were transferred to a pre-weighed 1.5 ml colorless eppendorf tube. 
Three volumes of buffer QG (contained guanidine thiocyanate) were added to one 
volume of gel. The tube was incubated for 10 minutes at 50°C or until the gel slices were 
completely dissolved. During the incubation, the gel was vortexed every 2-3 minutes to 
help dissolving.  
 
One volume of isopropanol was then added to the sample and mixed thoroughly. The 
sample was applied to a MinElute column in a 2 ml collection tube and then centrifuged 
for 1 minute to allow DNA binding to the column. The flow-through was discarded and 
the column was placed again into the same collection tube. An additional amount of 500 
µl of buffer QG was added to the column and centrifuged for 1 minute. The flow-through 
was discarded and the column returned back to the collection tube. 
  
Buffer PE (700 µl, composition not available due to trade secret) was added to the 
column for washing with incubation for 2-5 minutes at room temperature before being 
centrifuged for 1 minute. The flow-through was discarded and an additional 
centrifugation was done for 1 minute to remove residual ethanol from buffer PE. The 
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column was then transferred to a new 1.5ml eppendorf tube. Buffer EB (10 µl of 10 mM 
Tris-HCl, pH 8.5) was added to the centre of the column and then incubated at room 
temperature for 1 minute. The sample was then centrifuged to elute the DNA from the 
column.  
 
The purified sample of PCR product was sent to Complement Genomics (Sunderland, 
UK) for sequencing. The sequencing data were compared to the previously identified 
gene sequences using the NCBI BLAST programme available at the website: 
(http:www.ncbi.nlm.nih.gov/blastlb12seq/wblast2.cgi). The chromatogram of the 
sequencing data was produced using the Chromas Lite software (version 2.0) available 
from http://www.technelysium.com.au/. Any non-matching nucleotides between the 
sequenced and known data were analysed using the chromatogram. Each base is allocated 
a different colour, in the chromatogram, and the sequence is determined by the highest 
peak.   
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2.1.2  Histological examination of hair follicle structure and localization   
         of  the HGF receptor by immunohistochemistry: 
 
2.1.2.1  Tissue samples: 
2.1.2.1.1  Human skin samples: 
Samples of full depth human scalp skin were obtained from non-balding healthy donors 
as a waste from routine surgery procedures, with full consent and Ethical Committee 
approval. The tissue samples were transferred into collection medium RPMI (Gibco, 
Paisly, UK). Samples were kept on ice and transported to the University. The samples 
were cleaned, trimmed of excess fat and dissected into small pieces approximately 1 cm² 
each and then washed in phosphate buffer saline (PBS). Each piece was transferred into 
1.5 ml eppendorf tube containing O.C.T (Raymond Lamb Ltd, Sussex, UK) and then 
placed in the freezer at -20°C until used. 
2.1.2.1.2  Deer skin samples: 
Deer skin samples were gathered from the neck-mane region of healthy animals routinely 
killed for food in Yorkshire. The samples were collected after animal death and dissected 
into strips. The tissue were placed into 50 ml falcon tubes containing collection medium 
which contained 500 ml RPMI 1640, 100 U/ml penicillin, 2 mM L-glutamine, 5X 
amphotericin, 100 µg/ml streptomycin (Gibco). The samples were kept on ice during the 
period of transportation. At the University, the samples were washed in sterile phosphate 
buffered saline (PBS), cleaned, trimmed of excess fat and cell debris, shaved, dissected 
into  approximately 1 cm² pieces and frozen in O.C.T at -20°C  until required.       
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2.1.2.2  Preparation of slides: 
Prior to tissue sectioning, glass slides (76 x 26 x1 mm; BDH, Lutterworth, UK) were 
cleaned and coated with poly-1-lysine (Sigma Aldrich, Ltd) to assist and ensure 
adherence of the cut sections. The slides were transferred and placed individually into a 
plastic slide holder, and cleaned by immersing in Pyroneg (Diversey, Lever Ltd, 
Northampton, UK) and distilled water for approximately 30 minutes. To remove the 
detergent, the slides were rinsed in distilled water and then soaked for 5 minutes in 
absolute alcohol, and dried in the drying cupboard. The slides were allowed to dry at 
room temperature. When dry, the slides were placed in 10% (v/v) poly-1-lysine in 
distilled water for approximately 10 minutes. When dry, the slides were placed in the 
original box and stored at room temperature until use. These slides were used for general 
histology and immunohistochemistry. 
2.1.2.3  Preparation of frozen tissue sections:     
Using a cryostat (Leica CM 1800 cryostat, Germany), sections of the skin samples were 
prepared at -27°C for general histology and immunohistochemistry. The skin samples 
were placed in the cryostat. O.C.T was applied to the metal holder to form an even disc 
and placed in the cryostat to freeze solid, ensuring all bubbles were removed.  The frozen 
O.C.T disc was then placed into the sample holder of the cryostat and sliced until even. 
The skin sample was dissected and placed onto the O.C.T disc orientated so that 
longitudinal follicles could be sectioned.  The sample was orientated to its side to ensure 
the blade concurrently cuts through the dermis and fat.  O.C.T was applied to the sample 
until no longer visible, and allowed to freeze solid. Sections (5µm diameter) were cut and 
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mounted on to labelled poly-l-lysine coated slides and placed into a labeled slide holder 
wrapped in foil, at -20°C until histological analysis. 
2.1.2.4  Investigation of hair follicle structure:  
2.1.2.4.1  Haematoxylin & eosin staining:  
Sections of human and deer skins were treated with haematoxylin and eosin staining      
to clearly visualise the normal histology of different parts of hair follicle. Prior to tissue 
staining, frozen slides were allowed to dry at room temperature for 45-60 minutes. The 
slides were fixed in ice cold acetone (Fisher Scientific Loughborough, UK) for 
approximately 10 minutes to fix the proteins. The sections were then rinsed in PBS three 
time for 3 minutes each. The slides were then flooded with haematoxylin for 2-5 minutes 
depending on how the stain seemed to penetrate the tissue and then rinsed in distilled 
water until excess haematoxylin was removed. The slides were then placed in Scott's tap 
water and allowed to blue for 2 minutes, followed by 5 minutes staining in 1% (w/v) 
eosin. The slides were rinsed in distilled water to remove excess eosin. The sections were 
then dehydrated by immersion in ascending concentrations of ethanol 50%, 70%, 95% for 
1 minute in each. Coverslips (VWR international, Leicester, UK) were then mounted 
using histomount (VWR international).       
2.1.2.4.2  Sacpic staining: 
Frozen sections of human and deer skin were stained with the Sacpic staining technique 
(Nixon, 1993; Nutbrown and Randall, 1996) in order to better differentiate the different 
components of hair follicle as an aid to interpretation of immunohistochemical staining. 
Different solutions were prepared prior to staining which include Celestine blue, safranin, 
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picric acid, ethanol, picro-indigo carmine, Scott's tap water and Gill's haematoxylin 
(Appendix I).  
The slides were removed from -20°C and allowed to dry at room temperature for 45-60 
minutes. To fix the proteins, the sections were placed into ice-cold acetone (Fisher 
Scientific) for 15 minutes. The sections were placed in celestine blue to mordant for 5 
minutes before rising in tap water. They were then flooded with Gill's haematoxylin for 5 
minutes, followed by a rinse in distilled water for 5 minutes. The sections were then 
blued by washing in Scott's tap water for 2 minutes, followed by staining in safranin for 5 
minutes. The sections were then dehydrated by rinsing in 70% ethanol and 95% ethanol 
for 1 minute each and differentiated in the picric acid/ethanol for 3 minutes. The slides 
were then rehydrated by immersing in 95% ethanol, 70% ethanol and then tap water for 1 
minute each. The sections were stained in picro-indigo carmine for 1 minute and then 
rinsed with tap water. The water was removed by dehydrating the sections in ascending 
alcohol 70% and 95% ethanol for 5 minutes each. The sections were cleared in 
histoclear/ethanol (50:50 v/v) and then absolute histoclear (National Diagnostic, Hull, 
UK) for 4 minutes each. Coverslips were then mounted using histomount.            
2.1.2.5  Immunohistochemistry: 
2.1.2.5.1  Detection of cytokeratin 6 expression by immunohistochemistry:  
Frozen tissue sections of human skin were removed from -20°C and fixed in cold acetone 
on ice. The sections were allowed to dry at room temperature. The sections were washed 
in sterile PBS three times. Each section was isolated by drawing a circle around it using a 
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Vector ImmEdge pen (Vector Laboratories, Peterborough, UK) to minimise the volume 
of antibody used and to treat each section individually.  
The sections were incubated with 0.3% (v/v) hydrogen peroxide (Sigma-Aldrich Ltd) 
made up in methanol (Fisher Scientific) for 30 minutes to eliminate endogenous 
peroxidise activity, followed by a wash in PBS for 5 minutes. The sections were 
incubated for 20 minutes in 5% (v/v) normal mouse serum (NMS; Sigma-Aldrich Ltd) in 
PBS to block non-specific protein binding sites in the tissue. The excess serum was 
blotted away from the slides.  
The primary antibody, which was a goat polyclonal anti-cytokeratin 6 antibody 
(Novocastra Laboratories, Newcastle upon Tyne, UK), was reconstituted to the stock 
recommended by the manufacturer using sterile water and then stored at -20°C until use. 
The primary antibody was then diluted 1:20 with 1.5% (v/v) normal mouse serum in 
PBS. After blocking, the sections were incubated with 150-200 µl of the diluted primary 
antibody per section for approximately 24 hours at 4°C. The slides were washed in PBS 
twice for 10 minutes each to remove excess unbounded primary antibody.  
Th sections were incubated with secondary biotinylated antibody (monoclonal antigoat 
IgG) 1:20 normal mouse serum in PBS for 30 minutes, followed by two washes in PBS 
for 10 minutes. The sections were then incubated with extravidin-peroxidase 1:20 normal 
mouse serum in PBS for 30 minutes. Extravidin binds to the secondary antibody and 
provides more sites for chromogen binding to enhance specific staining. The sections 
were washed twice by rinsing in PBS for 5 minutes each.  
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The peroxidase 3-amino-9-ethylcarbazole (AEC; Vector Laboratories) was added to the 
sections for 20-30 minutes to visualise and locate the antibody binding sites. The reaction 
of the AEC substrate with the peroxidase enzyme produces a red-brown chromogen. At 
this stage, progress of the colour development was monitored to prevent overstaining. 
After sufficient colour had developed, the reaction was stopped by rinsing in distilled 
water. The slides were allowed to dry and then mounted with an aqueous mountant, 
Aquamount (VWR international).  
A number of negative controls were used to assess the results; in the first one, the 
sections were incubated with PBS instead of the secondary antibody to check that the 
primary antibody was not activating the AEC without the presence of the secondary 
antibody. The second negative control involved replacing both the primary and secondary 
antibodies with PBS to check that the blocking had been efficient and there was no 
endogenous peroxidase activity remaining. The third negative control was by replacing 
the primary antibody with PBS to check that the secondary antibody was not binding 
non-specifically to the tissue without the presence of the primary antibody.  
2.1.2.5.2  Detection of  the HGF receptor, c-Met, by immunohistochemistry: 
The immunostaining procedure of c-Met was similar to that for cytokeratin 6 as 
mentioned before (section 2.1.2.5.1). However, sections were blocked with 5% (v/v) 
bovine serum albumin (BSA) in PBS for 20 minutes. A range of antibody concentrations 
were examined between 1:10 and 1:100 until the optimum one was achieved. A mouse 
monoclonal anti human c-Met antibody (Novocastra Laboratories Ltd) was applied to the 
sections at a dilution of 1:20 with 1.5% (v/v) BSA/PBS and left overnight at 4°C. The 
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slides were washed in PBS two times for 10 minutes each to remove excess unbounded 
primary antibody. The sections were then incubated with the secondary biotinylated 
antibody (Dako, Cambridge, UK) for 20 minutes, followed by two washes in PBS for 10 
minutes. The sections were then incubated with streptavidin for 20 minutes. The negative 
controls were as described in the cytokeratin 6 section (2.1.2.5.1).   
2.1.2.6  Visualising the staining:  
All stained sections, Sacpic, haematoxylin & eosin and immunohistochemistry, were 
examined using the Orthodox II light microscope (Leitz, Germany). The sections were 
captured using a Nikon Coolpix 4500 digital camera. The images then were transferred to 
the computer using Nikon View 5 software.  
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2.1.3  Investigation of  the expression of genes for specific molecules      
         in human cultured dermal papilla cells using RT-PCR:  
 
2.1.3.1  Dermal papilla cell lines:  
The dermal papilla cells were provided from Professor Randall’s stock, Centre for Skin 
Sciences, University of Bradford. The cells were stored frozen in liquid nitrogen.  The 
dermal papilla cells were originally derived from non-balding areas (scalp) of two healthy 
women aged 34 and 37 years, undergoing elective cosmetic surgery operations with full 
donor consent.  
2.1.3.2  Cell culture procedure:  
2.1.3.2.1    Maintenance of cell cultures:  
The cryovials containing dermal papilla cells were removed from the liquid nitrogen and 
placed in a water bath at 37.5ºC to defrost. Following the completion of the thawing, the 
contents of each cryovial were placed into a polystyrene rectangular canted-neck cell 
culture flask with a surface area of 25 cm² (Thomas Scientific, USA). Each flask 
contained 10 ml RPMI 1640 growth medium (Gibco, Paisly, UK). The growth media was 
routinely supplemented with penicillin (10 units/ml), streptomycin (100 µg/ml), 
fungizone (2.5 ng/ml), 2 mM L-glutamine and fetal calf serum (20%, v/v). The flasks 
were placed in the incubator for 24 hours to allow the cells to attach to the surface of the 
flasks. Cell culture was carried out in a humidified atmosphere at 37ºC in 95% air and 5% 
CO2 using a Heraeus B5060 EK incubator. The medium was changed every 3 days. The 
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maintenance of the dermal papilla cells was performed in a Class II MDH laminar flow 
cabinet.   
2.1.3.2.2  Visualising cell cultures:  
Growing cultures were viewed daily using an inverted, phase contrast microscope (Leitz, 
Wetzlar, Germany) to observe general morphology and growth conditions. Photographs 
of cultures were taken under a phase contrast microscope (Leitz).  
2.1.3.2.3  Passaging of cell cultures:  
Passaging was carried out when cell cultures reached approximately 90% confluence. 
Trypsinisation was performed to detach cells from the flask by proteolysis. The medium 
was emptied from the flasks and the cells were rinsed three times in a suitable amount of 
sterile PBS (10-15 ml), to remove any excess serum protein which could possibly 
inactivate the trypsin. An appropriate volume of trypsin/EDTA, approximately 500 µl, 
was added to each cell culture flask (25 cm²) and the flasks were replaced in the 
incubator for approximately 2-3 minutes until the cells had rounded up and detached. The 
cell detaching was viewed under a phase contrast microscope (Leitz) until all cells had 
detached from the surface of the flask. The cells of each flask were transferred and 
divided between three 25 cm² flasks containing 10 ml of fresh growth media. The flasks 
were placed back in the incubator and the media changed every 3 days.   
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2.1.3.2.4   Collection and storage of cultured cells: 
When cultured dermal papilla cells reached confluence, they were collected from the 
flasks using a cell scraper (Bioscience Technology, USA) and transferred to universal 
tubes. The tubes were spun down in a Sanyo Harrier 15/80 centrifuge (Jepson Bolton & 
Co Ltd, UK) at 1200 rpm for about 10 minutes until the cell pellets were formed. The 
supernatant was carefully removed to avoid disruption of the cell pellets. The pellets were 
resuspended in 2 ml of stabilization reagent, RNAlater, and used immediately or stored at 
-80 until required. The resulting pellets were used for RNA isolation and later cDNA 
synthesis as described in sections 2.1.1.3 and 2.1.1.6. Following cDNA synthesis, RT-
PCR was carried out to investigate gene expression for HGF, MSP and their receptors    
c-Met and RON, as described in section 2.1.1.7. After analysis of PCR products by 
electrophoresis, the identity of DNA fragments were verified and confirmed by 
sequencing, as described in section 2.1.1.8. 
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The cells were transferred 
into a culture flask (25 cm²) 
containing growth media & 
placed in an incubator  
Dermal papilla cells stored 
frozen in liquid nitrogen 
  
Medium was changed every 
3 days 
Cells were passaged when 
reached confluence 
After trypsinisation to detach 
cells from the flask, the 
contents were divided into 3 
flasks 
When confluent, the cells 
were collected for total RNA 
isolation, cDNA synthesis & 
RT-PCR 
Figure 2.3  Cell culture procedure 
 
Schematic diagram displaying the dermal papilla cell culture steps  
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2.2  Comparison of the gene expression of normal and balding scalp hair 
follicles from men with androgenetic alopecia:  
 
2.2.1  Biological materials: 
Samples of human scalp skin from occipital and frontal regions of balding individuals 
were obtained from healthy donors as a result of routine cosmetic dermatological 
surgeries, with full donor consent and ethical committee approval. Samples were 
collected as full depth skin of about 0.2 cm². Tissues were transferred to 50ml falcon 
tubes containing 30 ml RNA stabilisation reagent, RNAlater™, to inhibit RNAses, which 
had been pre-cooled on ice (4°C).  Tubes were labelled with details of date, sample 
origin, gender and age. The tubes were kept in ice for the duration of transportation 
(about two hours). Upon arrival at the university, the samples were stored in the fridge at 
4°C overnight to allow the RNAlater™ to penetrate the tissues. The next day, these 
samples were transferred into clean RNAlater™ and stored at -20ºC until required.  
 
 
Donor 
 
 
Gender 
 
Age 
 
Sample 
no. 
 
Sample status 
 
Body region 
 
Hamilton 
stage 
 
 
 
A 
 
 
B 
 
 
C 
 
 
 
 
 
male 
 
 
male 
 
 
male 
 
 
 
 
51 
 
 
56 
 
 
55 
 
 
 
1 
2 
 
3 
4 
 
5 
6 
 
 
 
non-balding 
balding 
 
non-balding 
balding 
 
non-balding 
balding 
 
 
Occipital scalp 
Frontal scalp 
 
Occipital scalp 
Frontal scalp 
 
Occipital scalp 
Frontal scalp 
 
 
 
IV 
 
 
IV 
 
 
IV 
                       
            Table 2.4 Samples used for isolation of whole anagen hair follicles from 
                        occipital and frontal areas of balding individuals (three healthy donors) 
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2.2.2  Total RNA isolation for DNA microarray & real-time PCR: 
 
Following dissection of the required number of hair follicles, the process of total RNA 
isolation was carried out in accordance to the manufacturer’s instructions using the 
RNeasy Mini kit (Qiagen Ltd, Sussex, UK). The microdissected hair follicles were placed 
in a glass homogeniser (3 ml) containing lysis solution which consisted of 3 µl of             
ß-mercaptoethanol (14 mM) with 350 µl of buffer RLT which contained guanidine 
thiocyanate. The hair follicles were disrupted and homogenised until they became 
undetectable and there were no visible solid remains. The homogenate was placed in a 
filtration column and centrifuged at 12000 g for 3 minutes (Eppendorf 5415 R) to remove 
any cellular debris and shear the DNA. Following centrifugation, the filtration column 
was discarded and an equal volume of 70% ethanol treated water was added to the 
cleared filtrate. The sample was mixed thoroughly by pipetting. 
The lysate/ethanol mixture (700 µl) was transferred to a RNeasy spin column placed in a 
2 ml collection tube and then centrifuged for 15 seconds at 8000 g. Following 
centrifugation, the flow-through was discarded and the RNA was bound to the column. 
The remaining sample was added to the binding column and the procedure repeated. The 
spin column was then transferred to a new collection tube.  
DNA digestion was carried out to eliminate any genomic DNA contamination using 
RNase-free DNase kit (Qiagen Ltd) containing the enzyme oligodeoxyribonuclease I 
which digests single and double strand DNA. DNase I stock solution was prepared by 
dissolving the lyophilized DNase I (1500 kunitz units) in 550 µl of RNase-free water. To 
avoid loss of DNase I, the RNase-free water was injected into the vial using a RNase-free 
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needle and syringe. Since DNase I is especially sensitive to physical denaturation, the 
mixture was mixed gently by inverting the vial without vortexing. The reconstituted 
DNase I was divided into single-use aliquots and stored at -20ºC until required.  
Buffer RW1 (350 µl, composition not available due to trade secret) was added to the 
RNeasy spin column and centrifuged for 15 seconds at 8000 g to wash the spin column 
membrane. DNase I stock solution (10 µl) was added to buffer RDD (70 µl, composition 
not available) and mixed by gently inverting the tube; residual liquid was collected from 
the sides of the tube by centrifuging briefly. The DNase I incubation mix (80 µl) was 
transferred directly to the RNeasy spin column membrane and placed on the benchtop at 
20-23ºC for 15 minutes. Buffer RW1 (350 µl) was added to the spin column and 
centrifuged at 8000 g for 15 seconds. Following centrifugation, the flow-through was 
discarded and the spin column was transferred into a new collection tube.  
To wash the spin column membrane, buffer RPE (500 µl, composition not available) was 
added to the column and centrifuged for 15 seconds at 8000 g; the flow through was 
discarded. Another 500 µl of buffer RPE was added to the column and centrifuged for 2 
minutes at 8000 g to remove the ethanol. After centrifugation, the RNeasy spin column 
was removed carefully and placed in a new 2 ml collection tube, and centrifuged for 1 
minute at 11,000 g. Long centrifugation dried the spin column membrane and ensured 
that no residual ethanol remained. The column was then transferred to a new 1.5 ml 
collection tube. The purified RNA was eluted from the column by adding the RNase-free 
water (30 µl) directly to the centre of the column and centrifuged for 1 minute at 8000 g. 
The column was discarded and the flow-through which contained purified RNA was used 
immediately or stored at -80ºC until used. 
- 011 - 
 
2.2.2.1  Assessing yield and purity of total RNA: 
The quality and integrity of total RNA was checked using the Agilent 2100 Bioanalyzer 
(Agilent Technologies, Santa Clara, USA) which uses a fluorescent assay involving 
electrophoretic separation to evaluate RNA samples qualitatively. The Bioanalyzer 
provides more sensitive qualitative analysis from less RNA than the traditional methods 
such as using a spectrophotometer and gel electrophoresis. It is faster than gels, saving 
time and materials while using small amount of RNA, as little as 1 µl of total RNA.   
The Bioanalyzer measures the amount of fluorescence as the RNA sample is pulsed 
through a microchannel over time. It calculates the ratio of ribosomal bands in total RNA 
samples and shows the percentage of ribosomal impurities in mRNA samples (Agilent). 
The Bioanalyzer software creates a graph called an electropherogram, which diagrams 
fluorescence over time and creates a gel image to accompany the graph for each sample.  
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2.2.3  Comparing  gene expression in isolated hair follicles in balding and 
non-balding individuals using DNA microarray: 
 
2.2.3.1  DNA microarray procedure: 
The biological materials used for DNA microarray analysis were described in section 
2.2.1. The hair follicles were microdissected from both balding and non-balding samples 
and then total RNA was extracted. Following total RNA isolation using the RNeasy Mini 
kit (Qiagen Ltd) as described in section 2.2.2, the quality of the resulting total RNA was 
checked using the Bioanalyzer 2100 (Agilent) (see section 2.2.2.1). All the subsequent 
technical procedures, including checking the quality and concentration measurement of 
RNA, cDNA synthesis, labelling, hybridization, washing and scanning of the microarray 
were done at the Sheffield Microarray Core Facility, The Medical School, University of 
Sheffield, UK. Initially, the Ambion WT expression kit (Ambion, Austin, USA) was used 
to prepare RNA samples for Affymetrix microarray analysis. This kit was designed to 
generate amplified sense-strand DNA without bias. The procedure was performed, 
according to the manufacturer’s instruction, in the following successive steps:  
2.2.3.1.1  First-strand cDNA synthesis: 
The first-strand master mix was prepared in a sterile tube (0.5 ml) by combining the first-
strand buffer mix (4 µl, composition not available due to trade secret) with the first-strand 
enzyme mix (1 µl) at room temperature. The contents were mixed thoroughly by gently 
vortexing and centrifuged briefly at 8000 g for about 5 seconds to collect the mix at the 
bottom of the tube. The master mix (5 µl) was transferred to a PCR reaction tube. The 
total RNA sample (5 µl) was added to the mix and the tube was centrifuged briefly at 
8000 g for a few seconds. The tube was incubated in a thermal cycler for 1 hour at 25ºC, 
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then 1 hour at 42ºC and then for at least 2 minutes at 4ºC. Following the incubation, the 
tube was centrifuged briefly as above for a few seconds and then placed in ice for 2 
minutes to cool the tube because transferring the second-strand master mix to a hot tube 
or holding the first-strand cDNA for longer than 10 minutes at 4ºC may significantly 
reduce the cRNA yield.   
2.2.3.1.2  Second-strand cDNA synthesis: 
In a nuclease-free tube, the second-strand cDNA master mix (50 µl) was prepared by 
combining nuclease-free water (32.5 µl), second-strand buffer mix (12.5 µl, composition 
not available due to trade secret) and second-strand enzyme mix (5 µl). The tube was 
mixed thoroughly and centrifuged briefly. The master mix (50 µl) was transferred to a 
reaction tube containing 10 µl of the resulting first-strand cDNA from the previous step. 
The tube was incubated in a thermal cycler for 60 minutes at 16ºC, for 10 minutes at 65ºC 
and for at least 2 minutes at 4ºC. The tube was centrifuged at 8000 g for 5 seconds to 
collect the cDNA at the bottom of the tube and then placed in ice.     
2.2.3.1.3  cRNA synthesis by in vitro transcription: 
cRNA was synthesized and amplified by in vitro transcription (IVT) of the second-strand 
cDNA template using T7 RNA polymerase. At room temperature, the IVT master mix 
was prepared by adding 24 µl of IVT buffer mix (composition not available) to 6 µl of 
IVT enzyme mix in a nuclease-free tube. The tube was mixed and spun down briefly for 
few seconds. The total volume of master mix (30 µl) was added to 60 µl of second-strand 
cDNA and mixed thoroughly by vortexing before centrifuging briefly at 8000 g. The tube 
was incubated in a thermal cycler for 16 hr at 40ºC and then overnight at 4ºC.   
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The resulting cRNA was purified to improve its stability and to remove any 
unicorporated nucleotides, salts and inorganic phosphate. In a sterile tube, the cRNA 
binding mix was prepared by combining nucleic acid binding beads (10 µl) to nucleic 
acid binding buffer concentrate (50 µl) and mixed thoroughly. The resulting binding mix 
(60 µl) was added to the cRNA sample and mixed by pipetting up and down 3 times. 
Isopropanol (100%; 60 µl) was added to the mix and then transferred to a well of a        
U-bottom plate. The plate was placed in a MixMate shaker (Krackeler Scientific Inc, US) 
and shaken gently for at least 2 minutes. This incubation allowed the cRNA to bind to the 
nucleic acid binding beads. The plate was placed in a magnetic stand to capture the 
magnetic beads. During this process, the nucleic acid binding beads formed pellets 
against the magnets in the stand. The supernatant was discarded leaving the beads in the 
plate. Nucleic acid wash solution (500 µl) was then added to the sample and shaken for 1 
minute. Following that, the plate was placed again in the magnetic stand to capture the 
beads and the supernatant was removed. To evaporate residual ethanol, the plate was 
shaken vigorously for 1 minute. The purified cRNA was eluted by adding 40 µl preheated 
elution solution (55 to 58ºC) and incubated for 2 minutes. After incubation, the nucleic 
acid binding beads were dispersed by vigorously shaking the plate for 3 minutes and then 
recaptured using the magnetic stand. The supernatant which contained the eluted cRNA 
was transferred to a new collection tube and used immediately or stored at -80ºC until 
required.  
2.2.3.1.4  2nd cycle cDNA synthesis: 
Sense-strand cDNA was synthesized by the reverse transcription of cRNA using random 
primers. The cRNA (10 µg; 22 µl) was combined with 2 µl random primers and mixed 
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thoroughly by gently vortexing and centrifuging at 8000 g for 5 seconds to collect the 
reaction mix at the bottom of the tube. The tube was then incubated in a thermal cycler 
for 5 minutes at 70ºC, 5 minutes at 25ºC, and then 2 minutes at 4ºC. In a nuclease-free 
tube, the 2nd-cycle master mix was prepared from 2nd-cycle buffer mix (8 µl, 
composition not available due to trade secret) and 2nd-cycle enzyme mix (8 µl), and then 
added to 24 µl of cRNA/random primer sample. The reaction mixture was incubated in a 
thermal cycler for 10 minutes at 25ºC, 90 minutes at 42ºC, 10 minutes at 70ºC, and for at 
least 2 minutes at 4ºC. After incubation, the tube was placed in ice and used for 
subsequent steps. On ice, RNase H (2 µl) was added to the 2nd-cycle cDNA to degrade 
the cRNA, leaving only the single-strand cDNA. After mixing by pipetting the tube was 
incubated in a thermal cycler for 45 minutes at 37ºC, 5 minutes at 95ºC, and for at least 2 
minutes at 4ºC.  
 
The resulting 2nd-cycle cDNA was purified to remove unincorporated dNTPs, salts and 
enzymes. The cDNA binding mix was prepared at room temperature in a sterile tube by 
mixing nucleic acid binding beads (10 µl) to nucleic acid binding buffer concentrate (50 
µl). Nuclease free water (18 µl) and the binding mix (60 µl) were added to the reaction 
mixture and mixed thoroughly. The contents were transferred to a well of a U-bottom 
plate and 120 µl of 100% ethanol was added to the mix and mixed by gently shaking 
using a MixMate shaker (Krackeler Scientific) for 2 minutes so that the cDNA in the 
sample bound to the beads during this incubation process. The plate was transferred to 
the magnetic stand to capture the magnetic beads and the supernatant removed. The 
nucleic acid wash solution (100 µl) was added to the contents and mixed by shaking for 1 
minute, the beads were captured using the magnetic stand. Vigorous shaking for 1 minute 
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evaporated the residual ethanol. The purified cDNA was eluted from the beads by 
incubating at room temperature for 2 minutes with 30 µl of preheated (55-58ºC) elution 
solution. The plate was shaken vigorously for 3 minutes to disperse the beads which were 
captured using the magnetic stand. The supernatant which contained the eluted cDNA 
was transferred to a new collection tube and used then for fragmentation labelling steps.  
 
 
 
 
 
 
 
 
 
Methods 
 
Step 1 
 
 
Step 2 
 
Step 3 
 
Step 4 
 
First-strand cDNA synthesis 
 
25˚C, 60 min 
 
 
42˚C, 60 min 
 
 
4˚C, 2 min 
 
 
 
 
Second-strand cDNA synthesis 
 
16˚C, 60 min 
 
 
65˚C, 60 min 
 
 
4˚C, 2 min 
 
 
 
 
cRNA synthesis (in vitro transcription) 
 
40˚C, 16 hrs 
 
 
4˚C, hold 
 
 
 
 
 
 
 
2nd-cycle cDNA denaturation 
 
70˚C, 5 min 
 
 
25˚C, 5 min 
 
 
4˚C, 2 min 
 
 
 
 
 
2nd-cycle cDNA synthesis 
 
25˚C, 10 min 
 
 
42˚C, 90 min 
 
 
70˚C, 10 min 
 
 
4˚C, 2 min 
 
 
RNase H hydrolysis 
 
37˚C, 45 min 
 
 
95˚C, 5 min 
 
 
4˚C, 2 min 
 
 
 
Table 2.5 Thermal cycling conditions used for preparing samples   
                 for DNA microarray analysis. 
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2.2.3.2  Fragmentation & labelling of single-strand DNA: 
This process was carried out using the GeneChip terminal labelling and hybridization kit 
(Affymetrix, Santa Clara, CA). The fragmentation master mix was prepared by 
combining RNase-free water (10 µl), 10X cDNA fragmentation buffer (4.8 µl), uracil-
DNA glycosylase (UDG) (1 µl) and apurinic/apyrimidinic endonuclease 1 (APE1) (1 µl) 
to recognize and fragment the cDNA at dUTP residues. The prepared master mix was 
then added to the sample tube which contained single-strand DNA (5.5 µg) and RNase-
free water (31.2 µl). The reaction mixture was vortexed gently, and spun down at 8000 g 
for a few seconds and then incubated in the thermal cycler for 60 minutes at 37ºC, for 2 
minutes at 93ºC, and then for 2 minutes at 4ºC.  
  
Following this incubation, labeling of fragmented single-strand DNA was performed. The 
labeling reaction mixture contained 5X TdT buffer (12 µl, 50 mM Sodium Cacodylate, 
pH 6.8, 5 mM Cobalt Chloride and 0.5 mM DTT), deoxynucleotidyl transferase (TdT) (2 
µl) and DNA labeling reagent contained Allonamid triphosphate (1 µl) to give the total 
volume 15 µl which added to the fragmented single-strand DNA (45 µl). The tube was 
incubated in the thermal cycler for 60 minutes at 37ºC, 10 minutes at 70ºC, and then for 
at least 2 minutes at 4ºC.  
 2.2.3.3  Hybridization: 
The hybridization process was carried out using the GeneChip hybridization, wash and 
stain kit (Affymetrix). In a 1.5 ml RNase-free eppendorf tube, the hybridization cocktail 
was prepared by combining 60 µl of the fragmented and labeled DNA, 3.7 µl of control 
oligonucleotide B2 (3 nM), 11 µl of 20X eukaryotic hybridization control, 110 µl of 2X 
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hybridization mix, 15.4 µl DMSO, and nuclease-free water (220 µl).  The tube was 
vortexed gently and spun down for few seconds. The hybridization cocktail was heated at 
99ºC for 5 minutes and cooled to 42ºC for 5 minutes, and then centrifuged at 12,000 g for 
1 minute. The GeneChip Human Exon 1.0 ST Array (Affymetrix) was equilibrated to 
room temperature immediately before use. The array was labelled with the name of the 
sample to be hybridized. An appropriate amount of hybridization mix was then injected 
into the array through one of its septa. The array was placed in a 45ºC hybridization oven 
at 60 rpm and incubated for about 17 hours.     
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 2.4 GeneChip® probe array and its parts 
Images were adapted and modified from the Affymetrix  manual.  
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2.2.3.4  Washing, staining & scanning of hybridized array: 
After 17 hours of hybridization, the array was removed from the hybridization oven. 
Wash and stain steps were carried out using the GeneChip hybridization, wash and stain 
kit (Affymetrix). The probe array was vented by inserting a clean pipette tip into one of 
the septa and the hybridization cocktail was extracted using a pipettor through the other 
septum. The array was refilled completely with a suitable volume of wash buffer A (6X 
SSPE, 0.01% Tween-20). 
  
The staining reagents consisted of streptavidin phycoerythrin (SAPE) solution and 
antibody solution. The SAPE solution mix was prepared by combining: 1X stain buffer 
(600 µl, 10 mM MES, 0.1 M NaCl, 0.01% Tween-20), 2 mg/ml BSA (48 μl), 10 μg/ml 
streptavidin phycoerythrin (SAPE) (12 µl) and deionized water (540 µl). Since SAPE is 
sensitive to light, it was stored in the dark at 4 °C and wrapped with foil. The antibody 
solution mix consisted of 2X stain buffer (300 µl), 2 mg/ml BSA (24 µl), 0.1 mg/ml goat 
IgG (6 µl), 3 μg/ml biotinylated antibody (3.6 µl), deionized water (266.4 µl). The wash 
and stain process was then carried out automatically in the Fluidics Station 450/250 
(Affymetrix) using Affymetrix® GeneChip Command Console (AGCC) software. 
  
After the wash protocols were completed, the intensity of the fluorescence of the array 
was scanned and measured using the Affymetrix® GeneChip® Scanner 3000 
(Affymetrix). The laser was warmed up by turning it on at least 10 minutes prior to 
scanning. The scanner was controlled by the AGCC software. After completing the 
scanning procedure, the scanned probe array image was ready for analysis.  
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Figure 2.5  Preparation of microarray and microarray procedure 
Image was reproduced and adapted from Somasundaram et al., (2002) 
with the author’s permission. 
 Treated sample  Normal sample 
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2.2.3.5  Microarray data analysis: 
 
 To study the changes in gene expression in balding versus non-balding scalp hair 
follicles, the Affymetrix GeneChip human exon 1.0 ST array containing 28,869 genes 
was used. A total of six chips were used in this study; one chip per sample. Following the 
scanning procedure, the scanned probe array image files were processed and analyzed 
using GeneSpring GX 11 software (Agilent technologies). The data was normalized to 
standard microarray data as per-gene normalization using the robust multi-array analysis 
(RMA) method (Irizarry et al., 2003). The normalization process aims to remove certain 
systematic biases from microarray data. The data was transformed to the log scale to 
stabilize the variation across the expression ranges associated with the probe 
concentration (Quackenbush, 2002; Cui & Churchill, 2003). The data distribution in 
balding and non-balding samples was visualized using box and whiskers plot. The 
correlation between the two conditions was plotted on a scatter diagram. The data quality 
was further investigated using principal component analysis (PCA) method (Komura et 
al., 2004; Shlens, 2009).  
 
Replicate data was organized in hierarchical clustering by both individual samples as well 
as grouped data. A t-test filter was used to determine which genes are significantly 
differentially expressed and to exclude all probe sets with differential expression t-test   
P-values of less than 0.05. A fold change filter was also used for further investigation.  
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2.2.4  Comparison of the expression of specific genes in non-balding and 
balding hair follicles using quantitative real-time PCR: 
2.2.4.1  RNA amplification: 
 
Due to the limited starting materials obtained from the androgenetic alopecia patients, the 
isolated total RNA (section 2.2.2) was amplified using the Smart™ RNA amplification 
kit (Clontech laboratories, USA) to synthesize high-quality RNA for use in quantitative 
real-time PCR. The amplification procedure was done in accordance to the 
manufacturer’s instructions in the following successive steps:  
2.2.4.1.1  First-strand cDNA synthesis: 
 
In a sterile 0.5 ml reaction tube, 1-3 µl of RNA sample (0.1-5 µg) was added to 1 µl of 
cDNA synthesis (CDS) primer II A (12 µM) and a suitable amount of nuclease-free water 
to give the total volume of 4.25 µl. The contents were mixed and centrifuged briefly at 
8000 g for few seconds in a eppendorf 5415 microcentrifuge. The tube was incubated in a 
thermal cycler for 3 minutes at 70ºC and then the temperature was reduced to 42ºC for 2 
minutes. The master mix was prepared by combining the following components in a 0.5 
ml RNase-free eppendorf tube in the order shown: 
  
 
 
 
 
 
Material 
 
 
Amount ( µl) 
 
 
5X First-Strand Buffer (25 mM Tris-HCl, pH 8.3, 15 mM 
MgCl2, 20 mM spermidine, 35 mM KCl) 
 
DTT (100 mM) 
 
RNase inhibitor (1 U/ µl) 
 
SMART™ T7 Oligonucleotide (10 µM) 
 
50X dNTP mix (dATP, dGTP, dCTP, dTTP; 10 mM) 
 
Smartscibe Reverse Transcriptase 
 
2.00 
 
 
0.50 
 
0.25 
 
1.00 
 
1.00 
 
1.00 
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The contents were mixed by vortexing and centrifuged briefly in the microcentrifuge. 
Following centrifugation, the master mix (5.75 µl) was added to the reaction tube 
prepared previously. The contents were mixed thoroughly by pipetting and centrifuged 
briefly. The reaction tube was returned immediately to the thermal cycler and incubated 
at 42ºC for 1.5 hr. The reaction was terminated by heating at 68ºC for 10 minutes.                                 
2.2.4.1.2  Second-strand cDNA synthesis: 
Following first-strand cDNA synthesis, the master mix for second-strand cDNA was 
prepared by combining the following components in a 0.5 ml RNase-free eppendorf tube 
in the order shown:  
  
 
 
 
 
 
The contents were mixed by vortexing and the tube centrifuged briefly at 8000 g for few 
seconds. This master mix (90 µl) was added to the reaction tube containing the first-
strand cDNA obtained from the previous step (section 2.2.4.1.1) and mixed by vortexing. 
The reaction tube was placed in a thermal cycler using the following program: 37ºC for 
15 minutes, 95ºC for 2 minutes, 60ºC for 1 minute, 68ºCf or 10 minutes.  
 
Material 
 
 
Amount ( µl) 
  
 
Nuclease-free water 
 
10X Advantage® 2 PCR buffer (10 mM Tris-HCl, 15 mM 
MgCl2, 50 mM KCl) 
 
50X dNTP mix (dATP, dGTP, dCTP, dTTP; 10 mM) 
 
T7 extension primer (10 µM) 
 
RNase H (10 U/µl) 
 
50X Advantage® 2 polymerase mix 
 
 
73 
 
10 
 
 
2.0 
 
2.0 
 
1.0 
 
2.0 
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2.2.4.1.3  Purification of double-strand cDNA: 
Prior to performing in vitro transcription, the double-strand cDNA was purified using the  
Atlas Nucleospin® Extraction II kit (Clontech). Two volumes of buffer NT (200 µl, 
contained chaotropic salt) was added to one volume of sample (100 µl PCR reaction 
mix). The sample was loaded on to a Nucleospin extract II column which was placed into 
2 ml collecting tube. The mixture was centrifuged for 1 minute at 11,000 g; the flow-
through was discarded and the column was placed into a new collecting tube.   
Buffer NT3 (600 µl) was added to the reaction mixture and centrifuged at 11,000 g for 1 
minute. The flow-through was discarded and the column was placed back into the 
collecting tube. To remove buffer NT3, the column was centrifuged for 2 minutes at 
11,000 g. The spin column was placed in a clean 1.5 ml tube.  
Buffer NE (50 µl, 5 mM Tris-HCl; pH8.5) was added to the column and was left to stand 
for 1 minute, before the tube was centrifuged at 12,000 g for 1 minute. A second aliquot 
(50 µl) of buffer NE was added to the column and the process repeated. The Nucleospin 
column was discarded and the eluted cDNA was centrifuged at 12,000 g for an additional 
3 minutes. The supernatant was transferred to a new collection tube.  
Linear acrylamide (3 µl), sodium acetate (10 µl) and 100% ethanol (250 µl) were mixed 
and added to the reaction tube which was placed at -20ºC overnight to precipitate the 
cDNA. The next day the tube was centrifuged for 20 minutes at 12,000 g. The 
supernatant was removed by pipetting and the pellet washed once in 100 µl of 70% 
ethanol for 10 minutes before dissolving in 9 µl nuclease-free water. The purified double-
strand DNA was used immediately or stored at -20ºC until required.    
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2.2.4.1.4  Synthesis of cRNA (in vitro transcription): 
Following purification of double-strand cDNA, in vitro cRNA synthesis was carried out. 
The transcription master mix was prepared by combining the following components at 
room temperature, in the order shown below:    
 
 
 
 
 
The tube was mixed by vortexing and centrifuged briefly at 8000 g for few seconds in the 
microcentrifuge. The transcription master mix (11 µl) was added to the purified double-
strand cDNA (9 µl) and mixed by vortexing before incubating at 37ºC for 12 hr. The 
resulting cRNA was purified as described below. 
2.2.4.1.5  Purification of cRNA: 
The cRNA was purified to remove any unicorporated ribonucleotides and small cDNA 
and RNA fragments. The purification process was carried out using the NucleoSpin® 
RNA II purification kit (Clontech). Buffer RA1 (300 µl, composition not available) was 
added to cRNA (20 µl) in a 0.5 ml RNase-free eppendorf tube and mixed well by 
pipetting. Ethanol (100%; 240 µl) was added to the mixture and mixed thoroughly. The 
 
Material 
 
 
Amount ( µl) 
 
 
10X T7 transcription buffer (20 mM Tris-HCl; pH 7.5, 50 
mM NaCl2, , 10 mM spermidine, 30 mM MgCl2) 
 
3X rNTP mix (ATP, CTP, GTP, UTP; 10 mM) 
 
RNase inhibitor (1 U/ µl)  
 
T7 RNA polymerase (1,000 U/µl)  
 
2.0 
 
 
7.0 
 
1.0 
 
1.0 
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sample was loaded into a Neucleospin column already inside a 2 ml collection tube. The 
tube was centrifuged for 60 seconds at 8000 g, and the flow-through discarded.   
 
The cRNA was washed by adding buffer RA3 (750 µl, composition not available) to the 
Nucleospin column and centrifuged at 14,000 g for 1 minute; the flow-through was 
discarded and the column placed into a new 2 ml collection tube. This process was 
repeated twice using 250 µl of buffer RA3 each. The tube was centrifuged at 14,000 g for 
a further minute to remove any residual wash buffer and dry the filter column, which was 
then transferred to a new 1.5 ml collection tube. The RNA was eluted by adding 30 µl of 
nuclease-free water to the centre of the column. After elution, the spin column was 
discarded and the eluted RNA was transferred to a new collection tube. The purified 
cRNA was either used immediately or stored at -80ºC until required.  
2.2.4.1.6  Checking the quality of purified cRNA: 
The quality and purity of the resulting RNA was evaluated using the NanoDrop 2000 
spectrophotometer (Thermo Scientific, Loughborough, UK) before synthesis of cDNA 
was carried out as described in section 2.1.1.6. The automatic path length capability of 
the NanoDrop 2000 spectrophotometer allowed for measurement of samples using the 
instrument’s standard method, with no special sample preparation required. All samples 
were measured on the NanoDrop 2000 without dilution. The elution solution (1.2 µl) was 
used as a control to set the background as zero and then 1.2 µl of each RNA sample was 
used for measurement of the RNA concentration. The NanoDrop 2000 created a graph for 
each sample measured. Figure 2.6 shows the basic use of NanoDrop 2000 instrument.  
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Figure 2.6 NanoDrop 2000 instrument (A) and checking the quality of RNA (B) 
 
(1) The sampling arm was raised and both the upper and lower pedestals were wiped                  
      using a dry, lint-free laboratory wipe.  
(2) The elution solution (1.2 µl) was used as a control to set the background as zero and  
      then the RNA sample (1.2 µl) was loaded onto the lower measurement pedestal. 
(3) The sampling arm was lowered and a spectral measurement was initiated using the                                
      software on the PC which was completed automatically.  
(4) When the measurement was completed, the sampling arm was raised and the sample    
      was wiped from both the upper and lower pedestals to prevent sample carryover and        
      to avoid residue buildup in subsequent measurements. 
      Images were adapted and modified from the Thermo Scientific manual.                                                                   
                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                       
A 
B 
(1) (2) 
(3) (4) 
- 007 - 
 
2.2.4.2  Primer design used for real-time PCR: 
The Ensemble genome browser was used to find the human genomic sequences for 
GAPDH, HGF, MSP, c-Met and RON, and the exon information part of each gene 
sequence was used for this purpose.  Primers, forward and reverse, for each gene were 
selected from the exon part of the genomic sequence. The primer combination was 
selected using two different exons, crossing an intron, to ensure that the correct sized 
product would only be obtained from cDNA and not from any contaminating genomic 
DNA sequence that might be present in the PCR mixture. The designed primers for each 
gene were checked by comparing with the specific human gene sequence of the target 
gene using the NCBI BLAST programme (http://www.ncbi.nlm.nih.gov/blast/b12seq/ 
wblast2/.cgi).  
After designing the primers was completed for each gene, they were checked using the 
Ensemble genome browser against the human genome of the target gene to see if they 
were only specific to the desired target sequence.  Ensemble blast was also used to check 
the exact chromosomal location of each primer, the length of matching area on the 
chromosome and the length of the gap between the end of the forward primer matching 
area and the start of reverse primer matching area, all done against human genome.  The 
primers for GAPDH, HGF, MSP, c-Met and RON were synthesised by Sigma Genosys 
Biotechnologies Ltd (Pampisford, UK).  The designed primers for each gene were first 
checked on human cDNA obtained from the universal human reference RNA (Stratagene, 
UK) which comprises a collection of RNA pooled from ten different cell lines for an 
optimal broad coverage of human genes (appendix II). The primer sequences, their 
optimised PCR conditions and expected amplicon size are detailed in table 2.6.   
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Expected 
amplicon 
size 
 
Optimal thermocycling 
conditions 
 
 
Primer  sequence 
 
 
Gene 
 
 
 
 
148 bp 
 
95°C for 3 minutes 
95°C for 10 seconds 
60.5°C for  30 seconds        
72°C for 15 seconds 
40 cycles 
 
 
 
F:  5’ ATC ACT GCC ACC CAG AAG 3’ 
R: 5’ CAG TGA GCT TCC CGT TCA 3’ 
 
 
 
GAPDH 
 
 
 
 
 
144 bp 
 
95°C for 3 minutes 
95°C for 10 seconds 
58.3°C for  30 seconds        
72°C for 15 seconds 
40 cycles 
 
 
 
F: 5’ TTCACAAGCAATCCAGAGGTACGC 3’ 
R: 5’ ATGATCCCAGCGCTGACAAATCTT 3’ 
 
 
 
 
 
HGF 
 
 
 
 
 
116 bp 
 
 
95°C for 3 minutes 
95°C for 10 seconds 
58.3°C for  30 seconds        
72°C for 15 seconds 
40 cycles 
 
 
 
F: 5’ AGGAGGATGTGGCAGATGC 3’ 
R: 5’ TTGAGTCCATGGCAGCAGT 3’  
  
 
 
MSP 
 
 
 
 
 
117 bp 
 
95°C for 3 minutes 
95°C for 10 seconds 
60.5°C for  30 seconds        
72°C for 15 seconds 
40 cycles 
 
 
 
F: 5’ ACAGTGGACCTCTAAGGGGCA 3’ 
R:  5’ AGGGACTTTGGCCCACAGTGA 3’ 
 
 
 
RON 
 
 
 
 
 
152 bp 
 
95°C for 3 minutes 
95°C for 10 seconds 
56.5°C for  30 seconds        
72°C for 15 seconds 
40 cycles 
 
 
 
F: 5’ATTTGGATAGGCTTGTAAGTGC 3’ 
R: 5’ TGTCAGAGGATACTGCACTTGT 3’ 
 
 
c-Met 
 
 
 
           Table 2.6  Primer sequences and PCR conditions for each specific  
                            gene used for real-time PCR. 
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2.2.4.3   The quantitative real-time PCR procedure: 
 
 
Real-time PCR was performed using the MyiQ™ single-colour real-time PCR detection 
system (Bio-Rad, UK) and SYBER® Green PCR Master Mix (Applied Biosystem, 
USA). For each real-time PCR reaction, the following reaction mix was prepared and 
used: SYBER® Green PCR Master Mix (12.5 µl), the forward primer of the target gene 
(1 µl), the reverse primer of the target gene (1 µl), the cDNA template (1 µl) and the 
mixture was brought to 25 µl by adding nuclease-free water (9.5 µl). The reaction 
mixture was then transferred into an optical 96-well reaction plate (Applied Biosystem) 
which was already labeled. Each well of the reaction plate was also supplied with 25 µl 
of the appropriate PCR master mix was added. Each well was tightly covered using 
specific optical caps. The highly expressed housekeeping protein, GAPDH, was used as 
an endogenous control.   
 
The plate was then transferred to a centrifuge (Eppendorf, 5810R) for centrifugation at 
3000 rpm for about 10-15 minutes and checked to verify that each reaction mix was 
positioned in the bottom of the well to ensure that there was no air bubbles inside the well 
which would interfere with the reading, see figure 2.7. The plate was then placed into the 
real-time PCR machine.   
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Real-time PCR was performed using specific forward and reverse primers for each cDNA 
target sequence. The annealing temperature for each target primer set was initially 
optimized using the cDNA template, synthesized from the universal human reference 
RNA (Stratagene, UK) which composed of total RNA isolated from 10 cell lines 
representing different human tissues which were chosen to ensure a standard broad 
coverage of human genes (appendix II). The real-time PCR was performed under the 
following cycling conditions: 94ºC for 3 minutes, followed by denaturing at 94ºC for 15 
seconds, annealing (gradient) of 55ºC to 63ºC for 30 seconds, followed by 72ºC for 15 
seconds; this was repeated for 40 cycles. The primer sequences, their optimized cyclic 
conditions and their expected amplicon size are detailed in table 2.6.  
Figure 2.7 The different positions of reaction mix in 96-well plate. 
 
(A) Correct position: the reaction mix is positioned in the bottom of the well 
 
(B) Incorrect position: the reaction mix is positioned on the side wall due to the                                                             
      lack of centrifugation 
 
(C) Incorrect position: presence of air bubbles at the bottom of the well due to the  
      plate was not centrifuged with sufficient time or speed.   
 
 
(A) (B) (C) 
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2.2.4.4   Data analysis: 
 
Real-time PCR data and the differences between samples and controls were calculated 
using the Genex database software based on the comparative (∆∆Ct) equitation method 
(Livak and Schmittgen, 2001) to calculate relative quantities of a nucleic acid sequence. 
The Ct is the threshold cycle during which a reaction emits the threshold level of 
fluorescence. The detectable amount of fluorescence when a signal is significantly greater 
than background, is known as the threshold. Data was normalized to the corresponding 
values of an endogenous control, glyceraldehyde 3-phosphate dehydrogenase 
(abbreviated as GAPDH or less commonly as G3PDH). A statistically based method, 
Student’s t-test, was used to determine significant differences in gene expression between 
the two conditions with P<0.05.    
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3- Results 
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3- Results 
 
 
3.1  Histological investigation of human and red deer hair follicles: 
 
The initial stage of this investigation required familiarisation of the hair follicle structure. 
To do this, cryosections of human and red deer skin were examined by histological 
staining using Sacpic (Nixon, 1993; Nutbrown and Randall, 1996) and haematoxylin & 
eosin staining techniques to clearly visualise the normal histology of the hair follicle and 
to aid the interpretation the immunohistochemical staining.  
In Sacpic staining, several different dyes were used to distinguish the different parts of 
the skin and hair follicle. In general, the Sacpic staining allowed the different structures 
of the hair follicles to be differentiated in both species (figures 3.1, 3.2, 3.3). The overall 
structure of the hair follicle was seen showing the connective tissue sheath as pale blue 
encasing the whole follicle, separating it from the dermis (blue/green). The fully 
keratinised hair fibre stained yellow surrounding by red inner root sheath and the outer 
root sheath (blue). The dermal papilla is situated in the hair bulb, surrounded by the hair 
matrix and attached to the connective tissue sheath at its base.  
                                
Colour Components 
 
Blue/green 
Bright blue 
Pale blue 
Blue 
Red 
Yellow 
Pink 
 
Dermis 
Collagen 
Connective tissue sheath 
Outer root sheath 
Inner root sheath 
Fully keratinised hair fibre 
Pre-keratinised hair fibre  
 
 
                                   Table 3.1  Interpretation of Sacpic staining 
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3.1.1  Red deer skin 
 
 
The histological staining of adult red deer stag neck (mane) skin with anagen hair 
follicles using Sacpic revealed a thin epidermal layer above a thick collagenous dermal 
layer stained blue/green; the hair follicles extended down into the dermis. The 
components of the hair follicles are highlighted by the Sacpic staining, the dermal papilla 
located within the hair bulb and surrounded by the hair matrix, the hair fibre surrounded 
by the inner root sheath and the outer root sheath. The connective tissue sheath 
encapsulated the entire follicle separating it from the dermis. Red deer hair follicles are 
larger than human scalp hair follicles and an obvious medulla was clearly seen within the 
hair (figure 3.1). Table 3.1 gives a summary of the Sacpic staining colours. 
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Figure 3.1 Histology of red deer hair 
follicle. 
 
Histological staining of cryosections of red 
deer hair follicle using Sacpic staining. The 
hair follicle extends into the thick dermal 
layer. The sections show the structure of deer 
hair follicle components including the outer 
root sheath (ORS), the inner root sheath (IRS), 
the connective tissue sheath (CTS), The hair 
cortex (CO), the medulla (MD) in the centre 
of the follicle. The hair bulb extends deep 
within the skin and includes the dermal papilla 
(DP) which is surrounded by the hair matrix 
(M) and attached to the connective tissue 
sheath (CTS) at its base. Scale bar (A 75 µm, 
B 69 µm), magnification (A x70, B x95). 
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3.1.2  Human skin: 
 
 
The histological staining of human scalp skin showed a thin epidermis, underlying 
collagenous dermis and a subcutaneous fat layer beneath into which the anagen hair 
follicles extend (figure 3.2). The hair follicles extend down into the subcutaneous adipose 
tissue. The different components of the hair follicle were highlighted by the Sacpic stain 
(figure 3.3) and haematoxylin & eosin (figure 3.5) which showed the hair shaft internal 
root sheath, outer root sheath, connective tissue sheath, hair matrix and derma papilla 
located within the hair bulb.  
Many hair follicle layers can be seen in horizontal cross-section of hair follicle using 
Sacpic (figure 3.4) and haematoxylin & eosin (figure 3.5). The hair follicles were 
sectioned in the upper part of the follicles in which fully keratinised hair fibres are 
present. The Scapic stain revealed greater details of the hair follicle structure.       
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Figure 3.2  Longitudinal section of human scalp skin stained with Sacpic staining                          
 
(A) A section of a 42 year old female human full depth scalp biopsy shows a thin 
epidermis (E), a thick dermal layer (D) stained blue/green, composed of collagen, and 
a longitudinal hair follicle which extends deep into the subcutaneous fat (SF). The 
fully keratinized hair fibre (H) stained yellow. Attached to the hair follicles are 
sebaceous glands (SG) which consists of several lobes clearly visible within the 
dermal layer. Scale bar (205 µm), magnification (x16). 
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Figure 3.3  Longitudinal section of human scalp anagen hair follicle stained with 
Sacpic staining                          
 
Different components of the human scalp hair follicle are clearly visible which include 
the connective tissue sheath (CTS), the outer root sheath (ORS), and the inner root 
sheath (IRS) stained red. The hair bulb is located in the subcutaneous fat (SF) deep 
within the skin and includes the dermal papilla (DP) which is surrounded by the hair 
matrix (M) containing melanocytes and attached to the connective tissue sheath (CTS) 
at its base. Scale bar (80 µm), magnification (x163). 
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Figure 3.4  Cross section of human scalp skin stained with Sacpic staining 
 
(A) Cross section of human scalp skin (male, age 45) shows the collagen fibers (C) 
as a part of the thick dermal layer, sebaceous glands (SG) which consists of several 
lobes, and hair follicles (HF). Scale bar (199 µm), magnification (x42). 
  
(B) Horizontal cross-section of a human scalp hair follicle shows different layers of 
the hair follicle including the hair fibre (F), the inner root sheath (IRS), the outer 
root sheath (ORS) and the connective tissue sheath (CTS). The inner root sheath has 
partially separated from the outer root sheath, probably during the staining 
procedure. Scale bar (25 µm), magnification (x196). 
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Figure 3.5  Histology of human scalp hair follicle using H & E. 
 
(A) Cross section of human skin (male, age 45) shows the collagen fibers (C) as a part of the dermal 
layer, subcutaneous fat (SF), hair shaft (HS), and hair follicle (HF), scale bar (199 µm), (x45). 
 
(B) Cross section of human scalp hair follicle shows the different layers of the hair follicles including 
the connective tissue sheath (CTS), the outer root sheath (ORS) and the inner root sheath (IRS), and 
the hair shaft (HS), scal bar (23 µm), magnification (x195). 
 
(C) Longitudinal section of lower human hair follicle. The section shows hair follicle components 
including the outer root sheath (ORS), the inner root sheath (IRS), the connective tissue sheath (CTS). 
The hair bulb extends deep within the skin and includes the dermal papilla (DP) which is surrounded 
by the hair matrix (M) and attached to the connective tissue sheath (CTS) at its base. Scal bar (75 
µm), magnification (x152). 
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3.2  RT-PCR analysis of the expression of the genes for HGF, MSP and                                                                                                         
their receptors, c-Met and RON, in human scalp hair follicles: 
 
3.2.1 Isolation of whole lower anagen hair follicles by microdissection:        
For the purpose of investigating the expression of HGF, MSP and their receptors, c-Met 
and RON, individual human hair follicles were isolated by microdissection as described 
in section 2.1.3.1. Dissection of the hair follicles proved to be extremely difficult and 
time consuming, requiring patience and dedication. Photographs of the dissection steps 
are displayed in figures 2.1, 3.6, 3.7, 3.8. The skin sample was cut at the junction between 
the epidermis and dermis using a sterile scalpel blade (figures 2.1, 3.5). Under the 
dissecting microscope, the hair follicles were plucked from the skin gently using fine 
forceps and then transferred into a petri dish containing RNAlater. The isolated hair 
follicles were cleaned of any dermis or fat debris under a higher magnification using 
syringe needles (figure 3.8). The clean follicles were transferred to fresh RNAlater 
placed on ice. A total of 60 follicles were collected from each sample. The resulting 
whole follicles from each sample were gathered for total RNA isolation, followed by poly 
(A) RNA extraction and then cDNA synthesis to be used in the PCR reactions for 
detecting gene expression. 
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Figure 3.6  Surface view of the lower part of human scalp skin. 
Human scalp skin (female, age 37) after cutting the junction between the 
epidermis and dermis (D). The hair follicles appear as dark circular shapes, 
frequently in groups of the hair follicles. Scale bar (500 µm), mag. (x20). 
 
Figure 3.7 Human scalp anagen hair follicles within the skin 
The hair follicles extend deep within the skin and (female, age 37). The hair 
bulbs are located in the subcutaneous fat. Whole hair follicles were 
microdissected for total RNA isolation and later the investigation into their 
expression  of specific molecules by RT-PCR. Scale bar (360 µm), 
magnification (x259). 
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Figure 3.8  Isolated human scalp hair follicle and its bulb. 
Isolated lower human scalp anagen hair follicle (male, age 30) (A) and isolated human hair 
bulb (B), show the different parts of the hair follicle including the dermal sheath, hair matrix & 
dermal papilla. The hair follicles were microdissected for the purpose of total RNA isolation 
and later investigating the expression of specific molecules using RT-PCR. Some blood 
vessels can be clearly seen in the connective tissue sheath. (Scale bar: 290 µm & 185 µm, 
magnification: x266 & x284 respectively). 
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3.2.2  Checking the quality of total RNA:   
The quality of total RNA for each sample was checked by agarose gel electrophoresis 
using 1.5% (w/v) agarose gel. Total RNA (10 µl) was mixed with blue/orange loading 
dye (2 µl) to assist loading and monitor the resolution of the sample. The electrophoresis 
tank was run at 100V for about 45 minutes and then the total RNA was visualised using 
the Uvitec gel documentation system at 312 nm wavelength and the image captured. 
Intact total RNA should have sharp 28S and 18S rRNA bands (Skrypina et al., 2003), 
with the 28S rRNA band should be approximately twice as intense as the 18S rRNA band 
(figure 3.9). This 2:1 ratio (28S:18S) is a good indication that the RNA is intact. 
Furthermore, partially degraded RNA will not exhibit a 2:1 ratio whereas completely 
degraded RNA will appear as very low molecular weight smear (Ambion, USA). The 
results for all five non-balding samples showed clear bands with much stronger bands for 
28S than 18S.    
 
 
        
 
 
 
 
 
 
Figure 3.9  Gel electrophoresis of total RNA  
Total RNA (10 µl) from five non-balding hair follicles 
samples (1-5) were loaded on a 1.5% agarose gel. The 
rRNA bands (28S and 18S) exhibited 2:1 ratio and are 
clearly visible in the total RNA gel.       
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3.2.3  Checking the quality of cDNA using β-actin: 
Prior to investigating the expression of the genes for HGF, MSP and their receptors, c-
Met and RON, RT-PCR was initially performed using primers specific for the positive 
control, housekeeping gene, β-actin. The β-actin PCR products from all five individuals 
samples were separated using agarose gel electrophoresis and visualised with ethidium 
bromide staining (figure 3.10). The detection of β-actin as a housekeeping gene would 
denote that the isolated RNA from all experimental samples was of sufficient quality for 
reverse transcriptase PCR to be performed successfully. The expression of the β-actin 
sequence amplified by RT-PCR in all five individual samples were similar in size to that 
expected from the human sequence which is 838 bp (see figure 3.10).  
When nuclease free water was used as a template in the negative control instead of 
cDNA, no PCR products were detected. This demonstrated that there was no DNA 
contamination in the samples used for RT-PCR and that the β-actin PCR products were 
the result of the amplification of cDNA synthesized from the mRNA samples.  
The identity of the β-actin PCR products was verified by sequence analysis, a band of 
expected size was excised from the gel, purified and sent for sequencing. The β-actin 
PCR products of the human hair follicles exhibited 96% correlation with the known 
human sequence through the use of the ensemble genome browser and the NCBI BLAST 
program (figure 3.11).  
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Figure 3.10  Expression of β-actin in non-balding scalp hair follicles. 
Reverse transcriptase PCR demonstrated expression of β-actin in mRNA from 
five human hair follicle samples. Hair follicle cDNA samples were taken from 
non-balding scalp of five individuals (3 males aged 30, 29, 37 and 2 females 
aged 37, 32). RT-PCR was performed using specific primers for β-actin. PCR 
products were applied to 1.5% (w/v) agarose gel for electrophoresis with 
ethidium bromide staining. DNA was visualized with UV illumination. Lane 1 
denotes 100 bp DNA molecular size marker (range from 100-1,500) (10 µl was 
loaded), Lane 2-6 human hair follicle β-actin PCR products (30 µl/lane). Lane 
7 contained the negative control in which nuclease free water was used as a 
template instead of cDNA. The cDNA amplification product was predicted to 
be 838 bp in length as indicated. 
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Figure 3.11 Sequencing results for β-actin RT-PCR product amplified by   
specific primers 
Following PCR products analysis by electrophoresis, the identity of DNA 
fragments were verified and confirmed by sequence analysis. The sequencing 
data (balck) were compared to the previously identified sequence (red) using 
NCBI BLAST programme. The query displays expected known gene sequence 
and the subject is the sequenced PCR product. Matching bases between the two 
sequences are indicated (׀). The β-actin PCR products from human hair follicles 
showed 96% correlation with the known human sequence.       
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3.2.4  Human hair follicles express the genes for HGF, MSP and their           
receptors, c-Met and RON:  
 
3.2.4.1  Human hair follicles express the gene for HGF 
The expression of the gene for HGF in human hair follicles was investigated using RT-
PCR. The resulting PCR products for HGF were separated using agarose gel 
electrophoresis and visualised with ethidium bromide staining. All five human hair 
follicle cDNA samples produced PCR products of the expected size 262 bp for the gene 
of HGF (figure 3.12).  
The negative control, in which cDNA was omitted from the PCR reaction mix and 
replaced with nuclease free water, was clear of any bands. This demonstrated that all 
PCR products were originated from the amplification of the cDNA synthesis from the 
mRNA samples and demonstrated an absence of any contamination.  
Sequence analysis was used to ascertain the identity of the PCR products for HGF. Bands 
of expected size of HGF gene were excised from the gel, purified and sent for 
sequencing. The homology of the sequenced HGF PCR products was compared to the 
known expected human sequence, obtained from the ensemble genome browser, using 
the NCBI BLAST program. The PCR products which produced from the experimental 
samples exhibited 95% homology to the known human sequence for HGF (figure 3.13).  
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Figure 3.12  Expression of HGF in non-balding scalp hair follicles. 
Reverse transcriptase PCR demonstrated expression of HGF in mRNA from 
five human hair follicle samples. Hair follicle cDNA samples were taken from 
non-balding scalp of five individuals (3 males aged 30, 29, 37 and 2 females 
aged 37, 32). RT-PCR was performed using specific primers for HGF. PCR 
products were applied to 1.5% (w/v) agarose gel for electrophoresis with 
ethidium bromide staining. DNA was visualized with UV illumination. Lane 1 
denotes 100 bp DNA molecular size marker (range from 100-1,500) (10 µl was 
loaded), Lane 2-6 human hair follicle HGF PCR products (30 µl/lane). Lane 7 
contained the negative control in which nuclease free water was used as a 
template instead of cDNA. The cDNA amplification product was predicted to 
be 262 bp in length as indicated. 
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Figure 3.13 Sequencing results for HGF RT-PCR product amplified by 
specific primers 
Following PCR products analysis by electrophoresis, the identity of DNA 
fragments were verified and confirmed by sequence analysis. The sequencing 
data (balck) were compared to the previously identified sequence (red) using 
NCBI BLAST programme. The query displays expected known gene sequence 
and the subject is the sequenced PCR product. Matching bases between the two 
sequences are indicated (׀). The HGF PCR products from human hair follicles 
showed 95% correlation with the known human sequence.        
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3.2.4.2  Human hair follicles express the gene for MSP: 
The expression of the gene for MSP in human hair follicles was investigated using RT- 
PCR. The resulting PCR products for MSP were separated using agarose gel 
electrophoresis and visualised with ethidium bromide staining. All five human hair 
follicle cDNA samples produced PCR products of the expected size 415 bp for the gene 
of MSP (figure 3.14). When nuclease free water was used as a template in the negative 
control instead of cDNA, no PCR products were detected. This demonstrated that there 
was no DNA contamination in the samples used for RT-PCR and that the MSP PCR 
products were the result of the amplification of cDNA synthesized from the mRNA 
samples.  
Sequence analysis was used to ascertain the identity of the PCR products for MSP. Bands 
of expected size of MSP gene were excised from the gel, purified and sent for 
sequencing. The homology of the sequenced MSP PCR products was compared to the 
known expected human sequence, obtained from the ensemble genome browser, using 
the NCBI BLAST program. The PCR products which were produced from the 
experimental samples exhibited 97% homology to the known human sequence for MSP 
(figure 3.15).  
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Figure 3.14  Expression of MSP in non-balding scalp hair follicles. 
Reverse transcriptase PCR demonstrated expression of MSP in mRNA from 
five human hair follicle samples. Hair follicle cDNA samples were taken from 
non-balding scalp of five individuals (3 males aged 30, 29, 37 and 2 females 
aged 37, 32). RT-PCR was performed using specific primers for MSP. PCR 
products were applied to 1.5% (w/v) agarose gel for electrophoresis with 
ethidium bromide staining. DNA was visualized with UV illumination. Lane 1 
denotes 100 bp DNA molecular size marker (range from 100-1,500) (10 µl was 
loaded), Lane 2-6 human hair follicle MSP PCR products (30 µl/lane). Lane 7 
contained the negative control in which nuclease free water was used as a 
template instead of cDNA. The cDNA amplification product was predicted to 
be 415 bp in length as indicated. 
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Figure 3.15 Sequencing results for MSP RT-PCR product amplified by 
specific primers 
Following PCR products analysis by electrophoresis, the identity of DNA 
fragments were verified and confirmed by sequence analysis. The sequencing 
data (balck) were compared to the previously identified sequence (red) using 
NCBI BLAST programme. The query displays expected known gene sequence 
and the subject is the sequenced PCR product. Matching bases between the two 
sequences are indicated (׀). The MSP PCR products from human hair follicles 
showed 97% correlation with the known human sequence.       
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3.2.4.3  Human hair follicles express the gene for RON: 
The expression of the gene for the MSP receptor, RON, in human hair follicles was 
investigated using RT-PCR. The resulting PCR products for RON were separated using 
agarose gel electrophoresis and visualised with ethidium bromide staining. All five 
human hair follicle cDNA samples produced PCR products of the expected size 217 bp 
for the gene of MSP (figure 3.16).  
The negative control, in which cDNA was omitted from the PCR reaction mix and 
replaced with nuclease free water, was clear of any bands. This demonstrated that all 
PCR products were originated from the amplification of the cDNA synthesis from the 
mRNA samples and demonstrated an absence of any contamination.  
Sequence analysis was used to ascertain the identity of the PCR products for RON. Bands 
of expected size of RON gene were excised from the gel, purified and sent for 
sequencing. The homology of the sequenced RON PCR products was compared to the 
known expected human sequence, obtained from the ensemble genome browser, using 
the NCBI BLAST program. The PCR products which were produced from the 
experimental samples exhibited 94% homology to the known human sequence for RON 
(figure 3.17).  
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Figure 3.16  Expression of RON in non-balding scalp hair follicles. 
Reverse transcriptase PCR demonstrated expression of RON in mRNA from 
five human hair follicle samples. Hair follicle cDNA samples were taken from 
non-balding scalp of five individuals (3 males aged 30, 29, 37 and 2 females 
aged 37, 32). RT-PCR was performed using specific primers for RON. PCR 
products were applied to 1.5% (w/v) agarose gel for electrophoresis with 
ethidium bromide staining. DNA was visualized with UV illumination. Lane 1 
denotes 100 bp DNA molecular size marker (range from 100-1,500) (10 µl was 
loaded), Lane 2-6 human hair follicle RON PCR products (30 µl/lane). Lane 7 
contained the negative control in which nuclease free water was used as a 
template instead of cDNA. The cDNA amplification product was predicted to 
be 217 bp in length as indicated. 
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Figure 3.17 Sequencing results for RON RT-PCR product amplified by 
specific primers 
Following PCR products analysis by electrophoresis, the identity of DNA 
fragments were verified and confirmed by sequence analysis. The sequencing 
data (balck) were compared to the previously identified sequence (red) using 
NCBI BLAST programme. The query displays expected known gene sequence 
and the subject is the sequenced PCR product. Matching bases between the two 
sequences are indicated (׀). The RON PCR products from human hair follicles 
showed 94% correlation with the known human sequence.       
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3.2.4.4  Human hair follicles express the gene for c-Met: 
The expression of the gene for the HGF receptor, c-Met, in human hair follicles was 
investigated using RT-PCR. The resulting PCR products for c-Met were separated using 
agarose gel electrophoresis and visualised with ethidium bromide staining. All five 
human hair follicle cDNA samples produced PCR products of the expected size 536 bp 
for the gene of c-Met (figure 3.18).  
When nuclease free water was used as a template in the negative control instead of 
cDNA, no PCR products were detected. This demonstrated that there was no DNA 
contamination in the samples used for RT-PCR and that the c-Met PCR products were the 
result of the amplification of cDNA synthesized from the mRNA samples.  
Sequence analysis was used to ascertain the identity of the PCR products for c-Met. 
Bands of expected size of c-Met gene were excised from the gel, purified and sent for 
sequencing. The homology of the sequenced c-Met PCR products was compared to the 
known expected human sequence, obtained from the ensemble genome browser, using 
the NCBI BLAST program. The PCR products which were produced from the 
experimental samples exhibited 95% homology to the known human sequence for c-Met 
(figure 3.19).  
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Figure 3.18  Expression of c-Met in non-balding scalp hair follicles. 
Reverse transcriptase PCR demonstrated expression of c-Met in mRNA from 
five human hair follicle samples. Hair follicle cDNA samples were taken from 
non-balding scalp of five individuals (3 males aged 30, 29, 37 and 2 females 
aged 37, 32). RT-PCR was performed using specific primers for c-Met. PCR 
products were applied to 1.5% (w/v) agarose gel for electrophoresis with 
ethidium bromide staining. DNA was visualized with UV illumination. Lane 1 
denotes 100 bp DNA molecular size marker (range from 100-1,500) (range 
from 100-1,500) (10 µl was loaded), Lane 2-6 human hair follicle c-Met PCR 
products (30 µl/lane). Lane 7 contained the negative control in which nuclease 
free water was used as a template instead of cDNA. The cDNA amplification 
product was predicted to be 536 bp in length as indicated.  
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Figure 3.19 Sequencing results for c-Met RT-PCR product amplified by 
specific primers 
Following PCR products analysis by electrophoresis, the identity of DNA 
fragments were verified and confirmed by sequence analysis. The sequencing 
data (balck) were compared to the previously identified sequence (red) using 
NCBI BLAST programme. The query displays expected known gene sequence 
and the subject is the sequenced PCR product. Matching bases between the two 
sequences are indicated (׀). The c-Met PCR products from human hair follicles 
showed 95% correlation with the known human sequence.       
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3.3  RT-PCR analysis of the expression of HGF, RON and c-Met         
      in human hair bulb components:  
 
3.3.1  Isolation of  whole lower anagen hair follicles by microdissection: 
To investigate the expression of HGF, RON and c-Met and to possibly localise the 
expression of these genes in human hair follicles, whole cleaned lower anagen hair 
follicles were dissected to isolate the three cell types of the hair bulb including the dermal 
sheath, the epithelial matrix and the dermal papilla (see section 2.1.3.2), (figures 2.1, 
3.20, 3.21). Three different individual samples were used for this investigation. A total of 
150 hair follicles were isolated from each individual (see table 2.2). Equal numbers of the 
three cell types of the hair bulb were collected separately from each individual for the 
total RNA isolation, poly (A) RNA isolation and cDNA synthesis.  
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Figure 3.20  Human hair bulb components   
 
Isolated human hair bulb (A) from anagen hair follicle (male, age 35) and its components (B), scale bar 
(195 µm &189 µm respectively). Human scalp anagen hair follicles were further dissected to isolate the 
dermal sheath, hair matrix and dermal papilla for total RNA isolation and later RT-PCR analysis to 
investigate genes expression. The hair bulb components were microdissected from 150 follicles from 
each of 3 individuals and processed separately. 
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Figure 3.21  Isolated human hair bulb components   
whole cleaned lower human anagen hair follicles were further dissected 
to isolate the dermal sheath (A), the epithelial hair matrix (B), and the 
dermal papilla (C). A total of 150 hair follicles were isolated from each 
individual (n=3) for the purpose of total RNA isolation and later 
investigating the expression of specific molecules using RT-PCR. Each 
sample of the three individuals was processed separately. (x284, x286, 
x300 respectively). 
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3.3.2  Checking the quality of cDNA, produced from human hair bulb   
         components, using β-actin:  
 
Prior to investigation the expression of the genes for HGF, RON and HGF receptor,        
c-Met, RT-PCR was initially performed using primers specific for the positive control, 
housekeeping gene β-actin. The resulting β-actin PCR products from each component 
were separated using agarose gel electrophoresis and visualised with ethidium bromide 
staining. The β-actin PCR products from all three cell types of the hair bulb corresponded 
to the anticipated size of the β-actin (838 bp), (figure 3.22). When the same amounts of 
cDNA were used, the resulting β-actin PCR products from the bulb matrix cDNA in all 
three samples showed the strongest intensity bands, followed by the dermal sheath and 
then the dermal papilla cDNA which exhibited the weakest bands. The negative controls, 
in which the template cDNA was excluded from the reaction mix, were clear of any 
bands. This indicated that there was no DNA contamination in the samples used for RT-
PCR (figures 3.22).  
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Figure 3.22  Expression of β-actin in non-balding scalp hair follicle components 
 
Human hair bulb components: the dermal sheath, the matrix and the dermal papilla, were 
microdissected from 150 follicles from each of 3 individuals [male, age 35 (A); female, age 
45 (B); male, age 29 (C)] and processed separately. mRNA was extracted and RT-PCR was 
performed using specific primers for β-actin. PCR products were applied to 1.5% (w/v) 
agarose gel for electrophoresis with ethidium bromide staining. DNA was visualized with 
UV illumination. Lane L denotes 100bp DNA molecular size marker (range from 100-
1,500) (10 µl was loaded), Lane DS dermal sheath β-actin PCR products (30 µl). Lane MX 
matrix β-actin PCR products (30 µl). Lane DP dermal papilla β-actin PCR products (30 µl). 
Lane N contained the negative control in which nuclease free water was used as a template 
instead of cDNA. The cDNA amplification product was predicted to be 838 bp in length as 
indicated.   
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3.3.3  RT-PCR analysis of the expression of RON in human hair bulb                
          components: 
 
 
To investigate the expression of RON in the hair bulb components, RT-PCR was further 
utilized using primers specific for RON. The RON PCR products, which produced from 
all three hair bulb components, corresponded to the expected size of (217 bp). They were 
all expressed much less strongly than β-actin. When the same amounts of cDNA were 
used, the RON expression was present with greater intensity in the matrix, followed by 
the dermal sheath cDNA and with the weakest band produced from the dermal papilla 
cDNA. This is a reflection of the β-actin bands produced from these three hair bulb 
components. The negative controls were free of any contaminating bands. Therefore, it 
seems that the dermal sheath, matrix and dermal papilla cells express the gene for RON 
(figures 3.23).  
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Figure 3.23  Expression of RON in non-balding scalp hair follicle components 
Human hair bulb components: the dermal sheath, the matrix and the dermal papilla, were 
microdissected from 150 follicles from each of 3 individuals [male, age 35 (A); female, age 
45 (B); male, age 29 (C)] and processed separately. mRNA was extracted and RT-PCR was 
performed using specific primers for RON. PCR products were applied to 1.5% (w/v) 
agarose gel for electrophoresis with ethidium bromide staining. DNA was visualized with 
UV illumination. Lane L denotes 100bp DNA molecular size marker (range from 100-
1,500) (10 µl was loaded), Lane DS dermal sheath RON PCR products (30 µl). Lane MX 
matrix RON PCR products (30 µl). Lane DP dermal papilla RON PCR products (30 µl). 
Lane N negative control in which nuclease free water was used as a template instead of 
cDNA. The cDNA amplification product was predicted to be 217 bp in length as indicated.  
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3.3.4  RT-PCR analysis of the expression of HGF in human hair bulb             
         components: 
 
 
The expression of HGF in human hair follicles was further clarified by the investigation 
of its expression in the three cell types of the hair bulb using the RT-PCR. Bands 
corresponding to the expected size of HGF (261 bp) were produced from the dermal 
sheath and the dermal papilla samples. When the same amounts of cDNA were used, no 
bands of the anticipated size of HGF were produced from the matrix cDNA samples. The 
HGF bands produced from the dermal sheath cDNA were of greater intensity than those 
produced from the dermal papilla cDNA. This reflects the differences in the cDNA 
quantity observed in the β-actin (figure 3.22). This indicated that the dermal sheath and 
dermal papilla cells express the HGF but not the matrix cells (figures 3.24). 
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Figure 3.24  Expression of HGF in non-balding scalp hair follicle components 
Human hair bulb components: the dermal sheath, the matrix and the dermal papilla, were 
microdissected from 150 follicles from each of 3 individuals [male, age 35 (A); female, age 
45 (B); male, age 29 (C)] and processed separately. mRNA was extracted and RT-PCR was 
performed using specific primers for HGF. PCR products were applied to 1.5% (w/v) 
agarose gel for electrophoresis with ethidium bromide staining. DNA was visualized with 
UV illumination. Lane L denotes 100bp DNA molecular size marker (range from 100-
1,500) (10 µl was loaded), Lane DS dermal sheath HGF PCR products (30 µl). Lane DP 
dermal papilla HGF PCR products (30 µl). Lane MX matrix HGF PCR products (30 µl). 
Lane N contained the negative control in which nuclease free water was used as a template 
instead of cDNA. The cDNA amplification product was predicted to be 262 bp in length as 
indicated.  
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3.3.5  RT-PCR analysis of the expression of HGF receptor, c-Met, in                                                       
         human hair bulb components: 
 
 
The gene expression of c-Met in the hair bulb components were further investigated 
using RT-PCR. The PCR products of the anticipated size for c-Met (536 bp) were 
produced from the dermal sheath and the dermal papilla samples but not from any of the 
matrix samples. When the same amounts of cDNA were used, the resulting c-Met PCR 
products produced from the dermal sheath was of greater intensity than the band 
produced from the dermal papilla (figures 3.25). This is a reflection of the β-actin PCR 
products produced from the hair bulb components (figure 3.22).   
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Figure 3.25 Expression of c-Met in non-balding scalp hair follicle components 
Human hair bulb components: the dermal sheath, the matrix and the dermal papilla, were 
microdissected from 150 follicles from each of 3 individuals [male, age 35 (A); female, age 
45 (B); male, age 29 (C)] and processed separately. mRNA was extracted and RT-PCR was 
performed using specific primers for c-Met. PCR products were applied to 1.5% (w/v) 
agarose gel for electrophoresis with ethidium bromide staining. DNA was visualized with 
UV illumination. Lane L denotes 100bp DNA molecular size marker (range from 100-
1,500) (10 µl was loaded), Lane DS dermal sheath c-Met PCR products (30 µl). Lane DP 
dermal papilla c-Met PCR products (30 µl). Lane MX matrix c-Met PCR products (30 µl). 
Lane N contained the negative control in which nuclease free water was used as a template 
instead of cDNA. The cDNA amplification product was predicted to be 536 bp in length as 
indicated. 
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3.4  Immunohistochemistry:  
 
 
3.4.1  Localisation of cytokeratin 6 in human hair follicles: 
 
 
The location of cytokeratin 6, a highly expressed cytoskeletal protein, was investigated in 
human hair follicles to learn the technique of immunohistochemistry using a highly 
expressed antigen. Immunohistochemistry was performed using a goat polyclonal anti 
cytokeratin 6 antibody which was diluted for use in human hair follicles at 1:20 with 
1.5% (v/v) normal mouse serum in PBS. Prior to treatment with the primary antibody, 
sections were blocked using 5% (v/v) normal mouse serum in PBS to block non-specific 
protein binding sites in the tissue.  
Three negative controls were included in each experiment to detect any non-specific 
binding to ensure that the colour detection system was not activated alone, to ensure that 
the secondary antibody is not binding non-specifically to the tissue, and that the primary 
antibody was not activating the red chromogen AEC solution without the presence of the 
secondary antibody. 
All the negative controls were clear of any non-specific staining. Therefore only the 
photograph of  the negative control, where the primary antibody was replaced with PBS, 
was included. Strong positive staining of cytokeratin 6 was present in the outer root 
sheath (figure 3.26, 3.27).  
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Figure 3.26 Expression of cytokeratin 6 in human scalp hair follicle.                   
Immunohistochemistry for cytokeratin 6, in 35 year old male scalp hair follicle, was 
performed using the goat polyclonal anti-cytokeratin 6 antibody (Novocastra 
Laboratories, UK) diluted 1:20 with 1.5% (v/v) NMS/PBS. Prior to treatment with the 
antibody, the tissue was blocked with 5% (v/v) normal mouse serum in PBS. 
(A) & (B) Negative control for cytokeratin 6. The section is free from any uptake of 
stain. The primary antibody was replaced with PBS however the secondary antibody 
and the AEC solution were applied. Scale bar (32 µm), magnification (x110). 
(C) & (D) Strong positive red staining of cytokeratin 6 can be seen in cells of the outer 
root sheath (ORS). Scale bar (29 µm), magnification (x120). 
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Figure 3.27  Expression of cytokeratin 6 in cross section of human scalp            
hair follicle.       
Immunohistochemistry for cytokeratin 6, in scalp hair follicle, was from a 35 year 
old male performed using the goat polyclonal anti-cytokeratin 6 antibody 
(Novocastra Laboratories, UK) diluted 1:20 with 1.5% (v/v) NMS/PBS. Prior to 
treatment with the antibody, the tissue was blocked with 5% (v/v) normal mouse 
serum in PBS. Sections were counterstained with Harris's haematoxylin.  
(A) Negative control for cytokeratin 6. The section is free from any uptake of stain. 
The primary antibody was replaced with PBS however the secondary antibody and 
the AEC solution were applied. Scale bar (27µm), magnification (x152). 
(B) Strong positive staining of cytokeratin 6 can be seen in cells of the outer root 
sheath (ORS). Scale bar (27µm), magnification (x152). 
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3.4.2  Immunohistochemical investigation of HGF receptor, c-Met, in   
          human hair follicles: 
 
 
The expression of hepatocyte growth factor receptor, c-Met, was investigated in human 
hair follicles using immunohistochemistry. A mouse monoclonal anti-human c-Met 
antibody was applied to the sections with 1.5% (v/v) bovine serum albumin in PBS. A 
range of antibody concentrations were examined between 1:10 and 1:100 until the 
optimum one was achieved which is 1:20. prior to treatment with the primary antibody, 
sections were blocked using 1.5% (v/v) bovine serum albumin in PBS.  
Three negative controls were included in each experiment to detect any non-specific 
binding to ensure that the colour detection system was not activated alone, to ensure that 
the secondary antibody is not binding non-specifically to the tissue, and that the primary 
antibody was not activating the red chromogen AEC solution without the presence of the 
secondary antibody. 
No positive staining was observed in all negative controls so only the photograph of the 
negative control, where the primary antibody was replaced with PBS, was included. The 
presence of c-Met was detected in the outer root sheath and the dermal papilla of human 
hair follicles (figure 3.28, 3.29).  
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Figure 3.28  Expression of the HGF receptor, c-Met, in human scalp hair follicle.  
 
Immunohistochemistry for the HGF receptor, c-Met, in 35 year old male scalp hair follicle, was 
performed using the mouse monoclonal anti-human c-Met antibody (Novocastra Laboratories, UK) 
diluted 1:20 with 1.5% (v/v) BSA/PBS. Prior to treatment with the antibody, the tissue was blocked 
with 5% (v/v) bovine serum albumin in PBS.  
(A) & (B) Negative controls staining for the HGF receptor, c-Met. The section is free from any uptake 
of stain. The primary antibody was replaced with PBS however the secondary antibody and the AEC 
solution were applied. Scale bar (30 µm, 25 µm), magnification (x115, x120).  
(C) & (D) Positive red staining of HGF receptor, c-Met, can be seen in cells of the outer root sheath 
(ORS). Scale bar (27 µm), magnification (x132).  
(E), (F) & (G) Positive red staining of c-Met in the ORS of cross sections of hair follicles. Scale bar 
(29 µm), magnification (x120, x149). 
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Figure 3.29  Expression of the HGF receptor, c-Met, in the dermal papilla of 
human scalp hair follicle.  
 
Immunohistochemistry for the HGF receptor, c-Met, in the dermal papilla of human 
scalp hair follicle, was performed using the mouse monoclonal anti-human c-Met 
antibody (Novocastra Laboratories, UK) diluted 1:20 with 1.5% (v/v) BSA/PBS. 
Prior to treatment with the antibody, the tissue was blocked with 5% (v/v) bovine 
serum albumin in PBS.  
 
(A) Negative controls staining for the HGF receptor, c-Met. The section is free from 
any uptake of stain. The primary antibody was replaced with PBS however the 
secondary antibody and the AEC solution were applied. Scale bar (17µm), (x375).  
 
(B) Positive red staining of HGF receptor, c-Met, can be seen in cells of the dermal 
papilla. Scale bar (17 µm), magnification (x375).  
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3.5 RT-PCR analysis of the expression of the genes for HGF, MSP and  
their receptors, c-Met and RON, in human cultured dermal papilla cells: 
 
Cultured dermal papilla cells from two individuals were used to investigate the gene 
expression for HGF, MSP, c-Met and RON using RT-PCR. The dermal papilla cells in 
culture increased in number gradually to give multi-polar shapes and formed small 
clumps (figure 3.30). When confluent, they were collected for RNA extraction, cDNA 
synthesis and gene expression investigation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.30  phase contrast images of human cultured dermal papilla cells. 
Dermal papilla (DP) cells were cultured for the purpose of total RNA 
extraction and cDNA synthesis to investigate gene expression using RT-PCR, 
scale bar (25 µm). 
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3.5.1 Checking the quality of cultured DP cells cDNA using β-actin: 
Prior to investigating the expression of the genes for HGF, MSP and their receptors, c-
Met and RON, RT-PCR was initially performed using primers specific for the positive 
control, housekeeping gene, β-actin. The β-actin PCR products from the two individual 
samples were separated using agarose gel electrophoresis and visualised with ethidium 
bromide staining (figure 3.31). The detection of β-actin as a housekeeping gene would 
denote that the isolated RNA from the experimental samples was of sufficient quality for 
reverse transcriptase PCR to be performed successfully. The expression of the β-actin 
sequence amplified by RT-PCR in both individual samples were similar in size to that 
expected from the human sequence which is 838 bp (see figure 3.31).  
When nuclease free water was used as a template in the negative control instead of 
cDNA, no PCR products were detected. This demonstrated that there was no DNA 
contamination in the samples used for RT-PCR and that the β-actin PCR products were 
the result of the amplification of cDNA synthesized from the mRNA samples.  
The identity of the β-actin PCR products was verified by sequence analysis, a band of 
expected size was excised from the gel, purified and sent for sequencing. The β-actin 
PCR products of the human cultured dermal papilla cells exhibited 98% correlation with 
the known human sequence through the use of the ensemble genome browser and the 
NCBI BLAST program (figure 3.32).  
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Figure 3.31  Expression of ß-actin in human cultured dermal papilla cells. 
Reverse transcriptase PCR demonstrated expression of ß-actin in mRNA from 
two human dermal papilla samples. The cDNA samples were taken from non-
balding dermal papilla cells of two individuals. RT-PCR was performed using 
specific primers for ß-actin. PCR products were applied to 1.5% (w/v) agarose 
gel for electrophoresis with ethidium bromide staining. DNA was visualized 
with UV illumination. Lane 1 denotes 100 bp DNA molecular size marker 
(range from 100-1,500) (10 µl was loaded), Lane 2 & 3 contained human 
cultured dermal papilla ß-actin PCR products (20 µl/lane). Lane 4 contained 
the negative control in which nuclease free water was used as a template 
instead of cDNA. The cDNA amplification product was predicted to be 838 bp 
in length as indicated. 
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Figure 3.32 Sequencing results for β-actin RT-PCR product amplified by   
specific primers 
Following PCR products analysis by electrophoresis, the identity of DNA 
fragments were verified and confirmed by sequence analysis. The sequencing 
data (balck) were compared to the previously identified sequence (red) using 
NCBI BLAST programme. The query displays expected known gene sequence 
and the subject is the sequenced PCR product. Matching bases between the two 
sequences are indicated (׀). The β-actin PCR products from cultured dermal 
papilla cells showed 98% correlation with the known human sequence.       
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3.5.2 Human cultured dermal papilla cells express the gene for HGF: 
The expression of the gene for HGF in human cultured dermal papilla cells was 
investigated using RT-PCR. The resulting PCR products for HGF were separated using 
agarose gel electrophoresis and visualised with ethidium bromide staining. Both dermal 
papilla cDNA samples produced PCR products of the expected size 262 bp for the gene 
of HGF (figure 3.33).  
The negative control, in which cDNA was omitted from the PCR reaction mix and 
replaced with nuclease free water, was clear of any bands. This demonstrated that all 
PCR products were originated from the amplification of the cDNA synthesis from the 
mRNA samples and demonstrated an absence of any contamination.  
Sequence analysis was used to ascertain the identity of the PCR products for HGF. Bands 
of expected size of HGF gene were excised from the gel, purified and sent for 
sequencing. The homology of the sequenced HGF PCR products was compared to the 
known expected human sequence, obtained from the ensemble genome browser, using 
the NCBI BLAST program. The PCR products which produced from the experimental 
samples exhibited 99% homology to the known human sequence for HGF (figure 3.34).  
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Figure 3.33  Expression of HGF in human cultured dermal papilla cells. 
Reverse transcriptase PCR demonstrated expression of HGF in mRNA from 
two human dermal papilla samples. The cDNA samples were taken from non-
balding dermal papilla cells of two individuals. RT-PCR was performed using 
specific primers for HGF. PCR products were applied to 1.5% (w/v) agarose 
gel for electrophoresis with ethidium bromide staining. DNA was visualized 
with UV illumination. Lane 1 denotes 100 bp DNA molecular size marker 
(range from 100-1,500) (10 µl was loaded), Lane 2 & 3 contained human 
cultured dermal papilla HGF PCR products (20 µl/lane). Lane 4 contained the 
negative control in which nuclease free water was used as a template instead of 
cDNA. The cDNA amplification product was predicted to be 262 bp in length 
as indicated. 
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Figure 3.34 Sequencing results for HGF RT-PCR product amplified by 
specific primers 
Following PCR products analysis by electrophoresis, the identity of DNA 
fragments were verified and confirmed by sequence analysis. The sequencing 
data (balck) were compared to the previously identified sequence (red) using 
NCBI BLAST programme. The query displays expected known gene sequence 
and the subject is the sequenced PCR product. Matching bases between the two 
sequences are indicated (׀). The HGF PCR products from human cultured dermal 
papilla cells showed 99% correlation with the known human sequence.        
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3.5.3 Human cultured dermal papilla cells express the gene for MSP: 
The expression of the gene for MSP in human cultured dermal papilla cells was 
investigated using RT- PCR. The resulting PCR products for MSP were separated using 
agarose gel electrophoresis and visualised with ethidium bromide staining. Both dermal 
papilla cDNA samples cDNA samples produced PCR products of the expected size 415 
bp for the gene of MSP (figure 3.35).  
When nuclease free water was used as a template in the negative control instead of 
cDNA, no PCR products were detected. This demonstrated that there was no DNA 
contamination in the samples used for RT-PCR and that the MSP PCR products were the 
result of the amplification of cDNA synthesized from the mRNA samples.  
Sequence analysis was used to ascertain the identity of the PCR products for MSP. Bands 
of expected size of MSP gene were excised from the gel, purified and sent for 
sequencing. The homology of the sequenced MSP PCR products was compared to the 
known expected human sequence, obtained from the ensemble genome browser, using 
the NCBI BLAST program. The PCR products which were produced from the 
experimental samples exhibited 96% homology to the known human sequence for MSP 
(figure 3.36).  
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Figure 3.35  Expression of MSP in human cultured dermal papilla cells. 
Reverse transcriptase PCR demonstrated expression of MSP in mRNA from 
two human dermal papilla samples. The cDNA samples were taken from non-
balding dermal papilla cells of two individuals. RT-PCR was performed using 
specific primers for MSP. PCR products were applied to 1.5% (w/v) agarose 
gel for electrophoresis with ethidium bromide staining. DNA was visualized 
with UV illumination. Lane 1 denotes 100 bp DNA molecular size marker 
(range from 100-1,500) (10 µl was loaded), Lane 2 & 3 contained human 
cultured dermal papilla MSP PCR products (20 µl/lane). Lane 4 contained the 
negative control in which nuclease free water was used as a template instead of 
cDNA. The cDNA amplification product was predicted to be 415 bp in length 
as indicated. 
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Figure 3.36 Sequencing results for MSP RT-PCR product amplified by 
specific primers 
Following PCR products analysis by electrophoresis, the identity of DNA 
fragments were verified and confirmed by sequence analysis. The sequencing 
data (balck) were compared to the previously identified sequence (red) using 
NCBI BLAST programme. The query displays expected known gene sequence 
and the subject is the sequenced PCR product. Matching bases between the two 
sequences are indicated (׀). The MSP PCR products from human cultured dermal 
papilla cells showed 96% correlation with the known human sequence.        
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3.5.4 Human cultured dermal papilla cells express the gene for RON: 
The expression of the gene for the MSP receptor, RON, in human cultured dermal papilla 
cells was investigated using RT-PCR. The resulting PCR products for RON were 
separated using agarose gel electrophoresis and visualised with ethidium bromide 
staining. Both dermal papilla cDNA samples produced PCR products of the expected size 
217 bp for the gene of MSP (figure 3.37).  
The negative control, in which cDNA was omitted from the PCR reaction mix and 
replaced with nuclease free water, was clear of any bands. This demonstrated that all 
PCR products were originated from the amplification of the cDNA synthesis from the 
mRNA samples and demonstrated an absence of any contamination.  
Sequence analysis was used to ascertain the identity of the PCR products for RON. Bands 
of expected size of RON gene were excised from the gel, purified and sent for 
sequencing. The homology of the sequenced RON PCR products was compared to the 
known expected human sequence, obtained from the ensemble genome browser, using 
the NCBI BLAST program. The PCR products which were produced from the 
experimental samples exhibited 97% homology to the known human sequence for RON 
(figure 3.38).  
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Figure 3.37  Expression of RON in human cultured dermal papilla cells. 
Reverse transcriptase PCR demonstrated expression of RON in mRNA from 
two human dermal papilla samples. The cDNA samples were taken from non-
balding dermal papilla cells of two individuals. RT-PCR was performed using 
specific primers for RON. PCR products were applied to 1.5% (w/v) agarose 
gel for electrophoresis with ethidium bromide staining. DNA was visualized 
with UV illumination. Lane 1 denotes 100 bp DNA molecular size marker 
(range from 100-1,500) (10 µl was loaded), Lane 2 & 3 contained human 
cultured dermal papilla RON PCR products (20 µl/lane). Lane 4 contained the 
negative control in which nuclease free water was used as a template instead of 
cDNA. The cDNA amplification product was predicted to be 217 bp in length 
as indicated. 
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Figure 3.38 Sequencing results for RON RT-PCR product amplified by 
specific primers 
Following PCR products analysis by electrophoresis, the identity of DNA 
fragments were verified and confirmed by sequence analysis. The sequencing 
data (balck) were compared to the previously identified sequence (red) using 
NCBI BLAST programme. The query displays expected known gene sequence 
and the subject is the sequenced PCR product. Matching bases between the two 
sequences are indicated (׀). The RON PCR products from human cultured 
dermal papilla cells showed 97% correlation with the known human sequence.        
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3.5.5 Human cultured dermal papilla cells express the gene for c-Met: 
The expression of the gene for the HGF receptor, c-Met, in human cultured dermal 
papilla cells was investigated using RT-PCR. The resulting PCR products for c-Met were 
separated using agarose gel electrophoresis and visualised with ethidium bromide 
staining. Both dermal papilla cDNA samples produced PCR products of the expected size 
536 bp for the gene of c-Met (figure 3.39).  
When nuclease free water was used as a template in the negative control instead of 
cDNA, no PCR products were detected. This demonstrated that there was no DNA 
contamination in the samples used for RT-PCR and that the c-Met PCR products were the 
result of the amplification of cDNA synthesized from the mRNA samples.  
Sequence analysis was used to ascertain the identity of the PCR products for c-Met. 
Bands of expected size of c-Met gene were excised from the gel, purified and sent for 
sequencing. The homology of the sequenced c-Met PCR products was compared to the 
known expected human sequence, obtained from the ensemble genome browser, using 
the NCBI BLAST program. The PCR products which were produced from the 
experimental samples exhibited 94% homology to the known human sequence for c-Met 
(figure 3.40).  
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Figure 3.39  Expression of c-Met in human cultured dermal papilla cells. 
Reverse transcriptase PCR demonstrated expression of c-Met in mRNA from 
two human dermal papilla samples. The cDNA samples were taken from non-
balding dermal papilla cells of two individuals. RT-PCR was performed using 
specific primers for c-Met. PCR products were applied to 1.5% (w/v) agarose 
gel for electrophoresis with ethidium bromide staining. DNA was visualized 
with UV illumination. Lane 1 denotes 100bp DNA molecular size marker 
(range from 100-1,500) (10 µl was loaded), Lane 2 & 3 contained human 
dermal papilla c-Met PCR products (20 µl/lane). Lane 4 contained the negative 
control in which nuclease free water was used as a template instead of cDNA. 
The cDNA amplification product was predicted to be 536 bp in length as 
indicated. 
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Figure 3.40 Sequencing results for c-Met RT-PCR product amplified by 
specific primers 
Following PCR products analysis by electrophoresis, the identity of DNA 
fragments were verified and confirmed by sequence analysis. The sequencing 
data (balck) were compared to the previously identified sequence (red) using 
NCBI BLAST programme. The query displays expected known gene sequence 
and the subject is the sequenced PCR product. Matching bases between the two 
sequences are indicated (׀). The c-Met PCR products from human cultured 
dermal papilla cells showed 94% correlation with the known human sequence.        
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3.6  Comparison of the gene expression of normal and balding scalp hair 
follicles from men with androgenetic alopecia using DNA microarray:  
 
3.6.1  Checking the quality of total RNA:  
 
The most important key for successful GeneChip microarray analysis is starting with high 
quality RNA. The total RNA quality and purity of the six RNA samples from the three 
matched pairs of samples of balding and non-balding anagen hair follicles (see section 
2.2.1) were evaluated using the Agilent 2100 Bioanalyzer (Agilent technologies, USA). 
Intact total RNA should have sharp 28S and 18S rRNA bands (Skrypina et al., 2003), 
with the 28S rRNA band being approximately twice as intense as the 18S rRNA band. 
This 2:1 ratio (28S:18S) is a good indication that the RNA is intact and not degraded. 
Furthermore, partially degraded RNA will not exhibit a 2:1 ratio, whereas completely 
degraded RNA will appear as a very low molecular weight smear (Ambion, USA). The 
results for all 6 samples showed clear bands with much stronger bands for 28S than 18S 
(figure 3.41). Non-balding samples gave stronger bands than those from balding  
follicles.  
 
Further quality check on the RNA were carried out by using the the Agilent Bioanalyzer 
to produce Electropherograms. High quality RNA electropherograms show several 
features: there should be clear and well defined 28S and 18S peaks, with a low 
background between the peaks, as well as minimal low molecular weight contamination. 
Moderately degraded RNA is characterised by the presence of a smaller 28S peak than 
that of 18S, high background between the 28S and 18S peaks and low molecular weight 
peaks. These features tend to interfere with the labelling and amplification which can lead 
to possibly poor array performance. Extreme degradation is characterized by the absence 
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of 28S and 18S peaks, and the presence of only low molecular weight peaks. This would 
badly affect in the labelling procedure and could not be used (Agilent, USA). 
Electropherograms (figures 3.42 and 3.43) showed high quality RNA had been prepared 
for all the follicle samples for the following reasons: there are clear 28S and 18S peaks, 
the noise between the peaks is very low with minimal low molecular weight noise and the 
ratios are close to two.       
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Fig 3.41  Electrophoretic separation of total RNA from non-balding and       
                balding hair follicles.  
 
RNA from balding samples (n=3) and non-balding samples (n=3) were 
evaluated using the Agilent 2100 Bioanalyzer. The rRNA bands (28S and 
18S) exhibited 2:1 ratio and are clearly visible in the total RNA gels. 
28S 
  
18S 
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Overall results for sample1 
RNA area: 396.4 
RNA concentration: 204 ng/µl 
rRNA ratio (28S/18S): 2.2 
18S area: 52.1 
28S area: 115.2 
18S (% of total area): 14.1 
28S (% of total area): 31.2 
18S start & end time: 40.31, 42.90 
28S Start & end time: 46.42, 50.37 
 
  
Fig 3.42  Electropherograms of non-balding hair follicle RNA samples 
 
RNA obtained from non-balding samples (n=3) were evaluated using the Agilent 
2100 Bioanalyzer. The graphs show high quality RNA for the following reasons: 
there are clear 28S and 18S peaks, the noise between the peaks is very low with 
minimal low molecular weight noise and the ratios are close to 2.    
Overall results for sample5 
RNA area: 192.3 
RNA concentration: 106 ng/µl  
rRNA ratio (28S/18S): 2.3  
18S area: 26.3  
28S area: 60.6 
18S (% of total area): 13.7  
28S (% of total area): 31.5 
18S start & end time: 40.35, 43.20  
28S Start & end time: 46.47, 50.28 
 
  
Overall results for sample3 
RNA area: 422.8 
RNA concentration: 233 ng/µl 
rRNA ratio (28S/18S): 2.1   
18S area: 63.9 
28S area: 133.3 
18S (% of total area): 15.1 
28S (% of total area): 31.5 
18S start & end time: 40.29, 42.96 
28S Start & end time: 46.26, 50.20 
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Fig 3.43  Electropherograms of balding hair follicles RNA samples  
 
RNA obtained from balding samples (n=3) were evaluated using the Agilent 
2100 Bioanalyzer. The graphs show high quality RNA for the following 
reasons: there are clear 28S and 18S peaks, the noise between the peaks is very 
low, with minimal low molecular weight noise and the ratios are close to 2.    
   
Overall results for sample2 
RNA area: 59.2 
RNA concentration: 33 ng/µl  
rRNA ratio (28S/18S): 1.9   
18S area: 8.3 
28S area: 16.1 
18S (% of total area): 14.1  
28S (% of total area): 27.1 
18S start & end time: 40.67, 43.20  
28S Start & end time: 46.60, 50.30  
 
  
Overall results for sample4 
RNA area: 61.6  
RNA concentration: 34 ng/µl   
rRNA ratio (28S/18S): 1.9  
18S area: 8.3 
28S area: 15.6 
18S (% of total area): 13.5 
28S (% of total area): 25.3  
18S start & end time: 40.67, 43.20  
28S Start & end time: 47.48, 50.21 
 
  
Overall results for sample6 
RNA area: 57.9  
RNA concentration: 32 ng/µl   
rRNA ratio (28S/18S): 1.9  
18S area: 6.7  
28S area: 12.8 
18S (% of total area): 11.6  
28S (% of total area): 22 
18S start & end time: 40.73, 42.69 
28S Start & end time: 47.41, 50.06 
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3.6.2 Microarray data analysis and data quality assessment: 
The difference in gene expression between balding and non-balding hair follicles in 
individuals with androgenetic alopecia was investigated using DNA microarray analysis. 
Initially, the microarray data were assessed for quality and overall differences between 
the two groups of matched non-balding and balding follicles.   
3.6.2.1 Data normalization and transformation:  
The microarray fluorescence intensity values were normalized using the Robust Multi-
array Analysis (RMA) method (Irizarry et al., 2003). These values were transformed to a 
logarithmic scale. The normalization process aims to remove certain systematic biases 
from microarray data (Smyth & Speed, 2003). The normalized intensity values were 
visualized using Box-and-Whiskers plots (figure 3.44), which displays the distribution of 
these values for the experimental groups, balding follicles (n=3) and non-balding follicles 
(n=3). To better display this large range of values and to ensure a more even 
representation of data, the box plot was generated by log signal intensities rather than 
absolute signal intensities (Quackenbush, 2002). The key features of the box plot are the 
smallest observation (minimum), the largest observation (maximum), the first quartile 
(Q1) or the 25
th
 percentile of the values, and the third quartile (Q3) or the 75
th
 percentile 
of the values. The band near the middle of the box represents the median or the second 
quartile (Q2) or the 50
th
 percentile of the values. Values not included between the 
whiskers represent values beyond 1.5 times IQR. It is clear from the graph that the 
variance and shape of distribution are different in both conditions. This indicates that the 
normalized values are appropriate to be taken to subsequent steps of analysis.  
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Fig 3.44 Box-and-Whiskers plot displaying the distribution of microarray 
intensity values in balding and non-balding follicle samples.  
 
The diagram showing the distribution of the intensity values for non-balding 
samples (n=3) and balding samples (n=3) through their five-number summary 
including the minimum and maximum observations, the first quartile (Q1), the 
third quartile (Q3) and the median (Q2). The inter quartile range (IQR) is the 
range between Q1 and Q3. Values beyond 1.5 times IQR are shown in red. It is 
clear from the graph that the variance and shape of distribution are different in 
both conditions.  
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3.6.2.2 Correlation between grouped data:  
Since the relationship between two variables is described by their correlation, correlation 
analysis of the normalized fluorescence intensity values of each gene by all balding and 
all non-balding follicles was carried out (figure 3.45). A scatter diagram has been used as 
one of the tools of quality control to check the quality of these data (Lee and Park, 2007). 
The graph in figure 3.45 gives a clue that the two variables are related and how they 
move together. This plot showed the correlation between the gene expression of balding 
samples (n=3) and non-balding ones (n=3). The results showed that the correlation 
coefficient equals - 0.74 indicating there is a negative correlation (P<0.03) in gene 
expression between the balding and non-balding samples. The correlation curve on the 
plot indicates that the gene expression pattern follows a downward slope and it moves 
down and to the right from a high-value on the y-axis down to a high-value on the x-axis. 
In other word, when the balding sample has high fluorescence associated with expression 
of one gene, then the non-balding sample is tending to have a low amount of 
fluorescence, i.e binding or expression. In addition, the reverse pattern also occurs with 
high fluorescence in a non-balding sample corresponding to low expression in a balding 
one.  
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Normalized intensity values of non-balding follicles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.45 Scatter plot shows the correlation of gene expression between 
balding and non-balding follicles.  
 
The diagram reveals the correlation between the gene expression of balding 
follicles (n=3) versus non-balding follicles (n=3). The correlation curve 
shows that gene expression follows a downward slope indicating that the 
pattern of gene expression is running in a band from upper left to lower 
right. The correlation coefficient equals - 0.74 indicating there is a negative 
correlation (P<0.03) in gene expression between the balding group and non-
balding one.  
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3.6.2.3  Principal Component Analysis (PCA):  
The quality of the microarray data was investigated further using the principal component 
analysis (PCA) method. This test provides a roadmap for reducing a complex data set to a 
lower dimension (Komura et al., 2004; Shlens, 2009). The three dimensional graph (3D) 
in figure 3.46 shows each sample discrimination and shows clear differences between 
balding and non-balding follicles. Each sample demonstrated variations from each of the 
others. However, the balding group is separated distinctly from the non-balding group. 
The principal component 1 (PC1), principal component 2 (PC2) and principal component 
3 (PC3) are plotted on the x, y and z axes respectively. PC1 and PC2 indicate 20.68% and 
17.17% variations respectively within the same group, whereas PC3 indicate 55.36% 
variation when all samples are grouped together. This denotes that there are differences in 
gene expression between balding and non-balding follicle samples.      
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non-balding 
balding 
Principal component 2  
PC2 (17.17%) 
 
Principal component 3  
PC3 (55.36%) 
 
Principal component 1  
PC1 (20.68%) 
 
Fig 3.46 Principal components analysis (PCA) shows the discrimination of 
balding and non-balding samples.  
 
Three-dimensional (3D) graph, PCA analysis, shows that the experimental samples 
separated into two distinct groups, balding (blue dots) and non-balding (red dots). 
Principal components (PC): PC1, PC2 and PC3 are plotted on the x, y and z axes 
respectively. PC1 and PC2 indicate 20.68% and 17.17% variation respectively 
within the same group, whereas PC3 indicates 55.36% variation in the total gene 
expression.  
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3.6.3 Comparison of overall differences in gene expression between   
balding and non-balding follicles in androgenetic alopecia: 
 
 
3.6.3.1  Sample clustering:  
To obtain an overall view of the similarities and differences between the non-balding and 
balding hair follicles, gene clusters were compared in each individual sample. Genes 
were organized into balding versus non-balding follicles by both individual samples as 
well as grouped samples. Genes that have the most similar expression profiles were 
clustered together and arranged based on similarity in pattern of gene expression (Eisen 
et al., 1998). 
 
The hierarchical clustering analysis showed a clear variability in gene expression in each 
individual though there were obvious pattern of similarities between the three non-
balding and three balding samples (figure 3.47). When the samples were combined into 
two groups, balding and non-balding (figure 3.48), the clustering analysis showed that the 
expression of genes were segregated into discrete clusters in the balding group compared 
to the control, non-balding one. 
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       1             2                3               4               5              6 
 
Individual A Individual B Individual C 
increase decrease 
Expression 
Fig 3.47 A comparison of the gene expression profile in individual balding and 
non-balding follicle samples from androgenetic alopecia men using a microarray 
profiling approach. Hierarchical clustering diagram showing individual expression 
patterns for balding samples (2, 4, 6) versus non-balding ones (1, 3, 5). The diagram 
shows clear differences in gene expression between the two conditions in each 
individual. The colour scale for gene expression is shown on the left.   
 Non-balding      Balding      No-balding      Balding       Non-balding    Balding 
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Non-balding Balding 
increase decrease 
Expression 
Fig 3.48 A comparison of the gene expression profile in pooled balding 
and non-balding follicle samples from androgenetic alopecia men 
using a microarray profiling approach. Hierarchical clustering diagram 
showing pooled data obtained from balding samples (n=3) versus non-
balding ones (n=3) when the individual samples were combined. The 
diagram shows clear differences in gene expression between the two 
conditions. The colour scale for gene expression is shown on the right.   
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3.6.3.2  Statistical analysis:  
A statistically based method, the t-test, was used to analyse the meanings of the 
microarray experimental results to determine which genes were significantly 
differentially expressed, and to assess the associated uncertainty. It takes the variability of 
gene expression into account on a gene-per-gene basis. After applying the t-test, a total of 
2,481 genes were differentially expressed in balding follicles, out of the 28,869 genes on 
the microarray gene chip, and showed a significant change in gene expression with        
p-values of less than 0.05 (figure 3.49 A). Analysis of the gene list showed that 1,462 
genes were up-regulated and 1019 genes were down-regulated in balding scalp (figure 
3.49 B). Table 3.2 summarizes the number of genes changed significantly in balding 
samples compared to non-balding ones when different levels of significant were used. 
Significantly differentially expressed genes, 2,481 genes in total, were visualized by 
drawing a volcano plot which highlighted the fold change between the conditions (figure 
3.50).  
 
 
 
 
 
 
 
P value 
 
 
< 0.05 
 
< 0.01 
 
< 0.005 
 
< 0.001 
 
Total number of genes 
 
 
2481 
 
781 
 
469 
 
115 
 
Up-regulated 
 
 
1462 
 
485 
 
301 
 
77 
 
 
Down-regulated 
 
 
1019 
 
296 
 
168 
 
38 
 
Table 3.2 The number of genes changed significantly (P<0.05) in balding versus 
non-balding scalp follicles after performing the t-test with the data obtained from 
the DNA microarray analysis. 
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Figure 3.49 Changes in the number of genes expressed between non-balding 
and balding scalp follicles from men with androgenetic alopecia  
 
Diagram (A) displays the total number of genes (2,481) which changed 
significantly (P<0.05) in balding versus matched non-balding scalp follicles after 
performing the t-test with the data obtained from the DNA microarray analysis.  
 
Diagram (B) displays the number of genes whose expression was up and down 
regulated significantly (P<0.05) in balding follicles compared to matched non-
balding follicles after performing the t-test with the data obtained from the DNA 
microarray analysis.   
   
 
(A) Genes with altered expression in balding follicles 
(B) Gene expression altered up or down in balding follicles  
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Figure 3.50 Volcano plot showing differentially expressed genes in 
balding follicles compared to non-balding follicles.  
 
The diagram shows a volcano plot displaying differentially expressed genes 
in balding versus non-balding samples for the data obtained from the DNA 
microarray analysis. Significantly different genes, 2,481 out of 28,869 genes 
detected as changed, are highlighted in red (P<0.05). The y-axis is the 
negative log of the p-value at base 10, while the x-axis is the log2 of the fold 
change.  
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3.6.3.3  Fold change (FC) analysis:  
Fold change analysis was also used to identify genes with expression differences between 
balding samples and non-balding ones. There is no associated value of fold change that 
can indicate the level of confidence in the designation of genes as differentially expressed 
or not differentially expressed (Cui and Churchill, 2003), though it is frequently used as 
an easy measure of difference. Table 3.3 and figure 3.51 display the changes in the 
number of genes expressed significantly differently after the t-test in balding versus non-
balding follicles with different fold change cut-offs. Twelve genes were expressed 
differently using a 2 fold cut-off which did not show significance using the t-test, 
whereas it was 276 genes in the case of using a 1.5 fold cut-off (see figure 3.50). 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fold change 
 
 
FC> 1.0 
 
FC> 1.5 
 
FC> 2.0 
 
Total number of genes 
 
 
2481 
 
370 
 
68 
 
Up-regulated 
 
 
1462 
 
203 
 
41 
 
Down-regulated 
 
 
1019 
 
167 
 
27 
Table 3.3 The number of genes changed significantly (P<0.05) in balding 
versus non-balding scalp follicles after performing the t-test and fold 
change filters with the data obtained from the DNA microarray analysis. 
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Figure 3.51 Changes in the number of significantly differentially 
expressed genes between non-balding and balding scalp follicles from 
men with androgenetic alopecia expressed by fold change 
 
Diagram (A) displays the total number of genes (2,481) which changed 
significantly (P<0.05) in balding versus matched non-balding scalp follicles 
after performing the t-test and fold change filter with the data obtained from the 
DNA microarray analysis.  
 
Diagram (B) displays the number of genes whose expression was up and 
down regulated significantly (P<0.05) in balding follicles compared to 
matched non-balding follicles after performing the t-test and fold change 
filter with the data obtained from the DNA microarray analysis. 
   
 
(A) Genes with altered expression in balding follicles  
(B) Gene expression altered up or down in balding follicles  
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 The number of genes changed significantly (P<0.05) in balding follicles was classified 
further. Table 3.4 and figure 3.52 show the changes in the number of genes expressed 
differentially in balding follicles compared to non-balding follicles at different levels of 
significance after applying the t-test and different fold change cut-offs. Sixty-eight genes 
out of 2481 which were significantly differentially expressed using the t-test, also 
differed by more than 2 fold; 17 of those genes were very highly significantly different.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P-value 
 
 
< 0.05 
 
 
< 0.01 
 
 
< 0.005 
 
 
< 0.001 
 
 
Number of genes (FC> 1.0) 
 
 
2481 
 
 
781 
 
 
469 
 
 
115 
 
 
Number of genes (FC> 1.5) 
 
 
370 
 
 
180 
 
 
130 
 
 
43 
 
 
Number of genes (FC> 2.0) 
 
 
68 
 
 
48 
 
 
40 
 
 
17 
 
Table 3.4 The number of genes changed significantly in balding versus non-balding scalp follicles 
by gene microarray analysis at different levels of significance and different fold change cut-offs. 
 
Figure 3.52 Changes in the number of genes expressed between balding and non-
balding scalp follicles from men with androgenetic alopecia. Diagram displays the total 
number of genes which changed significantly in balding versus matched non-balding follicles 
after performing the t-test and fold change filter at different levels of significance and 
different fold change cut-offs with the data obtained from the DNA microarray analysis.  
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3.6.4 Comparison of the expression of keratin and keratin associated 
protein genes in balding and non-balding scalp hair follicles in men with 
androgenetic alopecia: 
 
Since non-balding scalp follicles are larger and produce more hair than those showing 
some miniaturization, the expression of the keratin genes in balding hair follicle samples 
from three men was compared to those in their non-balding follicles. The expression 
levels of ten keratin genes were significantly down-regulated in balding follicles 
compared to non-balding ones using Student’s t-test (P<0.05) by about 1.811-2.627 fold 
(figure 3.53).  
 
The expression of the keratin associated protein genes was also compared. The 
expression levels of eight keratin associated protein genes were significantly down-
regulated (P<0.05) by about 1.731-3.011 fold, whereas only KRTAP10-7 was up-
regulated by 1.104 fold in balding follicles compared to non-balding ones (figure 3.54). 
Therefore, the majority of keratin associated protein genes showed a significant reduction 
in expression in balding follicles compared to non-balding follicles. 
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Figure 3.53 Comparison of the expression of keratin genes in balding versus 
non-balding scalp follicles from men with androgenetic alopecia using fold 
change analysis.    
 
DNA microarray analysis of keratin gene expression showed that ten keratin genes 
were significantly down regulated in balding follicles compared to non-balding 
follicles, (*P<0.05, **P<0.01). 
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Figure 3.54 Comparison of the expression of keratin associated protein genes 
in balding versus non-balding scalp follicles from men with androgenetic 
alopecia using fold change analysis.  
 
DNA microarray analysis showed that eight keratin associated protein genes were 
significantly down-regulated, whereas only KRTAP10-7 was up-regulated in 
balding follicles compared to non-balding follicles. Blue colour indicates down-
regulated and green colour indicates up-regulated. (*P<0.05, **P<0.01, #P<0.001) 
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3.6.5 Comparison of the expression of androgen receptor gene and        
5α-reductase gene in balding and non-balding follicles in men with 
androgenetic alopecia: 
 
Since balding follicles are more responsive to androgens in vivo as this drives their 
miniaturization (Randall, 2008) and since cultured dermal papilla cells from balding 
follicles contain more androgen receptors than non-balding scalp follicles (Hibberts et al., 
1998), the levels of androgen receptor gene expression were also compared. The gene 
expression level of androgen receptor was significantly up-regulated in balding follicles 
when compared to non-balding ones using Student’s t-test (P<0.03) by about 1.856 fold 
(figure 3.55).  
 
Since 5α-reductase type II plays an important role in conversion of testosterone to 
dihydrotestosterone which is a more potent androgen and binds to the androgen receptors 
with a higher affinity than testosterone (Jenkins et al., 1992; Liu and Yamauchi, 2008) 
and is believed to play a role in androgenetic alopecia (Randall, 2007), the expression 
levels of 5α-reductase type II gene were also investigated. The gene expression level of 
5α-reductase type II was significantly up-regulated (P<0.01) in balding follicles when 
compared to non-balding follicles by about 1.698 fold (figure 3.55).   
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Figure 3.55 Comparison of the expression of the androgen receptor gene and  
5α-reductase type II gene in balding versus non-balding scalp follicles from men 
with androgenetic alopecia   
 
DNA microarray analysis was performed to investigate the gene expression levels of 
androgen receptor and 5α-reductase type II in balding follicle samples (n=3) 
compared to matched non-balding follicle samples (n=3). Data are the means ± SEM 
from three different individuals. Androgen receptor expression and 5α-reductase type 
II expression were both significantly up-regulated in balding follicles compared to 
non-balding follicles (*P<0.03, **P<0.01).  
   
* 
** 
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3.6.6 Comparison of the expression of some potential paracrine factor 
genes in balding and non-balding scalp hair follicles in men with 
androgenetic alopecia: 
 
 
The widely accepted mechanism of androgen action involves the stimulation of androgen 
receptors in the dermal papilla which alter the production of paracrine factors which 
regulate other cells in the follicle (Randall, 1994; 2008). Several paracrine factors have 
been implicated in androgen effects on hair follicles and in the regulation of hair growth. 
These include: TGF-ß1 (Inui et al., 2002; 2003), SCF (Randall et al., 2008), IGF (Itami et 
al., 1995b), IGF-IR (Liu et al., 1993), IGFBP3 (Conover and Powell, 1991), IL-1ß 
(Ruckert et al., 2000), IL-1α (Harman and Nevins, 1993), IL-6 (Kwack et al., 2010), and 
VEGF (Lachgar et al., 1996c; Aslan et al., 2005). Therefore, the expression of these 
factors was investigated.   
 
The expression level of the TGF-ß1 gene was significantly up-regulated (P<0.01) in 
androgen-responsive follicles of balding scalp compared to normal follicles by about 
1.848 fold (figure 3.56). In contrast, the expression level of the SCF gene was also 
significantly down-regulated (P<0.04) in balding follicles compared to non-balding ones 
by about 1.934 folds (figure 3.57).  
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Figure 3.56 Comparison of the expression of the TGFß-1 gene in balding 
versus non-balding scalp follicles from men with androgenetic alopecia   
 
DNA microarray analysis was performed to investigate the expression of TGFß-1 
in balding follicle samples (n=3) compared to matched non-balding follicle 
samples (n=3). Data are the means ± SEM from three different individuals. TGFß-
1 expression was significantly up-regulated in balding follicles compared to non-
balding follicles (**P<0.01).  
   
** 
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Figure 3.57 Comparison of the expression of the SCF gene in balding versus 
non-balding scalp follicles from men with androgenetic alopecia   
 
DNA microarray analysis was performed to investigate the expression of SCF in 
balding follicle samples (n=3) compared to matched non-balding follicle samples 
(n=3). Data are the means ± SEM from three different individuals. SCF expression 
was significantly down-regulated in balding follicles compared to non-balding 
follicles (*P<0.04).  
   
* 
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The gene expression levels of the IGF-I and its receptor, IGF-IR, were significantly 
down-regulated in balding follicles when compared to non-balding ones using Student’s 
t-test (P<0.02, P<0.002) by about 1.762 and 1.588 fold respectively (figure 3.58). In 
addition, the expression of the receptor, IGF-IR, was higher than that of IGF-I in both 
matched balding and normal follicles. The expression level of the IGFBP3 gene was also 
significantly reduced (P<0.001) in androgen-responsive follicles of balding scalp by 
about 1.914 (figure 3.59).  
 
The gene expression levels of some other inhibitory factors including IL-1ß, IL-1α, and 
IL-6 were significantly up-regulated (P<0.04, P<0.01, and P<0.03 respectively) in 
balding follicles compared to normal follicles by about 1.993, 1.793 and 1.861 fold 
respectively (figures 3.60). In contrast, the expression level of the VEGF gene was 
significantly reduced (P<0.03) in androgen-responsive follicles of balding scalp by about 
1.57 fold. 
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Figure 3.58 Comparison of the expression of the IGF-I gene and its 
receptor, IGF-IR, gene in balding versus non-balding scalp follicles from 
men with androgenetic alopecia   
 
DNA microarray analysis was performed to investigate the gene expression of 
IGF-I and IGF-IR in balding follicle samples (n=3) compared to matched non-
balding follicle samples (n=3). Data are the means ± SEM from three different 
individuals. The expression of both genes were significantly down-regulated in 
balding follicles compared to non-balding follicles (*P<0.02, ***P<0.002).  
   
* 
*** 
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Figure 3.59 Comparison of the expression of the IGFBP3 gene in balding 
versus non-balding scalp follicles from men with androgenetic alopecia   
 
DNA microarray analysis was performed to investigate the expression of IGFBP3 
in balding follicle samples (n=3) compared to matched non-balding follicle 
samples (n=3). Data are the means ± SEM from three different individuals. 
IGFBP3 expression was significantly down-regulated in balding follicles compared 
to non-balding follicles (#P<0.001).  
   
# 
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Figure 3.60 Comparison of the expression of the interleukin family genes,    
IL-1ß, IL-1α and IL-6 in balding versus non-balding scalp follicles from men 
with androgenetic alopecia   
 
DNA microarray was performed to investigate the expression of IL-1ß, IL-1α and 
IL-6 in balding follicle samples (n=3) compared to matched non-balding follicle 
samples (n=3). Data are the means ± SEM from three different individuals. The 
expression of all these genes was significantly up-regulated in balding follicles 
compared to non-balding follicles (*P<0.05, **P<0.01).  
   
* 
* 
** 
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Figure 3.61 DNA microarray analysis show significantly changes in gene 
expression (up- and down-regulated) for some potential paracrine factors 
and their receptors in balding follicles compared to matched non-balding 
follicles after performing fold change analysis. These factors have been 
implicated in the regulation of human hair growth. Blue colour indicates 
down-regulated and green colour indicates up-regulated. (*P<0.05, 
**P<0.01, ***P<0.005, #P<0.001). 
up-regulated down-regulated 
** 
   * 
  *  
*** 
  # 
   * 
 ** 
   * 
   * 
   * 
  *   
  *   
  *   
 * 
    *** 
- 205 - 
 
3.6.7 Comparison of the expression of HGF family genes in balding and 
non-balding scalp hair follicles in men with androgenetic alopecia: 
 
 
The expression levels of several members of the HGF family and their receptors in three 
balding hair follicle samples were compared to matched non-balding follicles from three 
men with androgenetic alopecia were investigated using DNA microarray analysis. The 
gene expression level of HGF was significantly down-regulated in balding follicles when 
compared to non-balding ones using Student’s t-test (P<0.04) by about 1.756 folds 
(figure 3.62). The expression level of the HGF receptor, c-Met, gene was lower than HGF 
and was also significantly reduced (P<0.03) in balding follicles when compared to non-
balding follicles by about 1.584 folds (figure 3.62).   
 
The gene expression level of MSP was significantly down-regulated (P<0.05) in 
androgen-responsive follicles of balding scalp by 1.803 folds (figure 3.63). The 
expression level of the MSP receptor, RON, gene was also significantly decreased in 
balding follicles when compared to non-balding ones using Student’s t-test (P<0.05) by 
about 1.644 folds (figure 3.63). In addition, the expression of the receptor, RON, was 
lower than MSP in both normal and balding follicles.  
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Figure 3.62 Comparison of the expression of the HGF gene and its receptor, 
c-Met, gene in balding versus non-balding scalp follicles from men with 
androgenetic alopecia   
 
DNA microarray was performed to investigate the expression of HGF and c-Met 
in balding follicle samples (n=3) compared to non-balding follicle samples 
(n=3). Data are the means ± SEM from three different individuals. The 
expression of both genes were significantly down-regulated in balding follicles 
compared to non-balding follicles (*P<0.05).  
   
* 
* 
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Figure 3.63 Comparison of the expression of the MSP gene and its receptor, 
RON, gene in balding versus non-balding scalp follicles from men with 
androgenetic alopecia   
 
DNA microarray was performed to investigate the expression of MSP and RON 
in balding follicle samples (n=3) compared to non-balding follicle samples 
(n=3). Data are the means ± SEM from three different individuals. The 
expression of both genes were significantly down-regulated in balding follicles 
compared to non-balding follicles (*P<0.05).   
   
* 
* 
- 208 - 
 
3.7  Comparison of the expression of the genes for HGF, MSP and their 
receptors, c-Met and RON, in non-balding and balding scalp hair follicles 
from men with androgenetic alopecia using real-time PCR analysis: 
 
To complement the results from the DNA microarray analysis, quantitative real-time 
PCR was carried out to compare the levels of four genes involved in the mechanism of 
action of the hepatocyte growth factor family in matched normal and balding follicles in 
men with androgenetic alopecia. Initially, the method for this was developed using non-
balding scalp follicles.  
3.7.1  Annealing temperature optimization for each set of primers:   
The annealing temperature for the GAPDH, HGF, MSP, c-Met, and RON primers was 
optimized using the gradient feature of the real-time PCR detection system. A range of 
different temperatures was examined to determine the optimal temperature for each set of 
primers to work, i.e. which would give the highest signals (figures 3.64 and 3.65). The 
optimization reaction mixture for each gene contained the following components: PCR 
master mix, DNA-binding dye (SYBR Green), cDNA template generated from human 
reference RNA (appendix II), and specific primer sequences for each gene as appropriate. 
Table 3.6 shows the optimal annealing temperature for each set of primers which gave 
the highest signals.  
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Gene 
 
Optimization conditions 
 
 
 
GAPDH 
 
Annealing temperature (˚C) 
 
 
55.5 
 
56.8 
 
58.3 
 
60.5 * 
 
63 
 
Peak height  
 
 
157 
 
175.32 
 
169.89 
 
240.93 
 
142.6 
 
 
HGF 
 
Annealing temperature (˚C) 
 
 
55.5 
 
56.8 
 
58.3 * 
 
60.5 
 
63 
 
Peak height  
 
 
172.89 
 
 
177.42 
 
 
230.73 
 
200.15 
 
203.38 
 
 
c-Met 
 
Annealing temperature (˚C) 
 
 
55.5 
 
56.8 * 
 
58.3 
 
60.5 
 
63  
 
Peak height  
 
 
184.59 
 
221.91 
 
204.88 
 
214.99  
 
186.63 
 
 
MSP 
 
Annealing temperature (˚C) 
 
 
55.5 
 
56.8 
 
 
58.3 * 
 
60.5 
 
63 
 
Peak height  
 
 
55 
 
55.5 
 
69.4 
 
55.1 
 
18.53 
 
 
RON 
 
Annealing temperature (˚C) 
 
 
55.5 
 
56.8 
 
58.3 
 
 60.5 * 
 
63 
 
Peak height  
 
 
29.62 
 
31.57 
 
35.77 
 
36.9 
 
28.42 
 
 
 
 
 
 
Table 3.5 Annealing temperature optimization for each primer set 
which used for real-time PCR. * Optimal annealing temperature (˚C) 
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HGF 
Figure 3.64 Annealing temperature optimization for HGF primers and 
c-Met primers. Different temperatures were examined to determine the 
optimal annealing temperatures for HGF primers (A) and c-Met primers 
(B) using the gradient feature of the real-time PCR detection system. Each 
reaction mixture contained a cDNA template generated from human 
reference RNA, SYBR Green, PCR master mix and HGF/c-Met primers as 
appropriate. The 58.3˚C reaction yielded the highest signal for HGF, 
whereas it was 56.8˚C for c-Met. Therefore, they were selected as the 
optimal annealing temperatures for HGF primers and c-Met primers 
respectively.  
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The optimal reaction at 60.5 ˚C 
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Figure 3.65 Annealing temperature optimization for MSP primers 
(A) and RON primers (B). Different temperatures were examined to 
determine the optimal annealing temperatures for MSP primers (A) and 
RON primers (B) using the gradient feature of the real-time PCR 
detection system. Each reaction mixture contained a cDNA template 
generated from human reference RNA, SYBR Green, PCR master mix 
and MSP/RON primers as appropriate. The 58.3˚C reaction yielded the 
highest signal for HGF, whereas it was 60.5˚C for c-Met. Therefore, they 
were selected as the optimal annealing temperatures for MSP primers and 
RON primers respectively.  
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3.7.2 The relative expression levels for HGF and its receptor c-Met in                                 
non-balding scalp hair follicles:   
 
The relative expression levels of HGF and c-Met were investigated using relative 
quantitative real-time PCR. Since SYBR Green binds to any double stranded DNA, it is 
necessary to examine the specificity of HGF and c-Met PCR products. Melt-curve 
analysis allows the identification of any non-specific product which may be amplified 
with the HGF and c-Met such as genomic DNA contamination and primer-dimers as the 
presence of a non-specific product would show up as an additional peak in the melt-
curve. The melt-curves for HGF and c-Met genes contained only single peaks indicating 
that these reactions generated only one product for each gene in each of the five samples 
used, and no contaminating products were present (figure 3.66). It is apparent from the 
graphs that the melting temperature (the inflection point) occurred around 80˚C in both 
HGF and c-Met. The expression levels of HGF and c-Met relative to those of GAPDH in 
non-balding scalp hair follicles were analyzed using quantitative real-time PCR. Data 
from all five individual hair follicle samples were collected as cycle threshold (Ct) and 
the HGF and c-Met expression levels were calculated by normalizing the data against 
those of the endogenous control GAPDH in each sample. All five non-balding hair 
follicle samples expressed both HGF and c-Met, with the relative expression levels of 
HGF (7.282 ± 0.657) being higher than that of its receptor, c-Met (4.442 ± 0.537) 
(P<0.0001) (figure 3.67). 
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Figure 3.66  Melt-curve analysis for HGF and its receptor, c-Met.  
 
Melt-curves were generated by real-time PCR for HGF (A) and c-Met (B) 
from five different non-balding hair follicle samples. The melt-curves for 
both genes contain only one peak indicating that no contaminating products 
are present in these reactions and the reactions in (A) and (B) both generated 
only one product. The melting temperature of amplified HGF and c-Met 
products or the points of inflection occurred at about 80˚C in both cases.  
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Figure 3.67  Relative expression levels of HGF & c-Met in non-balding follicles   
 
Relative quantitative real-time PCR was performed to analyze the relative 
expression levels of HGF and c-Met in human non-balding scalp hair follicles. 
Expression levels were calculated by normalizing the value against those of the 
endogenous control (GAPDH). Data are the mean values ± SEM from five 
different individuals in both cases (#P<0.0001).  
   
# 
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3.7.3  The relative expression levels for MSP and its receptor RON in  
non-balding scalp hair follicles:   
 
The relative gene expression levels of MSP and RON were also investigated using 
relative quantitative real-time PCR. The melt-curves for MSP and RON genes contained 
only single peaks indicating that these reactions generated only one product for each gene 
in each of the five samples used, and no contaminating products were present (figure 
3.68). It is apparent from the graphs that the melting temperature (the inflection point) 
occurred around 80˚C in both genes, MSP and RON. The relative expression levels of 
MSP and RON in non-balding scalp hair follicles were again analyzed using quantitative 
real-time PCR, normalized against the endogenous control GAPDH. All five non-balding 
hair follicle samples expressed both MSP and RON, with the relative expression levels of 
MSP (11.081 ± 0.560) being higher than that of its receptor, RON (6.814 ± 0.862) 
(P<0.002) (figure 3.69). In addition, the relative gene expression levels of MSP were 
significantly higher (P<0.0005) than that of HGF and the relative expression levels of 
RON were significantly higher (P<0.01) than that of c-Met.   
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Figure 3.68  Melt-curve analysis for MSP and its receptor, RON.  
 
Melt-curves were generated by real-time PCR for MSP (A) and RON (B) from 
five different non-balding hair follicle samples. The melt-curves in both 
conditions contain only one peak indicating that no contaminating products are 
present in these reactions and the reactions in (A) and (B) both generated only 
one product. The melting temperature of amplified MSP and RON products or 
the points of inflection occurred at about 80˚C in both cases.  
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Figure 3.69  Relative expression levels of MSP & RON in non-balding follicles   
 
Relative quantitative real-time PCR was performed to analyze the relative expression 
levels of MSP and RON in human non-balding scalp hair follicles. Expression levels 
were calculated by normalizing the values against those of the endogenous control 
(GAPDH). Data are the mean values ± SEM from five different individuals in both 
cases (***P<0.002).  
   
*** 
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3.7.4  Comparison of the expression levels for hepatocyte growth factor 
family and their receptor genes in balding scalp follicles with non-balding 
follicles in men with androgenetic alopecia using real-time PCR: 
3.7.4.1 Checking the quality of amplified RNA:  
The total RNA quality and purity of each sample of amplified RNA was evaluated using 
the NanoDrop 2000 spectrophotometer (Thermo-scientific, UK). One single peak of 
absorbance occurred at the wavelength 260 nm for each sample (figures 3.70 and 3.71) 
indicating that the RNA is intact as degraded RNA shows more than one peak. The 
following table shows the concentrations of amplified RNA obtained from six different 
samples. All RNA samples exhibited a 260/280 ratio close to 2 indicating high quality 
resulting RNA. 
 
 
 
 
 
 
 
 
 
 
 
 
Donor 
 
 
Sample 
 
Sample type 
 
Concentration 
(ng/µl) 
 
 
260/280 
Ratio 
 
 
A 
 
1 (non-balding) 
 
 
RNA 
 
14680 
 
2.09 
 
2 (balding) 
 
 
RNA 
 
12718 
 
2.10 
 
 
 
B 
 
 
 
3 (non-balding) 
 
 
RNA 
 
 
12321 
 
1.95 
 
4 (balding) 
 
RNA 
 
 
14589 
 
1.99 
 
 
C 
 
5 (non-balding) 
 
 
RNA 
 
 
15170 
 
2.11 
 
6 (balding) 
 
 
RNA 
 
 
13821 
 
2.00 
Table 3.6 The concentrations of cRNA obtained from six different samples of 
human hair follicles measured using the NanoDrop 2000.  
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Fig 3.70 Checking the quality of amplified RNA from non-balding follicles 
 
RNA obtained from non-balding follicle samples (n=3) were evaluated using 
the NanoDrop 2000 spectrophotometer. The single peak in each sample at the 
wavelength 260 nm indicates that the RNA is intact. 
Sample 1 
(non-balding) 
 
Sample 3 
(non-balding) 
Wavelength (nm) 
 
Wavelength (nm) 
 
Wavelength (nm) 
 
A
b
so
rb
an
ce
 
A
b
so
rb
an
ce
 
A
b
so
rb
an
ce
 
Sample 5 
(non-balding) 
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Fig 3.71 Checking the quality of amplified RNA from balding follicles 
 
RNA obtained from non-balding follicle samples (n=3) were evaluated using 
the NanoDrop 2000 spectrophotometer. The single peak in each sample at the 
wavelength 260 nm indicates that the RNA is intact. 
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3.7.4.2 The relative expression levels of HGF in balding and non-balding 
scalp hair follicles: 
 
Melt-curves of all qRT-PCR products of both non-balding and balding hair follicles 
contained only  single peaks indicating that these reactions generated only one product 
for HGF, and no contaminating products were present (Figure 3.72 A and B). The 
melting temperature (the inflection point) for HGF also occurred at 80˚C in all three of 
both sets of follicles, non-balding and balding. To confirm the melt-curve results and 
check the size of the product, the HGF products for the same reactions were applied to a 
1.5% agarose gel for electrophoresis (figure 3.72 C and D). There was only a single band 
of the anticipated size (144bp) for HGF in each sample. This demonstrated that there was 
no contamination in the samples and the HGF products originated from the amplified 
cDNA and suggested that the primers were identifying the correct gene sequence.  
The relative expression levels of the HGF gene in three balding hair follicle samples 
compared to those three non-balding follicles were analyzed using relative quantitative 
real-time PCR against that of the endogenous control GAPDH (figure 3.73). The relative 
expression level of HGF was significantly reduced in balding follicles (2.452 ± 0.365) to 
less than half the expression in non-balding ones (5.498 ± 0.278) using Student’s t-test 
(P<0.01).  
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Figure 3.72 Melt-curve analysis for HGF in non-balding and balding follicles   
 
Melt-curves for HGF were generated by real-time PCR for non-balding samples 
(A) and balding samples (B). The melt-curves in both conditions contain only one 
peak indicating that no contaminating products are present in these reactions and 
the reactions in (A) and (B) generated only one product. The melting temperature 
of amplified HGF products, the points of inflection, occurred at about 80˚C.  
 
To confirm the melt-curve results and check the size of the product, the HGF 
products for the same reactions were applied to 1.5% agarose gel for 
electrophoresis. There was only a single band of the anticipated size (144bp) for 
HGF in both non-balding follicles (C) and balding follicles (D). DNA ladder 
indicates 100bp DNA molecular size marker (range from 100-1,500).   
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Figure 3.73 Comparison of the expression levels of the HGF gene in balding 
versus non-balding scalp follicles from men with androgenetic alopecia   
 
Relative quantitative real-time PCR was performed to analyze the relative 
expression levels of HGF in balding follicle samples (n=3) compared to non-
balding follicle samples (n=3). Expression levels were calculated by normalizing 
data against the endogenous control gene, GAPDH. Data are the mean values ± 
SEM from three different individuals in both conditions. HGF expression was 
significantly reduced in balding follicles compared to non-balding follicles 
(**P<0.01)  
   
** 
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3.7.4.3 The relative expression levels of c-Met in balding and non-balding 
scalp hair follicles: 
 
Melt-curves of all qRT-PCR products of both non-balding and balding hair follicles 
contained only single peaks indicating that these reactions generated only one product for 
c-Met, and no contaminating products were present (Figure 3.74 A and B). The melting 
temperature (the inflection point) for c-Met also occurred at about 80˚C in all three 
samples of both sets of follicles, non-balding and balding. To confirm the melt-curve 
results and check the size of the product, the c-Met products for the same reactions were 
applied to 1.5% agarose gel for electrophoresis (figure 3.74 C and D). There was only a 
single band of the anticipated size (152bp) for c-Met in each sample. This demonstrated 
that there was no contamination in the samples and the c-Met products originated from 
the amplified cDNA and suggested that the primers were identifying the correct gene 
sequence.  
The relative expression levels of the c-Met gene in three balding hair follicle samples 
compared to those three non-balding follicles were analyzed using quantitative real-time 
PCR against that of the endogenous control GAPDH (figure 3.75). The relative 
expression level of c-Met was significantly reduced (P<0.01) in balding follicles (1.203 ± 
0.202) to less than third of the non-balding follicles expression (3.895 ± 0.368). 
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Figure 3.74 Melt-curve analysis for c-Met in non-balding and balding follicles   
 
Melt-curves for c-Met were generated by real-time PCR for non-balding samples 
(A) and balding samples (B). The melt-curves in both conditions contain only one 
peak indicating that no contaminating products are present in these reactions and the 
reactions in (A) and (B) generated only one product. The melting temperature of 
amplified c-Met products, the points of inflection, occurred at about 80˚C.  
 
To confirm the melt-curve results and check the size of the product, the c-Met 
products for the same reactions were applied to 1.5% agarose gel for 
electrophoresis. There was only a single band of the anticipated size (152bp) for 
HGF in both non-balding follicles (C) and balding follicles (D). DNA ladder 
indicates 100bp DNA molecular size marker (range from 100-1,500).   
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Figure 3.75 Comparison of the expression levels of the c-Met gene in balding 
versus non-balding scalp follicles from men with androgenetic alopecia   
 
Relative quantitative real-time PCR was performed to analyze the relative expression 
levels of c-Met in balding follicle samples (n=3) compared to non-balding follicle 
samples (n=3). Expression levels were calculated by normalizing data against the 
endogenous control gene, GAPDH. Data are the mean values ± SEM from three 
different individuals in both conditions. c-Met expression was significantly reduced 
in balding follicles compared to non-balding follicles (**P<0.01).  
   
   
** 
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3.7.4.4 The relative expression levels of MSP in balding and non-balding 
scalp hair follicles: 
 
Melt-curves of all qRT-PCR products of both non-balding and balding hair follicles 
contained only single peaks indicating that these reactions generated only one product for 
MSP, and no contaminating products were present (Figure 3.76 A and B). The melting 
temperature (the inflection point) for MSP also occurred around 80˚C in all three samples 
of both sets of follicles, non-balding and balding. To confirm the melt-curve results and 
check the size of the product, the MSP products for the same reactions were applied to 
1.5% agarose gel for electrophoresis (figure 3.76 C and D). There was only a single band 
of the anticipated size (116bp) for MSP in each sample. This demonstrated that there was 
no contamination in the samples and the MSP products originated from the amplified 
cDNA and suggested that the primers were identifying the correct gene sequence.  
The relative expression levels of the MSP gene in three balding hair follicle samples 
compared to those three non-balding follicles were analyzed using relative quantitative 
real-time PCR against that of the endogenous control GAPDH (figure 3.77). The relative 
expression level of MSP was significantly reduced in balding follicles (3.461 ± 0.744) to 
less than half the expression in non-balding follicles (9.851 ± 0.996) using Student’s t-
test (P<0.03). 
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Figure 3.76 Melt-curve analysis for MSP in non-balding and balding follicles   
 
Melt-curves for MSP were generated by real-time PCR from non-balding samples 
(A) and balding samples (B). The melt-curves in both conditions contain only one 
peak indicating that no contaminating products are present in these reactions and the 
reactions in (A) and (B) generated only one product. The melting temperature of 
amplified MSP products, the points of inflection, occurred at about 80˚C.  
 
To confirm the melt-curve results and check the size of the product, the MSP 
products for the same reactions were applied to 1.5% agarose gel for electrophoresis. 
There was only a single band of the anticipated size (116bp) for MSP in both non-
balding and balding follicles (C). Lane1: DNA ladder, Lane 2, 3: MSP PCR products 
from non-balding and balding follicle samples respectively. DNA ladder indicates 
100bp DNA molecular size marker (range from 100-1,500).    
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Figure 3.77 Comparison of the expression levels of the MSP gene in balding 
versus non-balding scalp follicles from men with androgenetic alopecia   
 
Relative quantitative real-time PCR was performed to analyze the relative 
expression levels of MSP in balding follicle samples (n=3) compared to non-
balding follicle samples (n=3). Expression levels were calculated by 
normalizing data against the endogenous control gene, GAPDH. Data are the 
mean values ± SEM from three different individuals in both conditions. MSP 
expression was significantly reduced in balding follicles compared to non-
balding follicles (*P<0.03). 
   
* 
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3.7.4.5 The relative expression levels of RON in balding and non-balding 
scalp hair follicles:  
 
Melt-curves of all qRT-PCR products of both non-balding and balding hair follicles 
contained only single peaks indicating that these reactions generated only one product for 
RON, and no contaminating products were present (Figure 3.78 A and B). The melting 
temperature (the inflection point) for RON also occurred around 80˚C in all three samples 
of both sets of follicles, non-balding and balding. To confirm the melt-curve results and 
check the size of the product, the RON products for the same reactions were applied to 
1.5% agarose gel for electrophoresis (figure 3.78 C and D). There was only a single band 
of the anticipated size (117bp) for RON in each sample. This demonstrated that there was 
no contamination in the samples and the RON products originated from the amplified 
cDNA and suggested that the primers were identifying the correct gene sequence.  
The relative expression levels of the RON gene in three balding hair follicle samples 
compared to those three non-balding follicles were analyzed using relative quantitative 
real-time PCR against that of the endogenous control GAPDH (figure 3.79). The relative 
expression level of RON was significantly reduced in balding follicles (1.596 ± 0.458) to 
less than half the expression in non-balding follicles (4.599 ± 0.359) using Student’s t-
test (P<0.04).  
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Figure 3.78 Melt-curve analysis for RON in non-balding and balding follicles   
 
Melt-curves for RON were generated by real-time PCR from non-balding samples 
(A) and balding samples (B). The melt-curves in both conditions contain only one 
peak indicating that no contaminating products are present in these reactions and 
the reactions in (A) and (B) generated only one product. The melting temperature 
of amplified RON products, the points of inflection, occurred at about 80˚C in.  
 
To confirm the melt-curve results and check the size of the product, the RON 
products for the same reactions were applied to 1.5% agarose gel for 
electrophoresis. There was only a single band of the anticipated size (117bp) for 
RON in both non-balding follicles (C) and balding follicles (D). DNA ladder 
indicates 100bp DNA molecular size marker (range from 100-1,500).   
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Figure 3.79 Comparison of the expression levels of the RON gene in balding 
versus non-balding scalp follicles from men with androgenetic alopecia   
 
Relative quantitative real-time PCR was performed to analyze the relative expression 
levels of RON in balding follicle samples (n=3) compared to non-balding follicle 
samples (n=3). Expression levels were calculated by normalizing data against the 
endogenous control gene, GAPDH. Data are the mean values ± SEM from three 
different individuals in both conditions. RON expression was significantly reduced in 
balding follicles compared to non-balding follicles (*P<0.04).  
   
* 
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4- Discussion 
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4. Discussion 
Androgens are the major regulating hormones of human hair growth. It is believed that 
androgens act on hair follicles through the dermal papilla (Randall, 2008). In this model, 
circulating androgens enter the dermal papilla through its good blood supply and cause 
alteration in its production of paracrine regulatory factors, which influence the 
surrounding follicular components. These factors would play a role in altering the type of 
hair produced by androgen-dependent hair follicles. Paracrine factors may target the 
follicular melanocytes which control the amount of pigment produced, the keratinocytes 
which proliferate to produce the hair fibre, the follicular endothelial cells, and the cells of 
the connective tissue sheath, as well as the dermal papilla itself through an autocrine 
regulatory system. Investigating these factors could give us a better understanding of the 
mechanisms involved in androgen-dependent hair disorders. The aim of this study was to 
investigate the gene expression of some paracrine factors that may be involved in 
mediating androgen action in the human hair follicles, including members of hepatocyte 
growth factor family HGF, MSP, and their respective receptors, c-Met and RON, in 
human scalp hair follicles. 
  
As an initial step of this study, the structure of red deer and human hair follicles were 
investigated using histochemical staining for the purpose of familiarisation of hair follicle 
structure and for histological comparisons between both species. Longitudinal and 
horizontal cross-cryosections were prepared from red deer and human skin. Making 
sections of deer skin was easier to deal with within the cryostat than human skin due to 
the large size of deer hair follicles compared to human hair follicles, which are smaller 
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and less densely packed. Prepared cryosections from both skin types were treated with 
histochemical staining using Sacpic (Nixon, 1993; Nutbrown and Randall, 1996) and 
haematoxylin and eosin staining techniques to clearly visualise the normal histology of 
the hair follicle and to differentiate the various structures of the skin and hair follicle. 
Different components can be clearly seen in the sections of human scalp skin stained with 
Sacpic, including a thin epidermis followed by a thick dermal layer (blue/green) 
composed of collagen bundles (bright blue) (figure 3.2). The hair follicles extend deep 
within a subcutaneous fat layer as highlighted by the staining; the hair fibre (yellow) is 
surrounded by the inner root sheath (red) and outer root sheath (blue). The hair bulb at its 
base contains the dermal papilla, surrounded by the epithelial hair matrix containing 
melanocytes, and attached to the connective tissue sheath at its base. The connective 
tissue sheath (pale blue) encases the entire follicle separating it from the dermis (figures 
3.2, 3.3). These findings are similar to those previously observed in the human hair 
follicle using Sacpic staining (Nutbrown and Randall, 1996). Various layers of human 
hair follicles were also clearly seen in horizontal cross-sections (figures 3.4, 3.5), in 
which the hair follicles were sectioned in the upper part of the follicles, in which fully 
keratinised hair fibres are present and are stained yellow using Sacpic and pink using 
Haematoxylin and Eosin. 
 
Generally speaking, the overall structure of both human and red deer hair follicles were 
similar. However, deer hair follicles are larger than those of human scalp, extending deep 
within the dermis, and the medulla is much larger and clearly visible compared to those 
in human scalp (figure 3.1). The medulla is well developed in these animals to provide 
the insulatory properties of animal hair. 
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4.1  Identification of  hepatocyte growth factor family members and their    
      receptors in isolated human scalp hair follicles and their components:  
 
 
The investigation then moved on to investigate gene expression of specific molecules 
using RT-PCR. Human lower anagen hair follicles of normal (non-balding) scalp were 
isolated from five individuals by microdissection (figures 2.1, 3.6, 3.7, 3.8). The resulting 
whole follicles were collected from each sample for total RNA isolation, poly (A) RNA 
isolation and cDNA synthesis. The purity of total RNA was checked by agarose gel 
electrophoresis which exhibited the ratio 2:1 of rRNA (28S:18S) (figure 3.9). This 
indicated that the RNA was intact and suitable for use (Skrypina et al., 2003). RT-PCR 
was carried out to investigate the expression of genes for some potential paracrine factors 
in human hair follicles including HGF, MSP and their receptors c-met and RON. The 
presence or absence of specific gene sequences can be ascertained in cDNA produced 
from isolated poly (A) RNA by amplification using PCR.    
 
The highly expressed cytoskeletal protein, β-actin, was used as a positive control; a 
negative control, in which the cDNA was excluded from the reaction mix, was also 
included in each experiment. The β-actin gene was amplified using specific forward and 
reverse primers to ensure that the RNA isolated from all five individuals was of sufficient 
quality to perform RT-PCR successfully (figure 3.10). The β-actin PCR products from all 
five individuals were similar in size to that anticipated from the human sequence, which 
is 838bp (figure 3.10) (Shorter et al., 2008). In all the negative controls, no PCR products 
were found when the template cDNA was replaced with nuclease-free water in the 
reaction mix, indicating an absence of any contaminating DNA in the poly (A) RNA 
samples used for RT-PCR and confirming that the PCR products from all experimental 
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samples were a result of amplification of the cDNA produced from the poly (A) RNA of 
each sample.  
 
Following analysis of the β-actin PCR product by electrophoresis, the identity of the β-
actin PCR product was confirmed using sequence analysis. The sequencing data were 
compared to the previously identified human sequence, obtained from the ensemble 
genome browser, using the NCBI BLAST programme. β-actin PCR products from human 
hair follicles exhibited 96% correlation with the known human sequence (figure 3.11). 
The successful amplification of β-actin with all cDNA samples confirmed that the cDNA 
samples were of sufficient quality for further RT-PCR analysis to be performed.  
 
4.1.1  Investigating the expression of HGF and its receptor, c-Met, in    
         isolated non-balding scalp hair follicles and their components:  
 
 
The investigation then moved on to examine the suggestion that hepatocyte growth factor 
(HGF) is a possible paracrine factor involved in hair growth. It has been revealed that 
HGF may act as a powerful modulator of hair growth and be involved in morphogenesis 
and cycling (Jindo et al., 1995; Lindner et al., 2000), (section 1.11.3). In a variety of 
organs, HGF is known to exert its effect as a paracrine factor secreted by mesenchyme- 
derived cells acting on neighbouring epithelial or endothelial cells (Peus and Pittelkow, 
1996; Young-Ran et al., 2001).   
 
In this study, the expression of HGF and its receptor, c-Met, were investigated in human 
anagen hair follicles of non-balding scalp using the RT-PCR technique. The primer 
sequences used for HGF and c-Met had been previously optimised by Shimaoka et al. 
(1995) and by Imaizumi et al. (2000) respectively. cDNA was prepared from five 
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individual samples of isolated human hair follicles of non-balding scalp. When the 
resulting PCR products for each gene were separated using agarose gel electrophoresis 
and visualised with ethidium bromide staining, those from all five individuals 
corresponded to the anticipated size of HGF product 262 bp, when the HGF primers were 
used (figure 3.12). With the c-Met primers the bands also corresponded to the anticipated 
size 563 bp (figure 3.18). No bands were detected in the negative control lanes, indicating 
no contaminating DNA in the samples.  
 
The identity of HGF and its receptor, c-Met, genes were verified by sequencing and 
comparing the human hair follicle PCR products of both HGF and c-Met with the known 
human sequences (figures 3.13 and 3.19). Thus, the results showed that the mRNA of 
both HGF and its receptor, c-Met, were expressed in anagen hair follicles from non-
balding scalp of all five individuals (figures 3.12, and 3.18) demonstrating a possible role 
for HGF in the maintenance and control of human anagen hair follicles and supporting 
the suggestion that HGF may act as a powerful modulator of hair growth. 
       
Following detection of the expression of HGF and its receptor c-Met in whole isolated 
human hair follicles, the next stage was to determine the location of each molecule within 
the hair follicles. The three components of the human hair bulb, comprising the dermal 
sheath, the epithelial bulb matrix, which also contains melanocytes, and the dermal 
papilla, were microdissected individually. This was a very time consuming procedure 
(figures 3.20, 3.21). PCR products of predicted size (838 bp) were produced from all 
three hair bulb components for the β-actin; however, the expression of β-actin had much 
greater intensity in the epithelial matrix than the dermal sheath and the dermal papilla in 
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the components from each of the three individuals examined. The dermal papilla bands 
had least intensity (figure 3.22). This concurs with previous studies showing that the 
volume of the matrix was about ten times that of the dermal papilla, and the ratio between 
the number of cells in the dermal papilla and those dividing in the matrix was nine to one 
(Van Scott and Ekel, 1958; Elliott et al., 1991).  
 
The expression of HGF and c-Met were further investigated to refine their location in the 
three lower follicle components using RT-PCR. The results showed that gene expression 
of HGF was found in both the dermal sheath and dermal papilla, but not in the matrix 
(figure 3.24). The dermal papilla bands were less strong than those of the dermal sheath. 
This parallels the differences in the cDNA quantity observed in the case of β-actin. No 
bands were seen in the matrix lanes in either HGF gels. As the matrix cDNA was the 
strongest in β-actin analysis, if HGF is expressed in the matrix cells, bands should have 
been visible. The results indicated that the dermal papilla and dermal sheath have the 
capacity to synthesise HGF.  The results also revealed that the gene for the HGF receptor, 
c-Met, was expressed in both the dermal sheath and dermal papilla (figure 3.25) 
indicating their ability to produce c-Met which allow them to respond to HGF. It has been 
observed that the gene for HGF was strongly expressed in rat anagen, and slightly in 
telogen, follicles using cDNA extracted from skin sections (Yamazaki et al., 1999) and 
localised to the dermal papilla cells of mouse pelage anagen follicles using 
immunohistochemistry (Lindner et al., 2000). Yu et al. (2004) reported c-Met expression 
in human scalp cultured dermal papilla cells using RT-PCR and also in rat follicular 
matrix keratinocytes using in situ hybridisation.  
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Since the dermal papilla is believed to be the main regulator of the hair follicle and can 
determine what sort of hair is produced (Jahoda et al., 2001; Randall, 2008), cultured 
dermal papilla cells are used extensively as a model system (Itami et al., 1995a; Jahoda et 
al., 2001; Inamatsu et al., 2006; Hamada and Randall, 2006). Therefore, the expression of 
HGF and its receptor, c-Met, was examined also in human cultured dermal papilla cells 
of non-balding scalp hair follicles isolated from two different individuals using RT-PCR. 
The dermal papilla cells in culture increased in number gradually to give multi-polar 
shapes and formed small clumps (figure 3.30). When confluent, they were collected for 
RNA extraction, cDNA synthesis and gene expression investigation. The resulting PCR 
products for HGF and its receptor, c-Met, appeared on the agarose gel as distinct bands of 
the anticipated sizes of 262 bp and 563 bp respectively, and no bands were present in the 
negative controls indicating that the primer pair was binding specifically to the cDNA 
template (figures 3.33 and 3.39). Sequence analysis confirmed the identity of HGF and c-
Met PCR products (figures 3.34 and 3.40). This agrees with observations of prior studies 
which determined the gene expression of HGF in cultured dermal papilla cells derived 
from human hair follicles (Shimaoka et al., 1995; Merrick, 2000). In addition, Yu et al. 
(2004) showed that the gene for c-Met was expressed in cultured dermal papilla cells 
from human scalp hair follicles and rat vibrissae follicles using RT-PCR, concurring with 
the results reported here. This indicates that the dermal papilla cells can synthesise HGF 
and its receptor, c-Met, which would enable them to react to HGF in culture; this 
correspond to the results mentioned earlier using freshly isolated dermal papilla, i.e. as 
close to in vivo as possible.  It was important to confirm that cultured dermal papilla cells 
are behaving the same as in vivo if the cells are to be useful as a model system in this 
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area. There is a possibility of loss of normal gene expression as soon as the cultured cells 
are established (O’Shaughnessy et al., 2004).     
Immunohistochemistry was also used to locate the protein for c-Met in the human hair 
follicle. Several different concentrations of the reaction solutions and the blocking serum 
solutions were used to optimise the procedure until the optimum staining was obtained. 
Three negative controls were included in each experiment to detect any non-specific 
binding to ensure that the colour detection system was not activated alone, to ensure that 
the secondary antibody is not binding non-specifically to the tissue, and that the primary 
antibody was not activating the red chromogen AEC solution without the presence of the 
secondary antibody.    
                    
Initially, to learn the technique of immunohistochemistry, the location of cytokeratin 6, a 
highly expressed cytoskeletal protein, was examined in human hair follicles using a goat 
polyclonal anti-cytokeratin 6 antibody (Novocastra Laboratories, UK) with mouse serum 
for blocking and in the diluting procedure. Expression of cytokeratin 6 was detected in 
the outer root sheath of human hair follicles (figures 3.26, 3.27). These observations were 
consistent with the findings of previous studies using human hair follicles (Stark et al., 
1987), sheep wool follicles (Bond et al., 1996), and red deer follicles (Croft, 2002). 
    
The presence of c-Met within non-balding scalp hair follicles was then examined using 
immunohistochemistry using a mouse monoclonal anti-human c-Met antibody 
(Novocastra Laboratories, UK). The protein expression was detected in the outer root 
sheath and the dermal papilla cells of human anagen hair follicles (figures 3.28, 3.29). 
This concurs with previous reports detecting c-Met in the outer and inner root sheath in 
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anagen mouse follicles using immunohistochemistry (Lindner et al., 2000). From the 
results reported here, both RT-PCR and immunohistochemistry revealed the presence of 
HGF receptor c-Met in both dermal sheath and dermal papilla cells of human hair 
follicles.  
 
The detection of genes for both HGF and its receptor, c-Met, in the dermal papilla cells 
would enable this signalling system to work as an autocrine regulator. Dermal papilla 
cells have been shown to secrete autocrine regulatory factors which alter the growth of 
the dermal papilla cells in vitro (Thornton et al., 1998; Hamada and Randall, 2006). Since 
the size of the dermal papilla and number of cells it contains are directly related to the 
size of the hair produced by the follicles (Van Scott and Ekel, 1958; Elliott et. al., 1999), 
alteration in such factors could be important in androgen-stimulated alteration in hair 
follicle and hair size.  
 
4.1.2  Investigating the expression of MSP and its receptor, RON, in    
          isolated non-balding scalp hair follicles and their components:  
 
 
Another member of the hepatocyte growth factor family, macrophage stimulating protein 
(MSP), has also been implicated in hair growth control. McElwee et al. (2004) examined 
the effect of MSP on hair growth due to the similarity and close relationship between 
MSP and HGF. They observed that exposure to different concentrations of MSP led to 
increases in human hair follicle length when non-balding scalp follicles were cultured in 
vitro. In addition, MSP stimulated mouse telogen follicles to enter anagen in vivo 
(McElwee et al., 2004). These findings suggest MSP may be a possible paracrine factor 
produced by the dermal papilla cells.  
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In order to investigate the hypothesis that MSP may play a role as a potential paracrine 
factor affecting hair growth, the expression of MSP and its receptor RON were also 
investigated in human anagen hair follicles of non-balding scalp using RT-PCR as 
described previously. All five human hair follicle cDNA samples produced PCR products 
of the expected size: 415 bp for the gene of MSP (figure 3.14) and 217 bp for the gene of 
RON (figure 3.16) when separated using agarose gel electrophoresis. Sequence analysis 
also verified the identity of the DNA fragments for both MSP and RON.  
 
The results of this investigation agree with the finding of MSP in cultured cells derived 
from human occipital scalp dermal papilla and dermal sheath using western blotting, and 
the MSP receptor, RON, in the matrix, the dermal papilla and the dermal sheath using 
immunohistochemistry (McElwee et. al., 2004). In addition, Shorter (2007) showed that 
the gene for MSP was expressed in the three tissue types, the dermal sheath, the matrix 
and the dermal papilla, were microdissected from the human hair bulb of non-balding 
scalp follicles using RT-PCR.  
     
To localise the MSP receptor, RON, within human hair follicles using RT-PCR, cDNA 
was extracted from the three components of the hair bulb: the dermal sheath, matrix and 
dermal papilla. Gene expression of RON was found in all three tissue types of the human 
hair bulb. The expression had much greater intensity in the epithelial matrix than in the 
dermal sheath and the dermal papilla in the components from each of the three 
individuals examined. The dermal papilla bands had least intensity (figure 3.23). This 
parallels the differences in the cDNA quantity observed in the β-actin gels and shows 
interesting differences from the location of HGF and its receptor c-Met.  
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To confirm the expression of MSP and RON in the dermal papilla using RT-PCR, total 
RNA was extracted from human cultured dermal papilla cells of two individuals. It is 
apparent from the results that the PCR products from both samples corresponded to the 
expected size of MSP product 415 bp when the MSP primers were used (figure 3.35) 
whereas those with RON primers were 217 bp (figure 3.37). When the identity of MSP 
and RON were ascertained via sequencing, with the cultured human scalp dermal papilla 
cells’ PCR products of both MSP and RON exhibited homology with the known human 
sequences respectively (figures 3.36 and 3.38).   
 
The findings of this investigation indicated that the dermal papilla, the matrix and the 
dermal sheath have the capacity to synthesise the MSP receptor, RON, which allows 
them to respond to MSP. Since the earlier studies detected MSP in the dermal papilla and 
dermal sheath of human occipital scalp follicles (McElwee et al., 2004; Shorter, 2007) 
and also the bulb matrix (Shorter et al., 2007), this would suggests that this signalling 
pathway works as paracrine signalling system. This could be an autocrine response, as 
suggested earlier in the discussion of HGF and its receptor, since the dermal papilla can 
express both MSP and the receptor RON. On the other hand it could be the more normal 
paracrine route with the signal being produced by either the dermal papilla or the dermal 
sheath or the matrix cells and received by the receptors in one of the other tissues. Since 
all the cells in the bulb are potential targets of androgens (Randall, 2008) either directly, 
or indirectly via a signal from a direct target such as the dermal papilla, MSP and its 
receptor RON seem good candidate for a paracrine role in androgen-stimulated alteration 
of hair growth.   
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4.2  Comparison of the gene expression of some potential paracrine factors in  
normal and balding scalp hair follicles from males with androgenetic alopecia: 
 
  
The role of paracrine factors produced by dermal papilla cells in androgen-dependent hair 
follicles has been the focus of much research since they are believed to be important in 
determining the type of hair produced (Jahoda et al., 2001; Randall, 2008). The alteration 
of the size of the hair produced by a hair follicle, while at the same time maintaining 
many processes involved in hair growth and the hair cycle, probably requires a number of 
paracrine factors, some of them are inhibitory and others stimulatory. Androgens are the 
main known key regulator responsible for changing the type of hair produced by a hair 
follicle (Randall et al., 2008), stimulating enlarged follicles producing larger terminal hair 
in many areas after puberty, while causing reduction in follicle size on the scalp resulting 
in androgenetic alopecia. Therefore, having established a molecular biological approach 
to investigate paracrine factors in non-balding scalp follicles, this was extended to 
investigate how androgens alter gene expression in target follicles to change the type of 
hair produced. In this study, the focus was on comparing the gene expression in isolated 
non-balding and androgenetic alopecia hair follicles and determining whether there are 
significant differences between them using two comparative methods, DNA microarray 
analysis and quantitative real-time PCR. To maximize the likelihood of obtaining 
meaningful results, the comparisons were carried out using matched pairs of non-balding 
and balding follicles from the same men with androgenetic alopecia. 
  
The skin samples used were obtained from three healthy men undergoing cosmetic 
dermatological surgeries, aged 51, 56 and 55, with androgenetic alopecia (male pattern 
baldness), which was classified as class IV according to the Hamilton classification 
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(1951). The hair follicles were microdissected from two areas of the scalp from each 
individual: frontal scalp for the balding follicles and occipital scalp for the control, non-
balding ones. The non-balding and balding scalp hair follicles showed morphological 
differences which distinguished them from each other. The vast majority of the balding 
hair follicles were vellus follicles, though there were a few intermediate follicles. The 
balding vellus follicles were tiny in length and diameter compared to the matched 
terminal follicles of the non-balding scalp. They produced hairs which were mainly pale 
in colour, being less pigmented. Furthermore, the blood supply system in balding follicles 
was considerably reduced, concurring with a finding which was also recorded by 
Crovato, Moretti and Bertamino (1968) and Hibbert et al. (1996). The balding 
intermediate follicles were characterised by their intermediate length, their diameters 
being smaller than the terminal ones and wider than the vellus follicles, closer to those of 
vellus ones than those in non-balding follicles, and their bulbs being situated in the 
interface between the dermis and subcutaneous fat tissue compared to non-balding 
follicle bulbs, which were deep within the fat tissue. These observations concur with a 
recent study reported by Miranda et al., (2010). These differences in hair follicle size, 
shape, diameter and colour between the follicles from the two sites supports the use of 
these follicles to investigate changes in gene expression promoted by androgens. 
  
Isolation of balding follicles was very time-consuming and needed much care and 
patience due to their small size and pale colour. Following hair follicle isolation, the total 
RNA was extracted and later cDNA was synthesised. It was noticeable that the total RNA 
extracted from balding follicles was less than that extracted from the similar number of 
non-balding follicles, reflecting the difference in size between the balding and normal 
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follicles. Nevertheless, the electrophoretic separation of total RNA showed the rRNA 
bands (28S and 18S) exhibited a 2:1 ratio for all balding and non-balding samples 
indicating that the total RNA was intact (Skrypina et al., 2003), (see figure 3.41). The 
electropherograms also showed high quality RNA for all samples characterised by the 
presence of clear defined 28S and 18S peaks and little noise between the peaks with 
minimal low molecular weight noise (figures 3.42 and 3.43).  
 
DNA microarray analysis was carried out to investigate the changes in gene expression in 
matched non-balding and balding scalp hair follicles. The Affymetrix GeneChip human 
exon 1.0 ST array containing 28,869 genes was used in this study; six chips were used, 
one chip per sample. Following scanning of the hybridized arrays, DNA microarray data 
were analyzed using GeneSpring GX 11 software (Agilent).  
 
The robust multi-array analysis (RMA) method was used to normalize the experimental 
data to standard microarray data as per-gene normalization. This method aims to avoid 
and remove any systematic errors or biases from the data which may cause negative 
effects on the data analysis afterward (Irizarry et al., 2003). To stabilize the variation 
across the expression range and to treat up- and down-regulated genes in a similar 
fashion, the data were transformed to a log scale (Quackenbush, 2002; Cui and Churchill, 
2003). A box and whiskers plot (figure 3.44) showed the variation in the intensity values 
distribution in the balding and non-balding groups indicating that these results are 
appropriate to be taken forward to the next stage of analysis. 
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To check the quality of the microarray intensity values further, a scatter plot (figure 3.45) 
was used (Lee and Park, 2007). This revealed that there was a negative correlation in the 
gene expression between the balding and non-balding group (r= - 0.74, P<0.03). In other 
words, when the balding sample has high fluorescence associated with the expression of 
one gene, then the non-balding sample is tending to have a low amount of fluorescence, 
i.e binding or expression. In addition, the reverse pattern also occurs with high 
fluorescence in a non-balding sample corresponding to low expression in a balding one.  
 
The principal component analysis (PCA) method (Komura et al., 2004; Shlens, 2009) 
was used to clarify the quality of the microarray intensity values further. This type of test 
can reduce a huge number of complex data to a lower dimension. It is evident from the 
three-dimensional (3D) graph (figure 3.46) that the six experimental samples are 
separated into two distinct groups; the non-balding group and the balding group. The 
principal component 1 (PC1) and the principal component 2 (PC2), indicate 20.68% and 
17.7% variation respectively within the same group, whereas the principal component 3 
(PC3) on the z-axis indicates 55.36% variation in the total gene expression between the 
balding and non-balding groups. Thus, the PCA test revealed that there are clear 
differences in gene expression between the balding and non-balding samples and that 
there was much less difference within the three different samples in each type of follicles. 
 
As the checks on the quality of the microarray data had shown that they were appropriate 
for further analysis, gene clustering comparisons were performed. An overall view of 
DNA microarray experiment performance was gained by comparing gene clustering in 
each individual sample. The hierarchical clustering analysis showed a clear variability in 
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gene expression, though there were obvious similarities within the set of balding follicles 
and also within the set of non-balding ones (figure 3.47). When the samples were 
combined into two groups (figure 3.48), the clustering analysis showed that the overall 
gene expressions were separated into discrete clusters where genes that have the most 
similar expression profiles were clustered together (Eisen et al., 1998). 
 
The microarray data analysis was continued by applying a statistical method, Student’s   
t-test, to determine which genes are significantly differentially expressed and to extract 
the meanings of microarray experimental results. The t-test takes the variability of gene 
expression into account on a gene-per-gene basis. The result revealed that a total of 2,481 
genes were significantly differentially expressed in balding follicles, out of the 28,869 
genes on the microarray gene chip, showing a significant change in gene expression with 
probability values of less than 0.05. Of these 1,462 genes were up-regulated in balding 
follicles whereas 1,019 genes were down-regulated. For further investigation, the fold 
change filter was performed to determine differences in gene expression in both groups. 
Table 3.3 shows the number of genes changed significantly (P<0.05) in balding versus 
non-balding with different fold change cut-offs. The traditional approach for comparing 
analysis is to look for genes with two fold differences in expression i.e. increases or 
decreases of a hundred percent. However, a more biologically relevant approach is to 
look at genes whose expression is significantly altered as changes in levels of an enzyme 
in a cell for example would not need to be a hundred percent to have far reaching effects. 
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The hair keratins are the cytoplasmic intermediate filaments which form the main 
structural proteins of mammalian hair. They belong to a multi-gene family which consists 
of genes that are expressed in different type of epithelia (Powell et al., 1997). Since non-
balding scalp follicles are larger and produce more hair than those of balding scalp, the 
expression of the keratin genes were investigated. The data obtained from DNA 
microarray analysis showed that ten keratin genes were significantly (P<0.05) down-
regulated in balding follicles compared to non-balding follicles by about 1.811-2.627 fold 
(figure 3.53). This would be expected as balding follicles produce much smaller hairs 
than non-balding ones and suggest that these decreased levels of keratin genes in 
androgen-sensitive follicles of balding scalp may occur under the influence of androgen.  
 
Whether this is direct regulation or indirect via paracrine factors from the dermal papilla 
is not known as yet. Java-Suarez et al., (2004) observed the that keratin hHa7 was 
expressed in medullary cells of all types of male and female sexual hairs including beard, 
axillary and pubic hairs, but not in occipital terminal hairs using western blot analysis. 
They also reported its expression in beard and temple vellus hair follicles using 
immunohistochemistry. In addition, they demonstrated the expression of androgen 
receptor in beard hair follicles, and demonstrated the specific binding of the androgen 
receptor to all three putative hHa7 androgen receptor-binding elements, suggesting this 
type of keratin may be directly regulated by androgens. It has been reported that mouse 
endodermal cells that are deficient in keratin 8 and keratin 18 are more sensitive to TNF 
which induces cell death suggesting a functional link between these keratin and TNF 
signalling through their binding to the cytoplasmic domain of TNFR while moderates the 
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influence of TNF (Caulin et al., 2000), concurring with the observations reported by 
Inada et al., (2001) in human liver cells. 
  
Since balding follicles are more responsive to androgens in vivo as this drives their 
miniaturization (Randall, 2008), the gene expression levels of androgen receptor was also 
investigated in this thesis using DNA microarray analysis. The results revealed that the 
expression of androgen receptors was significantly up-regulated (P<0.03) with a 1.856 
fold increase in balding scalp hair follicles compared with the control follicles (figure 
3.55), supporting the original hypothesis. These results concur with earlier in vitro studies 
demonstrating that cultured dermal papilla cells derived from follicles from androgen-
sensitive regions, both balding scalp and beard, contain a higher level of androgen 
receptors than those derived from androgen-insensitive regions such as non-balding scalp 
(Randall et al., 1992; Hibberts et al., 1998). Another group also demonstrated that 
cultured dermal papilla cells derived from beard and auxillary follicles expressed the 
gene for androgen receptor, whereas this was only present at a low level in dermal papilla 
cells derived from occipital scalp follicles (Ando et al., 1999). These parallels support the 
microarray analysis and the difference in androgen receptor levels in balding follicles 
from normal men indicates that androgen should be able to regulate gene expression in 
balding follicles as the activated androgen receptor is a transcriptional regulator 
(Narayanan et al., 2008).  
 
Since the enzyme 5α-reductase plays an important role in conversion of testosterone to 
5α-dihydrotestosterone, a more potent androgen which binds to the androgen receptors 
with a higher affinity than testosterone (Jenkins et al., 1992; Randall et al., 2008) and 
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since it is expressed in cultured dermal papilla cells derived from both beard and scalp 
hair follicles (Liu and Yamauchi, 2008), the expression level of 5α-reductase type II gene 
was also investigated. Individuals deficient in 5α-reductase type II do not show male 
patterns of body hair, in spite of their circulating androgen. They only produce female 
patterns of pubic and axillary hair and have little or no beard (Wilson et al., 1993). This 
suggests that axillary and pubic follicles respond to testosterone, whereas the male 
secondary sexual hair demands metabolism of testosterone to 5α-dihydrotestosterone. In 
addition, the 5α-reductase type II inhibitor, finasteride, can restore hair growth in men 
with androgenetic alopecia (Kaufman et al., 1998). These observations support the 
microarray analysis which revealed that the gene expression level of 5α-reductase type II 
was significantly up-regulated (P<0.01) in androgen-responsive follicles of balding scalp 
when compared to matched non-balding follicles by 1.698 fold (figure 3.55) suggesting 
5α-dihydrotestosterone is the active androgen in these follicles.  
  
The investigation was continued using DNA microarray to examine the hypothesis that 
transforming growth factor-ß1 (TGF-ß1) is a paracrine factor produced by dermal papilla 
cells and is involved in altering the size of hair follicles during androgenetic alopecia. 
TGF-ß1 has been observed in organ culture as a strong inhibitor factor of human hair 
growth (Philpott et al., 1990). Androgens induced the production of TGF-ß1 by balding 
dermal papilla cells in vitro (Inui et al., 2002; 2003), and TGF-ß1 delayed catagen 
progression in mice in vivo (Tsuji et al., 2003). Androgens also stimulated balding 
cultured dermal papilla cells to produce TGF-ß2 (Hibino and Nishiyama, 2004) which is 
associated with the transition from anagen to catagen in human hair follicles in vitro 
(Soma et al., 2002). Another study showed that cultured balding dermal papilla cells have 
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the ability to produce inhibitory autocrine factors (Hamada and Randall, 2006). The 
microarray analysis in this thesis showed that the expression level of TGF-ß1 was 
significantly greater (P<0.01) by 1.848 fold in androgen-inhibited scalp hair follicles than 
in those from non-balding scalp (figure 3.56). This supports the earlier view that 
androgen may induce the production of TGF-ß1 in balding scalp follicles which may 
work as an inhibitory factor during androgenetic alopecia causing gradual formation of 
miniaturized follicles. Importantly, this also validates the microarray results. 
 
Stem cell factor (SCF) is known to play a role in the development of epidermal (Williams 
et al., 1992; Grichnik et al., 1998) and hair pigmentation (Geissler et al., 1988; 
Fleischman et al., 1991). Cultured dermal papilla cells derived from beard, balding and 
non-balding scalp secrete SCF (Hibberts et al., 1996b, Randall et al., 2008). Since the 
SCF receptor, c-kit, is expressed in scalp hair follicle melanocytes (Randall et al., 2008), 
this suggests that dermal papilla cells produce SCF to regulate follicular melanocytes and 
therefore alter hair pigmentation. Dermal papilla cells from beard follicles, which 
respond to androgen by producing darker hair in vivo, produce more SCF than those 
derived from non-balding scalp, which is androgen-insensitive (Hibberts et al., 1996b). In 
contrast, cultured cells from balding follicles, which respond to androgens by forming 
smaller paler hairs, secreted less SCF (Randall et al., 2008). This suggests that the 
production of SCF may be increased in beard hair follicles and reduced in balding ones 
under the influence of androgen, leading to formation of differently coloured hairs. In the 
DNA microarray results in this investigation there was a significant decrease (P<0.04) in 
the expression level of SCF in balding scalp follicles compared to the control, non-
balding follicles (figure 3.57). These observations make SCF a good candidate as a 
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paracrine factor produced by dermal papilla cells and controlled by androgens. In 
addition, the strong parallels between the SCF ELISA results from the cultured cells and 
the microarray analysis support the biological relevance of the microarray results. 
 
Insulin-like growth factor-I (IGF-I) was also investigated in this study as a possible 
paracrine factor implicated in androgen-regulation of hair follicle growth, using DNA 
microarray. IGF-I is a potent stimulator mitogen that has been shown to maintain anagen 
scalp hair follicles at different physiological concentrations in vitro (Philpott et al., 1994) 
and stimulate the proliferation of human skin keratinocytes in vitro (Barreca et al., 1992; 
Tavakkol et al., 1992). Previously, Itami et al., (1995b) showed that the production of 
IGF-I was increased in response to androgens in cultured beard dermal papilla cells in 
vitro. They also observed that androgens induced the proliferation of outer root sheath 
cells when co-cultured with dermal papilla cells, but this stimulatory effect was stopped 
when IGF-I was blocked using specific antibodies, indicating IGF-I as an androgen-
regulated stimulator of hair growth in beard follicles. The microarray data analysis of 
androgenetic alopecia follicles revealed that the expression level of IGF-I was 
significantly down-regulated (P<0.02) by 1.762 fold in balding scalp follicles compared 
to the normal follicles (figure 3.58), suggesting that this reduction may occur under the 
effect of androgens. We also found that the expression of insulin-like growth factor-I 
receptor (IGF-IR) was significantly reduced (P<0.002) in isolated balding follicles 
compared with the control follicles by 1.588 fold.  
 
The stimulatory action of IGF-I can be mediated by specific binding protein such as 
IGFBP3, which induces the cellular response to IGF-I, as its binding to the cell surface 
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leading to increased chances of receptor binding (Conover and Powell, 1991; Tesch et al., 
1993). In this study, a dramatic decrease of 1.914 fold in IGFBP3 expression in balding 
follicles at a high level of significance (P<0.001) was also observed (figure 3.59). 
Overall, although these results need further investigation, they do suggest that androgens 
may stimulate the growth of beard follicles by increasing the expression of IGF-I in beard 
dermal papilla cells to produce large follicles, and inhibit scalp hair follicle growth by 
decreasing the production of IGF-I and IGFBP3 in balding scalp follicles compounding 
the reduction of IGF-I and resulting in smaller follicles. 
 
Interleukin-1ß (IL-1ß) is a highly potent inhibitor of the growth of human hair follicles in 
organ culture in vitro (Xiong and Harmon, 1997). When IL-1ß was injected intradermally 
into the back skin of mice, this resulted in stimulation of the apoptosis of hair bulb 
keratinocytes in vivo (Ruckert et al., 2000). In organ culture, IL-1ß induced inhibition of 
human scalp hair follicles in vitro (Hoffmann et al., 1997). When human hair follicles 
were incubated with interleukin-1α (IL-1α), this also led to inhibition of hair follicles 
growth and hair fibre production (Harman and Nevins, 1993). The DNA microarray 
analysis in this thesis revealed that IL-1ß, and IL-1α were significantly up-regulated 
(P<0.04 and P<0.01 respectively) in androgen-responsive follicles of balding scalp 
compared to androgen-insensitive follicles of normal scalp by 1.993 and 1.793 fold 
respectively (figure 3.60). Recently, Kwack and colleagues (2010) found that the level of 
interleukin-6 (IL-6) was higher in conditioned media of balding dermal papilla cells than 
in those from non-balding dermal papilla cells. Following treatment with                       
5α-dihydrotestosterone, it was observed that the expression level of IL-6 was up-
regulated. In addition, injection of IL-6 into the back skin of mice resulted in the 
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induction of the catagen phase, whilst onset of the anagen phase was delayed by 
implantation with agarose beads containing IL-6. The microarray analysis also showed 
that the expression of interleukin-6 (IL-6) was also significantly up-regulated (P<0.03) in 
balding follicles compared to non-balding follicles by 1.861 fold (figure 3.60). These 
observations suggest that these inhibitory factors may be produced by androgen-sensitive 
follicles under the influence of androgen causing inhibition of hair growth. 
 
Vascular endothelial growth factor (VEGF) was also analyzed in the DNA microarray 
results due to its possible role as a modulator of angiogenesis during the hair growth 
cycle and during hair size changes. Anagen hair follicles have a well-developed vascular 
system. Cultured dermal papilla cells were observed to express and secrete VEGF 
(Lachgar et al., 1996c; Hibberts et al., 1996a; Merrick et al., 1999). The expression of 
VEGF has been found at low levels in catagen and telogen scalp dermal papilla cells 
using fluorescent in situ hybridization and confocal laser microscopy (Lachgar et al., 
1996b). This suggests that microvascular angiogenesis may occur at the beginning of 
every new anagen stage in the presence of VEGF. In the DNA microarray analysis, the 
expression of VEGF was significantly reduced (P<0.03) in androgen-responsive follicles 
of balding scalp with a decrease of 1.57 fold. This fits with the gradual changes in the 
size of androgen-responsive hair follicles, for instance during puberty, being reflected in 
the different size of their blood vessels (Montagna and Ellis, 1958). The secretion of 
VEGF was stimulated by androgens in both rodent and human androgen-sensitive 
prostate cancer (Joseph et al., 1997). In patients undergoing androgen deprivation therapy 
for prostate cancer, the levels of VEGF were decreased compared to its level prior to 
treatment (Aslan et al., 2005). Based on these observations, VEGF secretion seems to be 
- 267 - 
 
regulated by androgen in prostate, suggesting VEGF to be a potential paracrine factor 
involved in androgen-modulation of hair follicles.  
    
Since HGF may play a role as a powerful modulator of hair growth and be involved in 
morphogenesis and cycling (Jindo et al., 1995; Lindner et al., 2000), the expression of 
HGF and its receptor, c-Met, were focused on in the DNA microarray analysis to see if 
their expression was decreased or absent in balding scalp hair follicles compared to non-
balding ones. Following data analysis using the t-test, it was observed that the gene 
expression levels for HGF and its receptor, c-Met, were both significantly down-
regulated (P<0.04 and P<0.03 respectively) in androgen-dependent hair follicles of 
balding scalp compared to normal follicles of non-balding scalp (figures 3.62). The 
expression level of HGF in was suppressed by 1.756 fold whereas the expression of c-
Met had a decrease of 1.584 fold.  
 
These observations were then validated using another comparative method, quantitative 
real-time PCR. This method was initially developed using another set of non-balding 
follicles as matched balding and non-balding samples are too valuable to be used in new 
methods. Initially, specific forward and reverse primers for each gene were designed by 
selecting them from the exon part of the genomic sequence of the target gene to ensure 
that the correct-sized product would only be obtained from cDNA and not from any 
contaminating genomic DNA sequence that might be present in the PCR mixture. The 
designed primers for each gene were checked by comparing them with the specific 
human gene sequence of the target gene using the NCBI BLAST programme. The 
housekeeping protein, GAPDH, was used as an endogenous control. SYBR Green was 
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used in each reaction as a DNA binding dye to give the fluorescence signal. Initially, the 
designed primers for GAPDH, HGF and c-Met were optimised using the gradient feature 
of the real-time PCR detection system. The cDNA template used for the optimisation 
reactions was generated from human reference RNA because it is readily available and 
easy to prepare compared to the human hair follicle cDNA, which is very valuable, due to 
the limited sample availability and time consuming to prepare, because of the difficult 
hair follicles isolation prior to cDNA preparation and synthesis. The optimal temperatures 
for GAPDH, HGF and c-Met primers, which gave the highest signals and yielded the 
lowest cycle threshold values, were 60.5°C, 58.3°C and 56.8°C respectively (table 3.64). 
It is evident from figure 3.66 that the melt curves for both HGF and c-Met only contained 
a single peak, indicating that these reactions generated only one product for each target 
gene and no contaminating products were present. Thus, this demonstrated that the genes 
for both HGF and its receptor, c-Met, were expressed in isolated anagen hair follicles 
from non-balding scalp from all five experimental samples as seen in figure 3.66.  
 
Due to the limited sample availability from the androgenetic alopecia patients and the 
lower yield of total RNA, the extracted total RNA from all six samples was amplified to 
produce high-quality RNA for use in quantitative real-time PCR. The melt curves and 
agarose gel electrophoresis for HGF and c-Met in both balding and non-balding samples 
(figures 3.72 and 3.74) confirmed the absence of any contaminating products and 
confirmed there was only one band of the expected size (144bp) for HGF and (152bp) for 
c-Met confirming that the PCR products for both genes were produced from the 
amplification of cDNA. The relative gene expression levels of HGF were significantly 
(P<0.01) much lower in the small follicles from androgen-responsive balding scalp 
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(2.452 ± 0.356) than those from the larger androgen-insensitive normal scalp follicles 
(5.498 ± 0.278) (figures 3.73 and 3.75), supporting the DNA microarray results. The 
relative expression level of c-Met was also significantly down-regulated (P<0.01) in 
balding follicles (1.203 ± 0.202) when compared to its expression non-balding follicles 
(3.895 ± 0.368), confirming the observations of DNA microarray.   
  
Thus, both the DNA microarray and quantitative real-time PCR demonstrated that the 
levels of expression of both HGF and c-Met genes are reduced in miniaturised scalp 
follicles in men with androgenetic alopecia. These findings support the original 
hypothesis and suggest that androgens may have an inhibitory effect on the gene 
expression of HGF and its receptor, c-Met, in androgen-responsive balding scalp follicles 
leading to a reduction in the stimulatory action of HGF as a hair-growth-promoting 
factor. These results in combination with the identification of HGF and c-Met gene 
expression only in the dermal papilla suggest that reducing the production of HGF by 
dermal papilla scalp follicle cells under the influence of androgens may result in the 
formation of smaller or miniaturised follicles by an autocrine mechanism, whereas HGF 
in normal scalp may have a role in maintaining large hair follicles. Thus, HGF is a good 
candidate for involvement in androgen-modulated hair growth as a paracrine factor 
produced by the dermal papilla cells. Interestingly, HGF was also differently expressed in 
cultured dermal papilla cells derived from human non-balding and balding scalp and 
beard skin (Merrick, 2000). HGF expression was very low in balding scalp dermal papilla 
cells, whereas beard cells showed a greater HGF expression than a non-balding scalp 
cells in line with this study.  
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The investigation then moved on to examine whether another hepatocyte growth factor 
family member, MSP, a possible hair growth regulating paracrine factor, and its receptor, 
RON, could be reduced in androgen-sensitive follicles of androgenetic alopecia scalp 
compared to normal follicles, using the DNA microarray method. Exposure to different 
concentrations of MSP has resulted in increased human hair follicle length in vitro, and 
stimulated telogen follicles of mouse skin to enter anagen phase in vivo (McElwee et al., 
2004). Another study observed that MSP stimulated mouse epithelial cell growth in vitro 
(Wang et al., 1996b). The microarray analysis showed that the expression of both MSP 
and its receptor, RON, were considerably reduced (P<0.05) in balding scalp hair follicles 
compared to non-balding scalp hair follicles by about 1.803 and 1.644 fold respectively 
(figure 3.63).  
        
The findings of gene microarray analysis were then validated using the quantitative real-
time PCR in which MSP and its receptor, RON, were amplified using specific primer 
sequences for each gene which optimised initially to obtain the optimal annealing 
temperatures which were 58.3°C and 60.5°C respectively (figure 3.65). The melt curves 
and agarose gel electrophoresis for MSP and RON in both balding and non-balding 
samples confirmed the absence of any contaminating products and confirmed there was 
only one band of the expected size for MSP (166bp) and RON (117bp) confirming that 
the PCR products for both genes were produced from the amplification of cDNA (figures 
3.76 and 3.78). The relative expression levels of both MSP and its receptor, RON, were 
significantly reduced (P<0.03 and P<0.04 respectively) in androgen-dependent hair 
follicles of balding scalp (3.461 ± 0.744 and 1.596 ± 0.458 respectively) compared to 
androgen-insensitive follicles of non-balding scalp (9.851 ± 0.996 and 4.599 ± 0.359 
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respectively) (figures 3.77 and 3.79) supporting the microarray observations. This is 
similar to an earlier report by Shorter (2007) who was unable to detect MSP in isolated 
human hair follicles of balding scalp using RT-PCR.   
 
The differential expression of MSP and its receptor, RON, between small androgen-
responsive follicles of balding scalp and large androgen-insensitive follicles of normal 
scalp, suggests that androgens have suppressed the expression of these genes in vivo. 
Therefore, these results support the original hypothesis that androgens may also inhibit 
the gene expression for MSP and its receptor, RON, in androgen-dependent follicles of 
balding scalp, resulting in a decrease in the stimulatory effect of MSP as a hair growth 
promoter. Therefore, decreasing the production of MSP in androgenetic alopecia under 
the effect of androgens may lead to the formation of smaller hair follicles. However, this 
mechanism appears to be more complex than HGF and c-Met, because in contrast to 
HGF and c-Met whose expression was restricted to the dermal papilla, MSP and RON 
were found in both dermal papilla and epithelial cells of the follicle. 
 
Further work could be done to confirm that HGF and MSP have an effect on hair follicle 
growth using silencing RNA (siRNA) approach (Chen and Zhaori, 2010; Atkinson et al., 
2010) in isolated human scalp hair follicle organ culture (Shorter et al., 2008). This 
would aim to block the synthesis of HGF or MSP taking place by binding the mRNA 
with a complementary sequence. If HGF or MSP are necessary for hair follicle growth, it 
would be expected that hair growth in organ culture would be inhibited.   
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Another experiment could be applied to examine the role of hepatocyte growth factor 
family members, HGF and MSP, in androgen-regulation of hair growth by measuring the 
gene expression levels of these molecules in human cultured dermal papilla cells in the 
presence, and absence, of testosterone in vitro. The influence of testosterone on the 
expression of these molecules can be intercepted using anti-androgens for example 
cyproterone acetate. This is a difficult experiment to carry out because the cells would 
need to be derived from follicles which are sensitive to androgens for example beard or 
androgenetic alopecia follicles. These are now very difficult to obtain.  
 
Another experimental method could be done to confirm the effect of HGF and MSP on 
hair follicle growth in vitro using different concentrations of recombinant human HGF or 
MSP in the growth media, whereas control follicles should receive PBS instead. Hair 
follicle length should be measured everyday to see if there is any difference in their 
length comparing to control ones. The effect of these molecules on hair follicle length 
could be examined further by blocking their effects using specific antibodies. 
 
From the work in this thesis, it is clear that androgenetic alopecia involves reduction in 
the expression of a range of genes including HGF family members. Whether these genes 
are directly regulated by the androgen-androgen-receptor complex or altered as a result of 
an earlier response gene such as a transcription factor is currently unclear. Chromatin 
immunoprecipitation (CHIP) technique (Nelson et al., 2006) could be used to identify 
androgen binding sites in androgen regulated genes. It is based on precipitating a protein 
antigen out of solution using an antibody that specifically binds to that particular protein. 
CHIP is used to investigate the interaction between protein and DNA in the cells through 
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determining whether specific proteins are associated with specific genomic regions such 
as transcription factors on promoters or other DNA binding sites. Using this method, the 
androgen receptor would be selectively immunoprecipitated from a chromatin 
preparation using anti-AR antibodies to identify the DNA sequences associated with it. 
This should establish whether HGF family members or other genes identified in this 
thesis are directly regulated by androgens. Again the difficulty will be in obtaining 
sufficient androgen-sensitive human material to carry out these exciting studies.   
 
To conclude, the data provided in this thesis support the view that androgens may exert 
their effect on the hair follicle via its dermal papilla cells altering their production of 
paracrine factors, some of which are stimulatory and some of which are inhibitory. It is 
clear from the microarray analysis that the changes are not due to a simple switch on or 
off of a single factor or factors, but rather involve modulation of a range of factors. It is 
not surprising that this mechanism is complex, since the hair follicle is a complicated 
organ involving a range of cell types and regressive and regenerative processes during the 
hair cycle. All these processes need to be maintained to keep producing hairs even if the 
type, size and colour of the hair produced is altered due to androgen influence. These 
factors may target different follicular components resulting in changes in the type of hair 
produced. An equilibration between these stimulatory and inhibitory factors is required 
for hair follicle maintenance and normal hair production. Disruption of this balance may 
lead to disorders of hair growth such as androgenetic alopecia and hirsutism. Better 
understanding of the roles of these factors in androgen-regulating hair growth could lead 
to better treatments of hair disorders.   
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Appendix I 
 
Preparation of solutions for Sacpic staining:  
Celestine blue:  
Celestine blue (2.5g) was added to 5% aqueous solution of Ferric ammonium sulphate 
(500ml), this was boiled for 3 minutes, cooled and filtered. Glycerol (70ml) was then 
added and mixed well. 
Safranin:  
Safranin (6g) was added to Ethanol/H2O (1:1) (300ml), the solution was mixed 
thoroughly and filtered before use. 
Picric acid/ethanol:  
Saturated picric acid alcoholic solution (5ml) was added to absolute ethanol (300ml) and 
mixed thoroughly.  
Picro-indigo carmine: 
Indigo carmine (1g) was added to saturated picric acid aqueous solution (300ml) and 
mixed thoroughly. 
Scott's tap water:  
Potassium bicarbonate (2g) and magnesium sulphate (20g) were added to distilled water 
(1L) and mixed thoroughly. 
Gills haematoxylin: 
Haematoxylin (2g), sodium iodate (0.2g), aluminium sulphate (17.6g), and ethylene 
glycol (250ml), were added in order to distilled water (370ml) with glacial acetic acid 
(20ml). This was mixed on a magnetic stirrer for 1 hour at room temperature.  
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Appendix II 
 
Human reference total RNA: 
The universal human reference RNA (Stratagene, UK) is comprises a collection of total 
RNA pooled from ten different cell lines for an optimal broad coverage of human genes. 
Quantities of RNA from the individual cell lines optimized to maximize representation of 
gene transcripts present in low, medium, and high abundance.                                              
 
Human reference total RNA cell line derivations:  
 
1- Adenocarcinoma, mammary gland 
2- Hepatoblastoma, liver 
3- Adenocarcinoma, cervix 
4- Embryonal carcinoma, testis 
5- Glioblastoma 
6- Melanoma, skin 
7- Liposarcoma 
8- Histiocytic lymphoma, histocyte 
9- Lymphoblastic leukemia, T lymphocyte 
10- Plasmacytoma, myeloma, B lymphocyte 
 
 
 
 
 
 
 
 
 
